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ABSTRACT
During the last decade, the use of herbal medicine has expanded globally and gained
popularity. With the tremendous expansion in the use of herbal medicine worldwide, safety and
efficacy as well as quality control of herbal medicines have become more and more issues of
concern for both health authorities and the public. Although herbal medicine has been in use for
hundreds to thousands years, very limited science-based data exist to explicit its chemical
constituents, pharmacological activities and toxicity. Therefore, lack of scientific evidence for
herbal medicine usage elicits the need for systematic studies of herbal medicine, including
phytochemical, analytical, and biological investigation
Two projects are included in the dissertation. The first one is the “Science Based
Authentication of Dietary Supplements - Studies of Scutellaria Species on the Chemical
Constituents, Analytical Method, and Biological Activities”.

The second project is the

“Phytochemical Investigation of Pfaffia paniculata Kuntze”. American skullcap (Scutellaria
lateriflora L.), belonging to the family Labiatae, is native to North America and was used as a
tonic, tranquilizing, and antispasmodic remedies. Since 1989 safety concerns about American
skullcap were raised due to the reports of hepatotoxic reactions after skullcap-containing
preparations were ingested.

Therefore, this plant was listed in the FDA Poisonous Plant

Database and has been classified as an “Herb of Undefined Safety”. Meanwhile, it was reported
to be adulterated with germander, e.g. Teucrium chamaedry, and T. canadense, which is a group
of plants with hepatotoxicity. Very few studies have been previously reported associated with
iii

the quality control, toxicity investigation, and pharmacological activities of this herbal medicine
as well as compounds isolated from it. The primary objective of this project is to explore the
chemical constituents of American skullcap, which will be used as reference markers to develop
a validated chemical fingerprinting method for the differentiation of it from its adulterant,
germander.

From the MeOH extract of the aerial parts of this plant sixteen compounds,

including three minor coumarins in which two are new, six flavonoids, four triterpenes, two
steroids, and one fatty acid were isolated and characterized. In order to compare the similarity of
chemical components between American skullcap and Chinese skullcap (S. baicalensis), also to
obtain more marker compounds, the chemical components of Chinese skullcap, which is the
most often used herb medicine in this genus, were also studied and seventeen flavonoids have
been isolated. Based on the chemical constituents, a simple HPLC-PDA fingerprinting method
was developed, which can be used to authenticate S. lateriflora species, to distinguish it from its
potential adulterants, to compare the chemical profiles of related species in this genus, and to
assess the quality of commercial products claiming to contain S. lateriflora. In the present study
three classes of compounds, including eleven flavonoids isolated from two Scutellaria species
mentioned above and two phenylpropanoids, as well as one diterpene isolated from T.
canadense, were used as markers simultaneously to provide comprehensive analysis for the
above mentioned purposes. As part of the efforts of this project, a HPLC/ESI-MSn method was
established which allowed a fast characterization of thirteen flavonoids and one stilbene
derivative from American skullcap without time-consuming isolation of compounds even if
iv

reference compounds are not available. The biological activities of the two skullcap extracts and
thirteen flavonoids isolated from them were evaluated on a panel of bioassays, including
cytotoxicity, antioxidant, anti-inflammatory, estrogenic activity and activations on peroxisome
proliferator-activated receptor-alpha and -gamma (PARP

and PPARγ).

Neither skullcap

extracts nor pure compounds tested showed cytotoxicity against a panel of mammalian normal
and solid tumor cell lines at the tested concentrations. During the investigation of chemical
constituents of American skullcap no neoclerodane diterpenes, which are responsible for the
hepatotoxicity in germander (Kouzi et al., 1994), were found. Taken together, these evidences
suggest that the reports of hepatotoxic reactions on American skullcap might very likely be due
to its adulterant germander. In the present bioassay study, the most significant finding was the
identification of PPARs activation of skullcap extracts as well as several characteristic
flavonoids, such as baicalein, baicalin, wogonin, and chrysin etc. that provides some information
on possible new application of skullcap, especially American skullcap, for the treatment of
diabetic-related diseases. Also the potent activity of these flavonoids on PPARs suggests the
potential of these flavonoids as leads for PPARα and PPARγ agonists.
P. paniculata Kuntze, belonging to the family Amaranthaceae, is a large, rambling,
shrubby ground vine with an intricate, deep, and extensive root system. It is the most employed
species in commercial preparations in Brazil as “Brazilian ginseng” and has been commonly
used for three centuries with the same indications as American and Asian ginseng. More than
fifty preparations, which contained or were produced from plant P. paniculata are available on
v

USA market, but no analytical method(s) existed to assess the quality of P. paniculata raw
materials, and the products claiming to contain P. paniculata. In order to develop an appropriate
validated quantitative analytical method for the quality control of this plant material and dosage
form the detailed phytochemical investigation of P. paniculata was carried out. Two new
nortriterpenoids pfaffine A and B, one new compound pfaffine C, along with eleven known
compounds were isolated and identified from the roots of this plant. These compounds will be
used as markers for quality control of raw materials of P. paniculata as well as products claiming
to contain this species.
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First Project

Studies on Scutellaria Species: Chemical Constituents,
Analytical Methods and Biological Activities
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Chapter 1
Introduction

1.1. General background
Traditional medicine is the sum total of the knowledge, skills and practices based on the
theories, beliefs and experiences indigenous to different cultures, whether explicable or not, used
in the maintenance of health, as well as in the prevention, diagnosis, improvement or treatment
of physical and mental illnesses (WHO definition). It involves the use of herbal medicines,
animal parts and minerals, among which herbal medicines are the most widely used. The terms
complementary/alternative

medicine

(CAM),

non-conventional

medicine

are

used

interchangeably with traditional medicine in some countries. During the last decade, use of
traditional medicine has expanded globally and has gained popularity. According to the World
Health Organization (WHO), 80% of the population depends on traditional medicine for primary
health care in some Asian and African countries. In many developed countries, 70% to 80% of
the population has used some form of alternative or complementary medicine (e.g. acupuncture).
With the tremendous expansion in the use of herbal medicine worldwide, safety and efficacy as
well as quality control of herbal medicines have become issues of concern for both health
authorities and the public.
The safety problems associated with herbal medicines may result from adverse effects of
the herbs themselves and/or potential toxicity related to misidentification or mislabeling of the
plant species used in herbal medicines; the use of incorrect parts of plants; adulteration and
contamination with other plant species, undisclosed prescription or over-the-count drugs or
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heavy metals when the necessary naturally occurring plant substances are in short supply or
expensive or when the supplier intends to intensify a specific pharmacologic effect. In these
cases science-based research is needed to provide solid evidence of questionable herbal
medicines in order to ensure that traditional medicine is used properly.
Several methods can be used to be certain that the correct plant species has been
acquired. These methods include taxonomic examination (macroscopic and/or microscopic) or
biochemical [deoxyribonucleic acid (DNA) analysis using polymerase chain reaction (PCR)
techniques] or chemical (chromatographic methods) analysis, or metabolomics study.

The

taxonomic or genetic analysis can only be applied to intact or milled plants and are not possible
for them to deal with plant extracts. Under these circumstances chromatographic methods,
including, but not limited to, high performance liquid chromatography (HPLC), gas
chromatography (GC), capillary electrophoresis (CE), thin-layer chromatography (TLC), can be
used. Among them HPLC coupled with different detectors, such as ultraviolet absorbance (UV)
detector, evaporative light scattering detector (ELSD), or mass spectrometry (MS), are the most
popularly used methods to identify plants used in the herbal medicines.

These methods

commonly analyze a group of “active” molecules or arbitrarily chosen “marker” compounds in
complex plant extracts.

Also, metabolomics can be applied to authenticate the plant raw

materials as well as their products. NMR and MS are currently considered to be the most
universal approaches for metabolomics study. Acquisition of a complete metabolite profile of a
plant through metabolomics allows the identification of the plant species.
applications have been presented recently (Chio et al., 2004; Le Gall et al., 2004)
1.2. Overview of the Scutellaria genus
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Some pioneer

Scutelllaria is a unique cosmopolitan genus of the subfamily Scutellarioideae belonging
to Labiatae (Lamiaceae) family. About 360 species are found spread throughout the world and
in different climate areas (Poton, 1992). There are above 100 species in China and over 90
species in North American.
Essential oils, alcohols (derivatives of phenylethanol) and organic acids (esters and
glycosides of vanillic, syringic, and ferulic acids), iridoids, sesquiterpenes, neoclerodane
diterpenoids, steroids, cardenolides, tannins, and flavonoids have been isolated from the genus
Scutellaria (Chemesova et al., 1993; Plant Resources of the USSR. 1991).

Among them

phenolic compounds and clerodane diterpenoids are the main secondary metabolites reported.
Malikov‟s group published a thorough summary of phenolic compounds isolated and identified
from about 60 species in this genus up to 2002 (Malikov et al., 2002). Additional new phenolic
compounds have been reported from 2002 to 2010. We have updated and summarized these data
in Table 1-1. These reported phenolic compounds include: flavones, flavanones, isoflavones,
chalcones, biflavones, lignoflavones and phenylpropanoid glycosides. The last one, so-called
phenylpropanoids, are biogenetic precursors of flavonoids. These compounds are known to
contain reactive phenolic hydroxyls and carbonyls. These groups of compounds are certainly
interrelated and undergo mutual transformations (Mabry et al., 1975). Owing to the ability to
transform into chalcones and to form quinones, flavonoids are considered to be highly
physiologically active compounds with a wide spectrum of pharmacological activities.

S.

baicalensis is the most commonly used and thoroughly studied species in all aspects in this
genus. Sixty-four phenolic compounds have been isolated from this species. Other species have
been reported as rich sources of flavonoids including S. rivularis, S. indica, S. prastrata, S.
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amoena, and S. discolor from which 38, 33, 29, 28, and 27 flavonoids have been isolated,
respectively. Neoclerodane diterpenoids are the other characteristic compounds in some species.
Bruno et al. reviewed the neoclerodane diterpenoids isolated from this genus up to June 2001,
and reported that 120 natural neoclerodane diterpenoids have been isolated from Scutellaria
species. Thereafter 27 additional new neoclerodane diterpenoids have been reported during
2002-2010 and the data are compiled in Table 1-2. Moreover, 22 new neo-clerodane diterpenoid
alkaloids were reported from S. Barbata recently. Among them, a few compounds have shown
very potent activity against species of Lepidoptera, but whether this activity will be retained
under field conditions is not known. The responses of different species of insects to a specific
neoclerodane vary and small changes to the structural composition of a molecule can
significantly alter its activity (Bruno et al., 2002).
Many species of this genus are extensively used in traditional medical systems of China,
India, Korea, Japan, European countries, and North America.

Among them two species,

including American skullcap (S. lateriflora L.) and Chinese skullcap (S. baicalensis Georgi) are
the most popular ones with different medical uses, respectively.

Besides, Extracts of S.

orientalis are used as anti-hypertensive agents (Zaprametov et al., 1988).
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Table 1-1. The Species Studied and the Number of Phenolic Compounds Reported
species
S. adenostegia Briq.
S. adsurgens M. Pop.
S. alpina L.
S. altaica Fisch. ex. Sweet
S. altissima L.
S. amoena C. H. Wright.
S. araxensis Grossh.
S. baicalensis Georgi.
S. barbata D. Don.
S. columnae L (All)
S. comosa Juz.
S. creticola Juz.
S. discolor Colebr.
S. epilobiifolia A. Hamilt.

number of
compounds
6 (15)
4 (14)
20 (20)
1 (1)
11 (11)
28 (16)
0 (5)
64 (62)
16 (1)
2 (2)
19 (14)
10 (14)
27 (23)
4 (10)

S. galericulata I.
S. glabrata Vved.

4 (23)
6 (7)

S. granulosa Juz.

2 (2)

S. grossa Wall.
S. ikonnikovii Juz.
S. immaculata Nevski
S. incona Spreng.
S. indica L.
S. iskanderi Juz.
S. karjaginii Grossh
S. lateriflora L.
S. litwinowii Bornm. Et. Sint.
S. nepetoides M. Pop.
S. ocellata Juz.
S. oreophila Grossh.

species
S. orientalis L.
S. ovata Hill.
S. oxystegia Juz.
S. peregrina Ldb.
S. phyllostachya Juz.
S. planipes L.
S. polyodon Juz.
S. prilipkoana Grossh.
S. prostrata Jacq. et Benth.
S. przewalskii Juz.
S. pycnoclada Juz.
S. ramosissima M. Pop.
S. rehderiana Diels.
S. repens Buch-Ham, ex D.
Don
S. rivularis Wall.
S. scandens Buch-Ham. ex
D. Don.
S. scordifolia Fisch. ex
Schrank
S. sedelmeyeria Juz.
S. sevanensis Sosn.
S. squarrosa Nevski
S. strigillosa Hemsl
S. supina L.
S. tenax W. W. Smith.
S. tournefortii Benth.
S. transiliensis Juz.
S. ussuriensis (Regel) Kubo
S. virularis Wall
S. viscidulla Bunge
57 species

24 (19)
7 (7)
25 (8)
0 (1)
36 (33)
0 (10)
3 (3)
17 (1)
7 (10)
4 (4)
7 (7)
5 (5)

The number in parenthesis indicates the data reported by Malikov‟s group.
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number of
compounds
12 (6)
7 (7)
3 (3)
0 (1)
16 (7)
21 (13)
17 (13)
0 (1)
29 (30)
17 (18)
0 (16)
11 (11)
10 (7)
14 (14)
38 (28)
17 (16)
2 (14)
0 (3)
19 (19)
6 (6)
15 (15)
0 (19)
9 (5)
0 (4)
0 (6)
2 (2)
0 (2)
13 (7)
635

Table 1-2. The Number of Neoclerodane Diterpenoid Reported in Scutellaria Species
species

number of

species

compounds

number of
compounds

S. albida L.

7

S. hematochlora

1

S. alpine L.

19

S. lateriflora L.

5

S. alpine L.ssp.

8

S. linearis Benth.

4

S. altissima L.

2

Scutellaria parvula Michx.

1

S. baicalensis Georgi.

1

S. orientalis ssp. pinnatifida

5

S. barbata D. Don.

23

S. orientalis ssp sintenisii

2

javalambrensis Pau.

Sausskn. ex Bornm.
Scutellaria luteo-caerulea

5

S. polyodon Juz.

15

S. columnae L (All)

8

S. pontica C. Koch

9

S. cypria Rech. fil. var.

3

S. repens Buch-Ham, ex D.

16

Bornm. & Sint.

cypria

Don

S. cypria Rech. var. elatior

1

S. rivularis Wall.

11

13

Scutellaria rubicunda

2

R. D. Meikle
S. discolor Colebr.

Hornem ssp linneana
(Carnel) Rech.
S. drummondii Benth.

3

S. seleriana Loesen

1

S. galericulata I.

8

S. violacea Heyne ex Wall.

2

S. grossa Wall.

6

S. woronowii Juz.

2

S. guatemalensis

4

American skullcap is native to North America.

It was introduced into American

medicine in 1773 by Dr. Lawrence Van Derveer who used it to treat cases of hydrophobia. The
name of mad-dog herb stems from this. Subsequently, it came to be utilized primarily for its
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reputed tonic, tranquilizing, and antispasmodic remedies. It was introduced officially in The
United States Pharmacopia in the edition of period from 1863 to 1916 and then in The National
Formulary until it was dropped in 1947 (Claus, 1956). In America, skullcap is regulated as a
dietary supplement (DS). Since 1989 safety concerns of skullcap were raised. A report in the
British Medical Journal summarized the observed hepatotoxic effects of the herb in four women
who had been consuming proprietary products supposedly containing skullcap for the relief of
stress (MacGregor et al., 1989). Two cases of “skullcap” poisoning, including one fatality, were
reported from the Risk Hospital in Oslo, Norway, in 1991 (Huxtable, 1992). This plant was
listed in the FDA Poisonous Plant Database (FDA, 2008) and has been classified as an “Herb of
Undefined Safety” (Awad et al., 2003). Studies in Britain showed that many wholesalers there
were substituting germander for skullcap (Phillipson et al, 1984). Germander is a group of
Teucrium species, e.g. T. chamaedry, and T. canadense. The capsules containing germander
were marketed in France as a weight-control supplement and were associated with thirty cases of
hepatotoxicity (Pittler et al., 2003). Germander was banned in France and Italy in 1992. The
only approved use for germander in United State is as a natural flavoring in alcoholic beverages.
The toxicological studies have shown that one of the major neoclerodane diterpenes in
germander, teucrin A, is responsible for the hepatotoxicity. The furan ring moiety of this
diterpene is the key for toxicity. When it was reduced to tetrahydrofuran the hepatotoxicity
disappeared (Kouzi et al., 1994). American Herbal Products Association (AHPA) recommends
that appropriate steps be taken to assure that skullcap raw materials are free of the noted
adulterant, germander.
The root of S. baicalensis is used as a well known traditional Chinese medicine called
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“Huang Qin”. It was documented in an ancient Chinese herbal, “Shen-Nong-Ben-Cao-Jing”, as
a remedy for suppurative dermatitis, diarrhea and inflammatory diseases, and is officially listed
in the Chinese Pharmacopeia and Japanese Pharmacopeia JPXIII.

Traditional Chinese

physicians use it as a remedy for fever, allergic disease and inflammation, especially against
bacterial and viral infections of the respiratory and gastrointestinal tract, i. e., chronic bronchitis,
bacillary dysentery, viral hepatitis, and acute biliary tract infection. Other species, such as S.
amoena C. H. Wright, S. hypericifolia Levl. S. tenax W. W. Smith var patentipillosa (N.-M.) G.
Y. Wu, S. rehderiana Diels. S. viscidula Bge., and S. likiangensis Diels., have been used as
substitute as “Huang Qin” in China (Song et al., 1981). Over 60 phenolic compounds were
isolated from S. baicalensis. Only one diterpene was reported from it (Hussein et al., 1996). The
plant extract as well as some of the phenolic compounds isolated from it demonstrated diverse
bioactivities, including antitumor, antiviral, anti-inflammatory, antibacterial, antiallergic,
antioxidant, and anti-SARS coronavirus activities. But data associated with these bioactivities
are scattered over a huge volume of literature. Here we give a comprehensive review of the
diverse bioactivities of S. baicalensis, the phenolic compounds isolated from it, and preparations
containing this plant species.
Anticancer activity
The root extract of S. baicalensis (SBE) has a broad spectrum of anticancer activity. It
inhibits various cancer cell growths, including hepatocellular carcinoma, cholangiocarcinoma
(Yano et al, 1994), pancreatic carcinoma (Motoo et al, 1994), urothelial carcinoma (Ikemoto et
al, 2000) and breast cancer (So et al, 1997). The results of these early investigations were
substantiated by a series of studies. Ye et al. demonstrated that SBE exhibited a concentration-
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dependent growth inhibitory effects on squamous cell carcinoma (KB, SCC-25), prostate cancer
(PC-3, LNCaP), colon cancer (KM-12, HCT-15), breast cancer (MCF-7) and liver cancer
(HepG2). The inhibition concentration at 50% (IC50) for PC-3, LNCaP, MCF-7, KB, HepG2,
KM-12, SCC-25, HCT-15 was 0.52, 0.82, 0.9, 1.0, 1.1, 1.1, 1.2, 1.5 mg/mL, respectively.
Different types of cancers have different sensitivity to the effect of this herb, with prostate and
breast cancer being most sensitive (Ye et al., 2002).

Because SBE has a strong anti-

inflammatory effect, Zhang et al. tested its anticancer activity on head and neck squamous cell
carcinoma (HNSCC) in vitro and in vivo and investigated its effect on cyclooxygenase-2 (COX2), which converts arachidonic acid to prostaglandin E2 (PGE2) and is highly expressed in
HNSCC.

They found the production of PGE2 was strongly inhibited by SBE in a dose-

dependent manner.

These findings suggested that the anticancer activity of SBE can be

attributed, in part, to its inhibitory effect on PGE2 production via suppression of COX-2
expression and arachidonic acid release from cell membrane (Zhang et al., 2003). Further they
evaluated SBE as an anti-cancer agent both in vitro (in androgen-dependent and androgenindependent cell lines) and in vivo (in nude mice xengrafted with prostate cancer cells) and to
explore its ability to affect both COX-2 and cell cycle regulation pathway. The study, together
with others (Bonham et al., 2005), demonstrated that SBE inhibits androgen-independent
prostate cancer cells (PC-3) more strongly than it ihibits androgen-dependent cells (LCNaP),
which could be viable alternative therapy to prostate cancer patients who fail to respond to
conventional hormone-based treatment.

Another study showed that SBE inhibited the

proliferation of lymphocytic leukemia, lymphoma and myeloma cell lines by induction of
apoptosis associated with the modulation of the bc1 family of genes and mitochondrial damage.
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These results suggested that SBE is a potential anti-cancer agent against these hematological
malignancies (Kumagai et al., 2007).
On the other hand, SBE showed potent activity in combined treatment with standard
anticancer therapeutics as a biological modulator. SBE pretreatment decreased cisplatin-induced
kaolin intake in the rat model of simulated nausea.

It may play a therapeutic role in

chemotherapy-induced emesis (Aung et al., 2003).
S. baicalensis contains three major flavonoids, baicalein, baicalin and wogonin. The
anticancer activity of these compounds have been screened in different cell types (Chang et al.,
2001; Ikemoto et al., 2000; Lee et al., 2005; Ma et al., 2005; Sonoda et al., 2004). Taken
together, the differences in the anti-cancer activities of these flavonoids in different cell lines, in
part, may be cell type specific. For example, several studies implicated 12-lipoxygenase (12LOX) as a regulator of human cancer development. As a 12-LOX inhibitor, baicalein has been
shown to induce apoptosis in human gastric, breast, colon, hepatoma, prostate, and pancreatic
cancer cells (Chan et al, 2000; Chen et al, 2000; Ding et al, 1999; Kuntz et al, 1999; Po et al,
2002; Wong et al, 2001). One study showed that baicalein exerted a concentration-dependent,
growth-inhibitory effect on three cell lines of human hepatocellular carcinoma (HCC). Baicalein
strongly inhibited the activity of topoisomerase II and suppressed the proliferation of all three
cell lines after administration 6 h (Matsuzaki et al., 1996). The mechanisms of antiproliferative
effect of baicalein and related compounds, baicalin, wogonin, esculetin and scoparone, in human
T-lymphoid leukemia cells (CEM cells) were investigated.

The results demonstrated that

baicalein exhibited the greatest antiproliferative activity with an IC50 value of 4.7
a maximal suppression of 91.5

0.5 μM and

1.4 % in CEM cells. The protein tyrosine kinase activity in the
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CEM cells was significantly reduced by baicalein (10-6-10-4 M). The reverse transcriptionpolymerase chain reaction analysis of messenger ribonucleic acid (RNA) levels of plateletderived growth factor-A (PDGF-A) and transforming growth factor-β1 (TGF-β1) demonstrated
that baicalein reduced the PDGF-A messenger RNA (mRNA) level, while less affected the TGFβ1 mRNA. Baicalein exhibited the greater reduction on the expression of PDGF-A mRNA than
esculetin did (Huang et al., 1994).

So, antiproliferative effect of baicalein may be partly

mediated through inhibition of growth-related signal, protein tyrosine kinase, and reduction of
expression of growth factor, PDGF-A. Baicalein also inhibited growth by suppressing the COX2 expression resulting in decreased levels of PGE2 of two HNSCC cell lines SCC-25 and KB
(Zhang et al., 2003). Others have shown that baicalin stimulated activator protein-1 (AP-1) and
nuclear factor-κB (NF-κB) to induce expression of quinone reductase gene; this enzyme may be
able to act as a potential cancer chemopreventive agent by induction of phase II detoxification
enzyme (Park, H.J. et al., 2004). Besides baicalin, wogonin has shown to have an apoptosisinducing activity against human monocytic leukemia cell line THP-1, but not in human fetal lung
normal cells (Himeji et al., 2007).
Antiviral activities
SBE as well as its flavonoids showed anti-human immunodeficiency virus -1 (HIV-1),
anti-hepatitis B (anti-HBV), and anti-respiratory syncytial virus (anti-RSV) activities
(Buimovici-Klein et al., 1990; Ono et al., 1990).
Baicalein was found to be a potent inhibitor of the activities of reverse transcriptases
(RT) of murine leukemia viruses (MLV) and HIV. Under the reaction conditions specified for
each of the MLV- and HIV- reverse transcriptases, both enzyme activities were inhibited by
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more than 90% in the presence of 2 μg/mL baicalein (Ono, K., 1989).
Baicalin produced concentration-dependent inhibition of human T-lymphotropic virus
type-1 (HTLV-1) replication in productively infected T and B cells.

Moreover, baicalin

treatment selectively reduced the detectable levels of HTLV-1 p19 gag protein in infected cells
by 70% at concentrations that produced insignificant effects on total cellular protein and DNA
synthesis with no loss in cell viability. Resistance to HTLV-1 infection and virus-mediated
transformation was noted in uninfected peripheral blood lymphocytes pretreated with baicalin
before cocultivation with lethally irradiated chronically infected cells. Baicalin inhibited reverse
transcriptase activity in HTLV-1-infected cells as well as the activity of purified reverse
transcriptase from Moloney murine leukemia virus and Rous-associated virus type-2 (Baylor et
al., 1992).
The inhibitory effect of baicalin against HIV-1 infection and replication has been studied
in vitro (Kitamura et al., 1998; Li et al., 1993). The results showed that baicalin markedly
inhibited replication of HIV-1 in a concentration-dependent manner in normal peripheral blood
mononuclear cells (PBMC) stimulated with phytohemagglutinin (PHA). The effect was more
pronounced when the cells were pretreated with baicalin. Further, baicalin inhibited HIV-1
replication in PHA-stimulated PBMC from asymptomatic HIV-1-seropositive carries. The 50%
inhibitory concentration for HIV-1 replication was approximately 0.5 μg/mL. At a concentration
of 2 μg/mL of baicalin, copy numbers of HIV-1 proviral DNA were approximately 50 times less
than in untreated controls. In a cell-free infection system, baicalin inhibited the activity of HIV1 reverse transcriptase, but not the activity of human DNA polymerases α and γ (DNA
polymerase β was slightly inhibited). It also did not inhibit HIV-2 or murine leukemia virus RT.
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The mechanism of its anti-HIV-1 activity remains to be determined.

Another study

demonstrated that baicalin, at the noncytotoxic concentrations, inhibited both T cell topic (X4)
and monocyte topic (R5) HIV-1 Env protein mediated fusion with cells expressing CD4/CXCR4
or CD4/CCR5. Furthermore, presence of baicalin at the initial stage of HIV-1 viral adsorption
blocked the replication of HIV-1 early strong stop DNA in cells. Since baicalin did not inhibit
binding of HIV-1 gp 120 to CD4, it was proposed that baicalin may interfere with the interaction
of HIV-1 Env with chemokine correceptors and block HIV-1 entry of target cells (Li et al.,
2000). Baicalin coupling with Zn exhibited lower cytotoxicity and higher anti-HIV-1 activity
without changing its target on HIV-1 RT and on HIV-1 entry compared with baicalin in vitro
(Wang Q. et al., 2004). Combination therapy for AIDs patients has been studied. Synergistic
anti-HIV effects of baicalin with 3′-Azido-2′, 3′-dideoxythymidine (AZT) have been reported
(Inada et al., 1994), suggesting that baicalin might be potentially useful as part of a drug
combination regimen for the treatment of HIV-1 infections.
The difference in HIV-1 reverse transcriptase inhibitory activity between baicalein and
baicalin has been examined. The results indicated that HIV-1 reverse transcriptase inhibitory
activity of baicalein was four times higher than baicalin (Wu et al., 2001). The studies of
structure-activity relationship revealed that the presence of both the unsaturated double bond
between 2 and 3 of the flavonoid pyrone ring, and the three hydroxyl groups introduced on
positions 5, 6 and 7, were a prerequisite for the inhibition of reverse transcriptase activity. In
general, the presence of substituents (hydroxyl and halogen) in the B-ring increase toxicity
and/or decrease activity (Hu et al., 1994; Ono et al., 1990). Lee et al investigated the in vitro
effects of baicalein and baicalin on the three distinctive enzymic activities of the HIV-1 integrase
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- endonucleolytic, integration, and disintegration activity. They found that both compounds
inhibited the three enzymatic activities in a dose-dependent manner.

The 50% inhibitory

concentrations of baicalein and baicalin for endonucleolytic activities of HIV-1 integrase were
4.4, 3.3 and 25.9, 4.0 μM, respectively. In general, baicalein exhibited nearly 6- to 10-fold
stronger inhibition than baicalin for the three enzymic activities. These data demonstrated that
baicalein or baicalin can be used as a leading compound to develop anti-acquired immune
deficiency syndrome (anti-AIDS) chemotherapeutic agents targeting the HIV-1 integrase (Lee
M.J. et al, 2003).
SBE displayed anti-HBV effects at non-toxic dose, with inhibition percentage of
41.3±2.5 (p<0.001). Further study showed that the three major components (i.e., baicalein,
baicalin, and wogonin) extracted from S. baicalensis displayed the most effective anti-HBsAg
activities with inhibition percentage of 14.6±2.9, 19.5±3.4, and 45.4±2.7 respectively, at a dose
of 20 µg/mL. Only wogonin can suppress HBV surface antigen production (p<0.001) without
evidence of cytotoxicity. The latter action was confirmed by measuring an endogenous HBV
DNA polymerase repairing activity, since both the relaxed circular and linear forms of HBV
DNA are significantly reduced in the wogonin-treated group (Huang et al., 2000).
70% EtOH extract of S. baicalensis showed potent antiviral activities against RSV with
IC50 22.8 μg/mL and with selective index (SI=IC50/CC50) 1.7. Further purification of the active
extract of S. baicalensis led to the identification of wogonin and oroxylin A as the most potent
anti-RSV components. Their IC50 values were 7.4 μg/mL and 14.5 μg/mL, and SI values were
16.1 and 4.0, respectively (Ma et al., 2002). This data offered scientific support and chemical
basis for the traditional uses of this herb to relieve viral infection in the upper respiratory tract.
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Anti-inflammatory activity
The methanol extracts of S. baicalensis, S. rivularis and their major constituents,
including baicalein, baicalin and wogonin, possessed anti-inflammatory activity in vivo in
several animal models of inflammation, including carrageenan-induced paw edema and
adjuvant-induced arthritis in rats (Krakauer et al., 2001; Kubo et al., 1984; Lin et al., 1996; Park
S. et al., 2004). The anti-inflammatory action has been reported to be partly due to inhibition of
leukotriene synthesis by lipooxygenase in leukocyte (Butenko et al., 1993; Kimura et al., 1987).
Further investigations showed that these flavonoids possessed the inhibitory effects of
cyclooxygenase-2 and inducible NO synthase (iNOS) expression in the lipopolysaccharide
(LPS)-stimulated mouse macrophage cell line, RAW 264.7 (Chi et al., 2001; Kim et al., 1999;
Wakabayshi et al., 2000). Among them, wogonin was found to be one of the most potent
suppressors.

Wogonin

produced

dose-dependent

inhibitory

effects

on

12-O-

tetradecanoylphorbol-13-acetate (TPA) induced COX-2 expression, and prostaglandin E2 (PGE2)
production on the dorsal skin of mice. When applied topically (250-1000 μg/3 days) to the
dorsal skin of mice, wogonin inhibited COX-2 expression and PGE2 production induced by
multiple treatment with TPA.

At a dose of 200 μg/site/treatment, wogonin caused 55.3%

reduction of PEG2 production on the dorsal skin compared with an increased production in the
ATP-treated control group. It also significantly inhibited mouse ear edema induced by TPA in
both preventive (58.1% inhibition) as well as curative treatment (31.3% inhibition) schedules at
200 μg/ear/treatment. Also wogonin exhibited preventive effect against ethanol-induced gastric
mucosal damage in rats by either anti-inflammatory effects through dual actions on arachidonic
acid

metabolism,

i.e.,

induction

of

prostaglandin
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D2

and

suppression

of

5S-

hydroxyeicosatetraenoic acid (5S-HETE), or preventive induction of profuse apoptosis in the
stomach (Park, S. et al., 2004). Wogonin was the only flavonoid proved to down-regulate COX2 expression in mouse skin induced by TPA treatment (Park et al., 2001). In addition to
inhibition of inflammation-associated enzymes, such as cyclooxygenases (COX) and
lipoxygenases, these flavonoids have been found to regulate the expression level of several
inflammation-associated genes.

For instance, baicalin inhibited the production of various

cytokines from human peripheral blood mononuclear cells induced by super-antigen treatment
(Krakauer et al., 2001). Wogonin was also found to possess significant suppression on several
inflammatory-associated genes expression in intact as well as in the TPA-induced inflamed
mouse skin. It potently reduced COX-2 and tumor necrosis factor (TNF)-а gene expression
while intercellular adhesion molecule (ICAM)-1 and interleukin (IL)-1β were weakly affected.
Therefore, from these results, it is suggested that the modulation of preinflammatory gene
expression may be one of the in vivo action mechanisms of anti-inflammation by wogonin.
Investigations reported, all together, give a scientific basis for using Scutellairae species as a
source for anti-inflammatory agents (Chi et al., 2003).
Antioxidant activity
SBE could inhibit lipid peroxidation in rat liver homogenate (Kimura et al., 1981) and in
beef heart mitochondria (Hodnick et al., 1994). Antioxidant effects of SBE have been traced to
several of its flavones, which include baicalein, wogonin, scullcapflavone I and II (Kimura et al.,
1982; Takaji et al., 1980). Several results suggested that baicalein could inhibit iron-dependent
lipid peroxidation in microsomes (Gao et al., 1995). It was suggested that baicalein might be
exerting its protective effect through chelation of metals. Baicalein could also scavenge reactive
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oxygen species (ROS) such as hydroxyl radicals (·OH), superoxide anion radicals (·O2-)
(Hamada et al., 1993) and singlet oxygens (Criado et al., 1995). When a hypoxanthine (HX)xanthine oxidase (XOD) system was used for generation of O2-, baicalein inhibited XOD
(Hanasaki et al., 1994). This observation is consistent with an early study (Chang et al., 1993),
in which baicalein behaved as a non-competitive inhibitor of XOD. Further direct free radical
scavenging abilities of baicalein, baicalin, wogonin and wogonin glucuronide were examined by
electron spin resonance (ESR) spectrometry method. The results showed that the direct free
radical scavenging abilities of the four flavonoids decreased in the order of baicalein > baicalin >
wogonin > wogonin glucuronide. Baicalein and baicalin were shown to protect several types of
tissues against damage caused by ROS. With an o-di-hydroxyl group in the A ring, baicalein and
baicalin are much better free radical scavenger than wogonin and wogonoside. The direct free
radical scavenging abilities of baicalein and baicalin on alkyl radical and 2,2-diphenyl-lpicrylhydrazyl (DPPH) radical suggested that flavonoid with o-di-hydroxyl structure in the A
ring was an effective radical scavenger (Gao et al., 1998; 1999; 2000). Morimoto et al identified
a mechanism capable of consuming large amount of H2O2 via a peroxidase reaction that oxidizes
baicalein to 6,7-dehydrobaicalein (Morimoto et al., 1998). Kim et al reported that S. baicalensis
prevented neuronal cell death in the hippocampal CA 1 region induced by a four-vessel
occlusion (Kim et al., 2001), and attenuated apoptosis by inhibiting protein oxidation in a H2O2treated neuronal cell line (Choi et al., 2002). Based on the radical quenching and antioxidative
effects, baicalein could inhibit hippocampal neuronal death induced by 5 min of cerebral
ischemia in gerbils (Hamada et al., 1993), and baicalin, as a biological response modifier,
promoted the repair of DNA single strand breakage caused by H2O2 in cultured NIH3T3
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fibroblasts (Chen X. et al., 2003). Also, wogonin was reported to have a protective effect on
neuronal cells damaged by oxygen and glucose deprivation in rat hippocampal slices in culture
(Son et al., 2004), and could inhibit ischemic brain injury in a rat model of permanent middle
cerebral artery occlusion (Choi et al., 2002). In addition, baicalein as well as baicalin could
reduce cytotoxicity of amyloid β protein in PC12 cells, possibly by reduction of oxidative stress;
hence these flavonoids may be useful in the chemoprevention of Alzheimer‟s disease (Heo et al.,
2004).
Antibacterial activity
The water extracts of S. baicalensis were found to have growth-inhibition activity against
Salmonella typhimurium. The mechanism might be due to the fact that SBE could stimulate the
transcription of polyphosphate kinase, especially, in the early growth-stage of S. typhimurium
(Hahm et al, 2001).
In 1981, five flavonoids, including baicalein, baicalin and wogonin etc. isolated from S.
baicalensis, were tested against several strains of bacteria, including Escherichia coli IFO 3301,
Saracina lutae RIMD 3232, Bacillus subtilis IAM 1521, and Staphylococcus aureus 209P. It
was found that compound VIII [2(S)-5,7,2′,6′-tetrahydroxyflavanone] and baicalein had
antibacterial activity at a concentration of 250 μg/ mL (Kubo et al., 1981). Although baicalin
used alone showed only moderate antibacterial activity against Staphylococcus aureus,
significant synergistic activities against both methicillin-resistant Staphylococcus aureus
(MRSA) and penicillin resistant S. aureus in combination with β-lactams were observed. When
combined with 16 μg/mL baicalin, minimum inhibitory concentrations (MICs) of benzypenicillin
against

methicillin-resistant

Staphylococcus
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aureus

(MRSA)

and

penicillin-resistant

Staphylococcus aureus were reduced from 125 and 250 μg/mL to 4 and 16 μg/mL, respectively.
This activity of baicalin was dose-dependent. Viable counts showed that the killing of MRSA
and β-lactam-resistant S. aureus cells by 10 to 50 μg/mL ampicillin, amoxicillin,
benzylpenicillin, methicillin and cefotaxime was potentiated by 25 μg/mL baicalin. Therefore,
baicalin has the potential to restore the effectiveness of β-lactam antibiotics against MRSA and
other strains of β-lactam-resistant S. aureus (Liu et al., 2000). In view of its limited toxicity,
baicalin offers potential for the development of a valuable adjunct to β-lactam treatments against
otherwise resistant strains of microorganisms.
Antiallergic activity
Leukotrienes (LTs) were reported to support various cell growths, and basophil as well as
its precursor numbers increased in atopic patients (Reilly et al., 1987). Baicalein was found to
inhibit the production of LT B4 by human alveolar macrophages (Sakamoto, K. et al., 1980).
The antiallergic effect of baicalein on human basophil growth in vitro was examined using
different basophilic cells and shown that two-week cultured numbers of basophilic cell were
inhibited by baicalein (1-100 μM) in a dose-dependent manner (Tanno et al., 1989; 1991).
Further study was performed to examine the effects of baicalein on the proliferation and the
differentiation of human basophilic leukemia cell line KU812F.

The results showed that

baicalein suppressed the growth of basophilic leukemia cell at a concentration of approx. 10 μM,
and suggested that baicalein may affect allergic diseases by suppressing the growth and the
differentiation of basophils/mast cells (Tanno et al., 1994). Koda and his colleagues reported the
anti-allergic drug disodium cromoglycate (DSCG) and disodium baicalein 6-phosphate, which
suppressed the increase in capillary permeability caused by 48 h homologous passive cutaneous
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anaphylaxis (PAC) in rats, inhibited not only hyaluronidase activity in vitro but also the
activation of hyaluronidase induced by PAC in a dose-related manner. They suggested that
potent hyaluronidase inhibitory substances might have anti-allergic effects (Kakegawa et al.,
1992; Sakamoto, K. et al., 1980). The anti-allergic activity of baicalein was also evidenced from
the facts that it inhibited the histamine release from rat peritoneal exudate cells induced by
antigens, compound 48/80 and calcium ionophore A-23187, and from its inhibitory effect on
Shultz-Dale reaction using sensitized guinea pig ileum (Kakegawa et al., 1992).
Other activities
SBE was observed to have a specific inhibitory effect on CYP1A1/2 among cytochrome
P450 (CYP) enzymes involved in aflatoxin B1 (AFB1) metabolism by rat and human
microsomes (Kim et al, 2001). Further studies indicated that baicalein and wogonin might have
beneficial effects against benzo(a)pyrene- and AFB1-induced toxicities (Ueng et al, 2003). Also
baicalein inhibited hepatic testosterone 6-hydroxylation (CYP3A4) activity with an IC50 of 17.4
μM (Kim et al., 2002).

Baicalin had protective effects on acetaminophen (AP)-induced

hepatotoxicity. The hepatoprotective effects of baicalin against AP overdose may be due to its
ability to block the bioactivation of AP by inhibiting CYP2E1 expression (Jang et al., 2003).
Seki et al reported that the lipogenesis in the hamster sebaceous glands was suppressed 54% by
10-4 M wogonin. Thus, the therapeutic effects of experimentally used SBE for acne vulgaris
could be due to inhibition of lipogenesis by its active ingredients such as wogonin (Seki et al.,
1993).
Chinese skullcap and its principal active flavonoids exhibit diverse bioactivities,
including anticancer, antiflammatory, antiviral, antioxidation, antiallergic, and antibacteria
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activities, but the mechanisms of these activities have not been completely elucidated yet.
Beside baicalein and baicalin some minor components might have others special bioactivities
and should been investigated in the future.
1.3. Objectives of the dissertation
In America, the marketing of dietary supplement has grown dramatically following the
passage of the Dietary Supplement and Health Education Act (DSHEA) in 1994. Based on the
National Health Statistics Reports published in 2008, approximately 38 percent of adults and
approximately 12 percent of children in the United States are using some form of DS. The
annual sales exceed $23 billion. As use of these products increases, so does the potential for
adverse effects. The data provided by National Poison Control Center showed that the number
of adverse reaction reports increased steady each year since 1994, and the total number of such
reports was 35,400 from 1994 to 1999. In the circumstances, more and more attention has been
attracted from the government agencies, academic institutions, as well as industry. Great effects
have been made to prevent consumers from unsafe products. For example, the American Herbal
Products Association (AHPA) listed the known potential adulterants that have been encountered
in trade (see Table 1-3), and recommends that appropriate steps be taken to assure that the listed
raw materials are free of the noted adulterant; FDA set up the Poisonous Plant Database to list all
plants which have shown some possible toxicity. Also, FDA supported NCNPR by means of
funds appropriated by the U.S. congress to develop authentication, identification tools and
evaluate the safety of botanical dietary supplements in a broad range of fields including
cultivation, taxonomy, microscopy, chemical analysis, genetic fingerprinting, safety evaluation
and absorption, distribution, metabolism, and excretion (ADME) studies. Two projects of my
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dissertation are part of these efforts.
The objectives of the first project
In America there are many skullcap dietary supplement products on the market. As
mentioned in section 1.2., this plant species has been classified as “Herb of Undefined Safety” by
the FDA due to the reports of hepatotoxic reactions after skullcap-containing preparations were
ingested. Meanwhile, it was reported to be adulterated with germander, which is a group of
plants with hepatotoxicity, e.g. Teucrium chamaedry and T. canadense. But only limited data
associated with its chemical & pharmacological aspects are available. Therefore, the objectives
of this project was to explore the chemical constituents in it, to develop a reliable analytical
method(s) for the differentiation of skullcap from germander, to evaluate the toxicity as well as
bioactivities of the crude extract and compounds isolated from it.

Taken together, all

information generated here would be useful to solve the problems encountered with this herb and
to provide solid scientific support for the traditional usages of this plant.

22

Table 1-3. Ten Commonly Used BDS and Their Potential Adulterants (AHPA)
No.
1

herb in commerce

adulterant

Eleuthero root (Eleutherococcus

Periploca sepium root

senticosus)
2

Plantain leaf (Plantago lanceolata)

Digitalis lanata leaf

3

Skullcap herb (Scutellaria lateriflora)

Germander herb
(Teucrium chamaedrys)

4

Stephania root (Stephania tetrandra)a

Aristolochia fangchi root

5

Asian species of Cocculus spp.,

Aristolochia fangchi root

Diploclisia spp., Menispermum spp. and
Sinomenium spp. root
6

Asian species of Akebia and Clematis

Aristolochia mandshuriensis stem

stem
7

Costus root (Saussurea costusa)

Aristolochia debilis root

8

Vladimiria souliei root

Aristolochia debilis root

9

Black cohosh root/rhizome (Actaea

Chinese cimicifuga root/rhizomec

racemosab)

(Actaea spp.)

Ginkgo (Ginkgo biloba) leaf extract

Ginkgo (Ginkgo biloba) leaf extract

standardized to flavonol glycosides and

with added flavonol glycosides or

terpenes

aglycones (e.g., rutin, quercetin, etc.)

10

a

. Synonym = Saussurea lappa; b. Synonym = Cimicifuga racemosa

c

. Also known as sheng ma or Rhizoma Cimicifugae; is Actaea cimicifuga, syn. Cimicifuga

foetida; Actaea dahurica, syn. C. dahurica; A. heracleifolia, syn. C. heracleifolia; and possibly
other Asian species of Actaea.
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Chapter 2
Extraction, Isolation and Characterization of
Chemical Constituents of Scutellaria lateriflora L and S. baicalensis Georgi

2.1 Introduction
As mentioned in the previous chapter, the goal of this project was to develop and validate
an analytical method to differentiate between S. lateriflora and its potential adulterant
germanders, and to evaluate the bioactivities of individual compounds isolated from S. lateriflora
and S. baicalensis to provide solid scientific support for the traditional usages of this plant. All of
these can be achieved only when qualified reference standards are available.
Literature data pertaining to the chemical constituents of S. lateriflora are limited.
Sesquiterpenes were reported as the main components of the essential oil of S. lateriflora
(Yaghmai, 1988). Five neo-clerodane diterpenoids were isolated from the Me2CO extract of S.
lateriflora collected in the „Orto Botanico dell‟Università di Milano‟ at Tuscolano (Brescia,
Italy) (Bruno et al., 1998). Three flavone glucuronides and a flavanone glucuronide were
identified along with five flavones by HPLC-UV/MS (Gafner et al., 2003). In order to obtain
reference markers the present chemical investigation was undertaken. During the course of this
research, all efforts have been made to obtain more chemical markers with enough quantity for
structural elucidation and quality control.

Flavonoids are rich in many species of genus

Scutellaria, for instance S. baicalensis. On this base, the study of chemical components of S.
baicalensis was carried out since it was reported to be rich in flavonoids and more than sixty
flavonoids have been identified from this plant (Malikov et al., 2002).
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2.2 Experimental sections
2.2.1. General experimental procedures
Optical rotations were measured in MeOH using a Rudolph Research Auto Pol IV
polarmeter with a sodium lamp (589 nm) and a 1 dm microcell. UV spectra were acquired on a
Varian 50 Bio UV spectrophotometer. Circular dichroism (CD) spectra were measured using an
Olis DSM 20 CD instrument. Infrared (IR) spectra were obtained on a Bruker Tensor 27
spectrometer. Nuclear magnetic resonance (NMR) spectra were recorded in pyridine-d5 or
methanol-d4 on either a Varian 600 or Bruker Avance 400 NMR. All chemical shifts (δ) are
given in ppm with reference to solvents and coupling constants (Ј) are given in Hz. HRESIMS
were acquired on a Bruker MicroTOF mass spectrometer. A highly porous synthetic resin
(Diaion HP-20) was purchased from Mitsubishi Kagaku, Ltd. (Tokyo, Japan).

Column

chromatography (CC) was carried out on silica gel (40 µm for flash chromatography, J. T.
Baker), 100 C18-reversed phase silica gel (Sigma-Aldrich, 230-400 mesh) and Sephadex LH-20
(Mitsubishi Kagaku, Tokyo, Japan). The fractions were monitored by TLC on normal-phase
silica gel 60 F254 plates (Merck, Germany) and reversed-phase C18 F254s plates (Merck,
Darmstadt, Germany). Spots were visualized under UV light or by heating at 105 °C for 1-2 min
after spraying with anisaldehyde/H2SO4 reagent. HPLC was performed on an ODS column
(Phenomenex Luna C18, 10x250 mm, 5 μm) as well as a silica NP-column (Phenomenex Luna
Silica, 10x250 mm, 5 μm) and the elution was monitored at 240 nm.
2.2.2. Plant material
The aerial parts of S. lateriflora were purchased from Starwest botanicals
(http://www.starwest-botanicals.com) and authenticated by Dr. Vaishali Joshi at the National
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Center for Natural Products Research (NCNPR), University of Mississippi, where a voucher
specimen (voucher no. 2120) has been deposited.
S. baicalensis ethanol extract was purchased from Chinese Herbs Direct and
authenticated by comparing its TLC profile with that of the authentic sample provided by Dr.
Vaishali Joshi. A voucher specimen (Voucher No. 1181) has been deposited in the repository of
NCNPR.
2.2.3. Extraction and isolation
The dried powder of the aerial parts (850 g) of S. lateriflora was extracted by immersing
in MeOH (3 x 3 L) at room temperature for two days each time and the MeOH extracts were
combined. A brown crude viscous residue (127.6 g) was obtained after evaporation of the
solvent in vacuo. This MeOH extract (126.0 g) was subjected to passage over a Diaion HP-20
column (1.65 kg) eluting with 95% EtOH (7 L), MeOH-Me2CO (1:1, 8 L), Me2CO (6 L), EtOAc
(5 L), and CHCl3 (5 L), successively, to give seven fractions (A-G) (see scheme 2-1). Fraction D
(9 g) was subjected to normal-phase silica gel CC (288 g) eluting with cyclohexane-EtOAcMeOH mixtures of increasing polarity, to afford scutellaric acid (11, 11.2 mg) and a mixture of
1-triacontanol and 1-dotriacontanol in the ratio of 2:1 (32.1 mg). Fraction E (21.45 g) was
chromatographed on silica gel (556 g) and eluted with a gradient of CHCl 3-MeOH (99:1 to 7:3)
to give 52 fractions.

Fraction E-6 (128.1 mg) was subjected to reversed-phase silica gel

chromatography (Biotage RP-18, 40 g), eluted with MeOH-H2O 92:8 to afford lupenol (42.1
mg). Fraction E-8 (407.7 mg) afforded β-sitosterol (14, 213.2 mg) after crystallization from
MeOH. Fraction E-9 (103.2 mg) was purified by preparative TLC using hexanes-EtOAc (9:1) to
give a mixture of arachidic acid, behenic acid, and lignoceric acid in the ratio of 2:1:0.3 (42.7
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mg). Fraction E-10 was separated by Sephadex LH-20 CC, eluted with MeOH to afford two
main subfractions. Subfraction one was repeatedly purified by HPLC on RP-18 using a MeOHH2O gradient as well as on silica NP-column using a hexanes-EtOAc gradient to afford decursin
(3, 0.37 mg), scuteflorin A (1, 0.95 mg), and B (2, 0.51 mg). Fraction F (55 g) was subjected to
flash CC on silica gel (761 g), [cyclohexane-EtOAc (83:17 to 4:6), CHCl3-MeOH (94:6 to
87:13), MeOH] to give six main fractions.

Subfraction F-1 was purified further by

crystallization from MeOH to furnish palmitic acid (16, 21.3 mg). Subfraction F-2 (612.7 mg)
was subjected to normal-phase silica gel chromatography with a gradient of cyclohexane-EtOAc
(1:1 to 1:9) to give four fractions F2-1-F2-4.

Oroxylin A (5, 13.2 mg) was obtained by

crystallization (MeOH) from fraction F2-2. Fraction F2-1 and F2-3 were purified on Sephadex
LH-20, eluted with MeOH to afford dihydrooroxylin A (9, 4.6 mg) and dihydrochrysin (8, 3.2
mg), respectively.

The MeOH soluble part of subfraction F-3 (748 mg) was subjected to

Sephadex LH-20 CC eluted with MeOH to afford oroxylin A (5, 21.5 mg), wogonin (6, 27.9
mg), and chrysin (42.1 mg). The MeOH insoluble part of subfraction F-3 was crystallized from
MeOH to furnish ursolic acid (13, 57.9 mg). Subfraction F-4 (1.0223 g) was subjected to
Sephadex LH-20 CC, eluted with MeOH followed by normal-phase silica gel chromatography
with a gradient of cyclohexane-EtOAc (93:7 to 4:6) to give oroxylin A (5, 12.9 mg), wogonin (6,
12.7 mg), and pomolic acid (12, 17.9 mg).

Subfractions F-5 and F-6 were purified by

crystallization from MeOH to afford 5,7-dihydroxy-8,2′-dimethoxyflavone (7, 7.8 mg) and
daucosterol (15, 89.9 mg), respectively.
Compound 1: white powder; [α]25D + 25.2 (c 0.032, MeOH); UV (MeOH) λmax (log ε)
260 (1.31), 330 (0.58) nm; IR νmax 1720 (C=O), 1510-1620 cm-1 (aromatic –C=C–); for 1H
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(aceton-d6, 600MHz) and

13

C NMR (aceton-d6, 125 MHz) data, see Table 1; HR-ESI-MS m/z

365.1013 (M+Na, calcd. for 365.1001) and 707.2011 (2M+Na, calcd. for 707.2105).
Compound 2: white powder; [α]25D + 5.8 (c 0.017, MeOH); UV λmax (log ε) 255 (3.31),
330 (1.17) nm; IR νmax 1730 (C=O), 1520-1610 cm-1 (aromatic –C=C–); for 1H (aceton-d6,
600MHz) and
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C NMR (aceton-d6, 125 MHz) data, see Table 1; HR-ESI-MS m/z 365.1011

(M+Na, calcd for 365.1001) and 707.2085 (2M+Na, calcd. for 707.2105).
Methods of circular dichroism (CD) calculations: All calculations were performed at
298 K by the Gaussian03 program package (Frisch et al., 2003).

The AM1 method was

employed to scan the potential energy surface (PES) to identify conformers of compound 1.
Ground-state geometries were optimized at the B3LYP/6-31G** level, total energies of
individual conformers were obtained, and vibrational analysis was done to confirm these
minima. Single point energies of conformers of compound 1 were calculated at the B3LYPSCRF/6-31G**//B3LYP/6-31G** level with the COSMO model in MeOH. Conformational
distributions were calculated at B3LYP/6-31G** and B3LYP-SCRF/6-31G**//B3LYP/6-31G**
levels. TDDFT was employed to calculate excitation energy (in nm) and rotatory strength R in
dipole velocity (Rvel) and dipole length (Rlen) forms, at the B3LYP/6-31G** and B3LYP/AUGcc-pVDZ//B3LYP/6-31G**

levels

in

the

gas

phase

and

at

the

B3LYP-SCRF/6-

31G**//B3LYP/6-31G** level in MeOH. The calculated rotatory strengths were simulated into
an electronic circular dichroism (ECD) curve by using the Gaussian function:

Where ζ is the width of the band at 1/e height and ΔEi and Ri are the excitation energies
and rotatory strength for transition i, respectively. ζ= 0.20 eV and Rlen were used.
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The methanol soluble part of the extract of S. baicalensis was subjected to vacuum liquid
chromatography (VLC) on silica gel eluting with gradients of CHCl3/MeOH to afford fifteen
fractions. Fraction 3, 6, 11, 13, and 15 were further separated using different chromatographic
methods including silica gel column, Sephadex LH-20, and preparative thin layer
chromatography as shown in scheme 2-2. The methanol unsolvable part of the extract of S.
baicalensis was dissolved in H2O and adjusted to pH 2 using HCl. The acidic solution was
treated by adding MeOH to give baicalin crystals.
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SL
( S. laterifloria, 850.6 g)
MeOH, extract, 3000mlx3

Reside
(SL-2)

MeOH portion
(SL-1, 127.6g, 14%)

CHCl3, 3000mlx3
column with Diaion@ HP-20
eluting with differnt solvents

CHCl3 portion 20g

SLRE-12-13 SLRE-10-11 SLRE-9
5.7g
10g
3.47g

SLR-CHCl3 SLR-EtOAc SLR-Me2CO SLR-14-20
(2.38g)
9g
(30g)

residue

SLRE-4-6 SLRE-1-3
6.77g
55g

SLRE-8
2.28g

fatty acids

VLC
silica gel column
Hex-EtOAc
EtOAc-MeOH
MeOH

JLI65
VLC
JLI65-61 JLI65-81
lupenol sitosterol

SLRE46-22-23
5,7-dihydroxy-2',8dimethoxyflavone

SLRE46-10-13
0.6127g

SLRE46-1-2-s
Palmitic acid
SLRI-9-42-p
arachidic acid:behenic
SLRI-43-47
acid: lignoceric acid 3a,24-dihydroxy-olean-12-en-28-oic acid
(2:1:0.3)
Biotage
SLRI-9-42-p
Hex:CHCl3 1:1 to 1:9
1-triacontanol:1-dotriacontanol (2:1)

SLRE46-61-63
SLRE46-19-21
daucosterol
1.0223g
SLRE46-14-18
Sephadex LH-20
0.748g
SLRE46-19-21-20
SLRE46-19-21-70-77
Biotage-RP

SLRE46-10-13-81'-87' chrysin wogonin
SLRE46-10-13-60-68 SLRE46-10-13-69-77
8.1mg
oroxylin
A
49.4 mg
SLRE46-10-13-1'-53'
SLRE46-19-21-70-77-86-91
19.6 mg
Sephadex LH-20
3ß,19a-dihydroxy-urs-12-en-28-oic acid
dissolve in MeOH
Sephadex LH-20
SLRE46-19-21-70-77-16-61
SLRE46-10-13-60-68-1-13
dihydrooroxylin A

SLRE46-10-13-1'-53'-3-4
MeOH
SLRE46-10-13-1'-53'-8
JL-I-53-2
dihydrochrysin
Sephadex LH-20
SLRE46-10-13-60-68-24-25
SL-R-E-4-6-14-18-83-101
PTLC
SL-R-E-4-6-14-18-83-101-1
JL-I-53-2-83-101-1
oroxylin A

SL-R-E-4-6-14-18-109-125
JL-I-53-2-109-125
chrysin

SL-R-E-4-6-14-18-83-101-2
JL-I-53-2-83-101-2
wogonin

residue
SL-R-E-4-6-14-1
JL-I-53-1
uroslic acid

SL-R-E-4-6-14-18-83-101
HPLC

lateriflorin A

lateriflorin B

decursin

Chart 2-1. Scheme for isolation of chemical constituents from S. lateriflora
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S. baicalensis extract
(184.6 g)
MeOH
SB1-2

SB1-1 (86 g)

H2O, adjust pH
SB1-2-1
baicalin

Silica gel
VLC

fr.1

silica gel column

fr.11

fr.6

fr.3

MeOH+CHCl3

fr.13

Sephadex LH-20

fr.15

Sephadex
LH-20

SB1-6-1 solution SB1-11-75-81
ganhuangenin
SB1-3-36
silica gel
cry.
skullcapflavone II column
SB1-11-110-122
SB1-15-1
2,6,2',4'-tetrahydroxy
rutin
-6'-methoxychalcone
SB1-6-1-1 SB1-6-2
SB1-15-2
SB1-3-41-51 daidzein baicalein
wogonoside
Sephadex LH-20
Sephadex LH-20
SB1-15-3,4
MW=574

SB1-3-41-51-1

SB1-3-41-51-2

Sephadex LH-20
PTLC

SB1-13-86
hesperidin

SB1-13-A-8-11 SB1-13-45
ganhuangemin hesperetin

SB1-13-85
naringenin

SB1-3-41-51-1-1 SB1-3-41-51-1-2
genkwanin
wogonin

SB1-3-41-51-2-1 SB1-3-41-51-2-2
quercetin
oroxylin A

SB1-13-54
viscidulin I

Chart 2-2. Scheme for isolation of chemical constituents from S. baicalensis
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2.3. Results and discussion
From the MeOH extract of the aerial parts of S. lateriflora three minor coumarins,
scuteflorins A (1) and B (2), and decursin (3), along with six flavonoids, chrysin (4, Yuldashev et
al., 2005), oroxylin A (5, Xiao et al., 2003), wogonin (6, Xiao et al., 2003), 5,7-dihydroxy-2′,8dimethoxyflavone (7, Tomimori et al., 1988), dihydrochrysin (8, Jung et al., 1990),
dihydrooroxylin A (9, Xiao et al., 2003), four triterpenes, lupenol (10, Patra et al., 1988),
scutellaric acid (3a,24-dihydroxy-olean-12-en-28-oic acid) (11, Morota et al., 1995), pomolic
acid (3ß,19a-dihydroxy-urs-12-en-28-oic acid) (12, An et al., 2005), ursolic acid (13, An et al.,
2005 ), two steroids, β-sitosterol (14) and daucosterol (15, Tang et al., 2002) and palmitic acid
(16, Huang et al., 2007) were obtained (Figure 2-1). Among them two coumarins (1) and (2) are
new. Their structures were established by means of 1D and 2D NMR spectra as well as HRMS
data. The absolute configuration of them was determined by comparison of the experimental and
theoretical calculated CD spectra. The structures of known compounds were elucidated by
comparison of their NMR data with those reported. The absolute configuration of the two
flavanones, dihydrochrysin and dihydrooroxylin A was determined based on the specific rotation
data and comparison with the literature data. All of the known compounds except chrysin and
wogonin are reported for the first time from this plant.
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Structural elucidation of two new compounds
Scuteflorin A (1) was obtained as a white powder, [α]D + 25.2 (c 0.032, MeOH). The
HR-ESI-TOF-MS spectrum of compound 1 gave an [M+Na]+ ion at m/z 365.1013 and
[2M+Na]+ at 707.2011 that are consistent with the pseudomolecular formula C19H18O6Na (calcd.
for [M+Na]+ 365.1001 and calcd. for [2M+Na]+ 707.2105, respectively). The characteristic
bright blue fluorescence under UV 254 light and the UV absorption at λ 255 and 330 nm (α，βunsaturated C=O) along with an IR absorption band at 1719 cm-1 (C=O of α-pyrone and ester)
indicated that this compound might possess a coumarin skeleton. The 1H NMR spectrum of 1
(Table 2-1, Figure 2-3) shows a pair of doublets at δH 8.04 and 6.36 ascribable to H-3 and H-4 of
a coumarin moiety. The two singlets at δH 8.11 and 6.90 were assigned to H-5 and H-8 and
suggested 6, 7-disubstitution of the aromatic ring. The 6, 7-disubstitution was determined to
result from a dihydro-γ-pyranone ring based on the 1H and
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C NMR data (Figure 2-3 and 2-4)

and the (heteronuclear multiple-bond connectivity) HMBC correlations as depicted in Figure 2-2.
H-5 (δH 8.11) correlated with a carbonyl carbon at C-4′ (δC 187.8), H-3′ (δH 5.71) with C-2′ (δC
83.6 ), C-5′ (δC 26.2), C-6′ (δC 20.1), and C-4′ (δC 187.8), δH H-5′ (1.58) with C-2′, C-3′, and C6′, H-6′ (δH 1.39) with C-2′, C-3′, and C-5′. The 4′-carbonyl substitution explained the downfield
shift of H-5. The remaining resonances in the 1H and

13

C NMR spectra corresponded to a

senecioyloxy group (Erdelmeier et al., 1985) which was located at C-3′ according to the HMBC
correlation of H-3′ with C-1″ (δC 165.2 ppm). Thus, the planar structure of compound 1 was
deduced as 3′-senecioyloxy-4′-oxo-3′, 4′-dihydroxanthyletin and was given the trivial name
scuteflorin A.
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Table 2-1. NMR Data for Compounds 1 and 2 in Aceton-d6
compound 1
no.
δC
δH (J in Hz)
HMBC
2
159.9
3
115.6
4
144.5
5
128.7
6
118.2
7
162.2
8
106.0
9
160.6
10
115.1
2′
83.6
3′
76.5
4′
187.8
5′
26.2
6′
20.1
1″
165.2
2″
115.5
3″
160.5
4″
27.5
5″
20.5
* Not observed

6.36, d (9.6)
8.04, d (9.6)
8.11, s

C-4,7,9, 4′

6.90, s

C-6,7,9,10

5.71, s

C-2′,4′,5′,6′,1″

1.58, s
1.39, s

C-2′,3′,6′
C-2′,3′,5′

5.85, br

C-1″,3″,4″,5″

1.97, d (1.2)
2.20, d (1.1)

O
O

115.6
144.4
128.7
118.1
162.1
106.0
160.4
115.1
83.5
77.2
187.6
26.4
20.1
166.6
127.9
140.4
20.7
16.1

C-2″,3″,5″
C-2″,3″,4″

H

H

O

δC

H

compound 2
δH (J in Hz)
*
6.35, d (9.6)
8.04, d (9.6)
8.11, s

6.91, s

5.78, s
1.59, s
1.41, s

6.27, qq (8.4, 1.5)
1.95, p (1.5)
2.00, dq (7.2, 1.5)

H
H

O

O
H

Figure 2-2. Key HMBC correlations of compound 1.
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O

Figure 2-3. 1H-NMR spectrum of compound 1 in aceton-d6

Figure 2-4. 13C-NMR spectrum of compound 1 in aceton-d6
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Figure 2-5. H-H COSY spectrum of compound 1 in aceton-d6

Figure 2-6. HSQC spectrum of compound 1 in aceton-d6
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Figure 2-7. HMBC spectrum of compound 1 in aceton-d6
Compound 1 has a positive specific rotation (+ 25.2) compared to + 135 of (+)-decursin
(3) with its C-3΄S absolute configuration (Nemoto et al., 2003).

However, due to the

considerable structural differences between compounds 1 and 3 one may expect significant
changes in optical rotation value. We thus took recourse to ECD to determine its absolute
configuration by comparing the experimentally observed and theoretically calculated ECD
spectra. Using this approach, we have successfully defined the absolute configuration of several
natural products (Ding et al., 2007; 2008; 2009). The potential energy surface of compound 1 in
the gas phase was scanned at the AM1 level by rotating about the C3′-O (C1″), C1″-O (C3′) and
C1″- C2″ bonds. Six conformers were found and redefined at the B3LYP/6-31G** level.
Conformational analysis indicated that conformer 1a is predominant [95.6% at the B3LYP/631G** level in the gas phase by Gibbs free energies and 95.9% at the B3LYP-SCRF/638

31G**//B3LYP/6-31G** level in MeOH with “COnductor-like continuum Solvent MOdel”
(COSMO) by total energies] (see Figure 8, Table 2-2). Theoretical calculation of the ECD of
conformer 1a was performed by the time dependent density functional theory (TDDFT) method
at the B3LYP/6-31G** and B3LYP/AUG-cc-pVDZ//B3LYP/6-31G** levels in the gas phase,
and at the B3LYP-SCRF/6-31G**//B3LYP/6-31G** level in MeOH.

The calculated ECD

spectra of 1a in the gas phase and in MeOH, together with the experimental ECD of 1 in MeOH,
are shown in Figure 9. The overall patterns of the calculated ECD spectra are consistent with
that of the experimental one, i.e., positive Cotton effects (CE) in the 250-300 nm region and
negative CEs in the 300-350 nm region. Considering the extended π-system of the dihydro-γpyranone containing coumarin chromophore in 1, the positive CE near 260 nm and the shoulder
near 290 nm in the experimental ECD would be characteristic for this molecule.

This is

supported by analysis of the molecular orbitals involved in key transitions generating the ECD
spectrum of 1a at the B3LYP/6-31G** level in the gas phase. The calculated positive rotatory
strength at 272 nm (Table 2-3), which likely contributes to the positive CE near 260 nm in the
experimental ECD, originates via the transitions from MO88 to MO91 (Figure 2-10). Another
calculated positive rotatory strength at 294 nm, indicative of the shoulder near 290 nm in the
experimental ECD, is derived from the transition from MO90 to MO92. The calculated negative
rotatory strength at 317 nm, which may be associated with the negative CE beyond 300 nm in the
experimental ECD, is generated by the transition from MO90 to MO91. All four MOs involve
the π-electrons in the dihydro-γ-pyranone containing coumarin chromophore. The calculated
positive rotatory strength at 257nm (Table 2-3), which originates via the transition from MO86
to MO93, also contributes to the positive CE near 260 nm in the experimental ECD spectrum
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(Figure 2-10). The strong calculated positive rotatory strength at 210 nm results from the
transition from MO87 to MO93. Since these three MOs involve the electrons of the

-

unsaturated ester system that may rotate along the C3′-O (C1″), C1″-O (C3′) and C1″- C2″ bonds
in solution, caution should be exercised in using the CEs near these wavelengths to predict
absolute configuration. Based on the above evidence, we conclude that compound 1 retains the
same absolute configuration at C-3΄ as in (+)-decursin (3), but is assigned R in (1) due to the
reversal of the Cahn–Ingold–Prelog (CIP) priorities.

Figure 2-8. Optimized geometries of conformers of compound 1 at
B3LYP/6-31G** level in the gas phase.
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Table 2-2. Conformational Analysis of Compound 1.
in gas phase

species
a

ΔE
1a

b

PE%

c

ΔE′

0.00

93.1

1b

4.83

1c

in methanol
d

PE′%

e

ΔG

f

PG%

ΔEsg

PEs%h

0.00

94.3

0.00

95.6

0.00

95.9

0.0

4.99

0.0

5.73

0.0

4.95

0.0

8.17

0.0

7.96

0.0

8.08

0.0

6.66

0.0

1d

1.95

3.4

2.08

2.8

2.24

2.2

2.29

2.0

1e

7.27

0.0

7.31

0.0

7.71

0.0

7.14

0.0

1f

1.95

3.4

2.08

2.8

2.24

2.2

2.29

2.0

a,c,e

Relative energy, relative energy with ZPE, and relative Gibbs free energy at B3LYP/631G** level in the gas phase, respectively (kcal/mol). b,d,f Conformational distribution
calculated by using the respective parameters above at B3LYP/6-31G** level in the gas phase.
g,h
Relative energy (kcal/mol) and conformational distribution in methanol solution at B3LYPSCRF/6-31G**//B3LYP/6-31G** level with COSMO model, respectively.

Figure 2-9. Calculated ECD spectra of conformer 1a and the experimental ECD of compound 1
(red ▬ and olive ▬, in the gas phase at the B3LYP/6-31G** level; black ▬, in MeOH solvent
at the B3LYP-SCRF/6-31G**//B3LYP/6-31G** level with COSMO; green ▬, in the gas phase
at the B3LYP/AUG-cc-pVDZ//B3LYP/6-31G** level; blue ▬, experimental ECD in MeOH).
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Table 2-3. Key Transitions and Oscillator and Rotatory Strengths of Conformer 1a of
Compound 1 at the B3LYP/6-31G** Level in the Gas Phase.

a

Excited State

ΔEa (eV)

fc

Rveld

Rlene

90→91

3.91

317

0.180

-21.8

-19.8

90→92

4.21

294

0.162

25.8

26.4

88→91

4.55

272

0.039

7.9

7.4

86→93

4.83

257

0.011

18.6

19.2

87→93

5.89

211

0.431

84.8

84.1

b

(nm)

Excitation energy. b Wavelength. c Oscillator strength.

d

Rotatory strength in velocity form

(10 -40 cgs). e Rotatory strength in length form (10 -40 cgs).

Figure 2-10. Electron density surfaces of some orbitals involved in key transitions in the ECD
spectra of 1 at the B3LYP/6-31G** level in the gas phase.
Scuteflorin B (2) was obtained as white powder. [α]D + 5.8 (c=0.017, MeOH). Its
molecular formula C19H18O6 was determined to be same as compound 1 by the high resolution
ESI-TOF-MS data 365.1011 (calcd. [M+Na]+ for 365.1001) and 707.2085 (calcd. [2M+Na]+ for
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707.2105).

Analysis of the NMR data [1H,

13

C, heteronuclear single quantum coherence

(HSQC), correlation spectroscopy (COSY) and HMBC] (shown in Figure 2-11, 2-12, 2-13, 2-14,
and 2-15) of 2 showed that the 1H and

13

C NMR data of 2 are similar to those of compound 1

except that of the senecioyloxy group in 1 was replaced by an angeloyl group in 2 by comparison
with literature data (Erdelmeier et al., 1985) and 2D NMR data. Thus, compound 2 was assigned
as 3′-angeloyloxy-4′-oxo-3′,4′-dihydroxanthyletin and was given the trivial name scuteflorin B.
Since compound 2 is also dextrorotatory, the 3΄ R absolute configuration of 2 should be the same
as in compound 1.

Figure 2-11. 1H-NMR spectrum of compound 2 in aceton-d6
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Figure 2-12. 13C-NMR spectrum of compound 2 in aceton-d6

Figure 2-13. H-H COSY spectrum of compound 2 in aceton-d6
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Figure 2-14. HSQC spectrum of compound 2 in aceton-d6

Figure 2-15. HMBC spectrum of compound 2 in aceton-d6
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Seventeen flavonoids have been isolated after repeated chromatographic purification
from five fractions of S. baicalensis. Their structures were elucidated as baicalein (17), baicalin
(18), wogonin (6), wogonoside (19) and oroxylin A (5) (Miyaichi et al., 1988b), quercetin (24),
rutin (25), naringenin (27), hesperetin (28), hesperidin (29), and daidzein (30) (Kimura et al.,
1981), viscidulin I (23) and 2,6,2',4'-tetrahydroxy-6'-methoxychalcone (31, Iinuma et al., 1989),
skullcapflavone II (20, Kimura et al., 1981), ganhuangenin (21, Liu, Y.L. et al., 1984),
genkwanin (22, Bosabalidis et al., 1998), ganhuangemin (26, Liu, M.L. et al., 1984) (see Figure
2-16) using 1H-NMR, 13C-NMR, HMQC and HMBC as well as comparison with reported data.
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R8
R7

R2'

R4 '

O
R 6'

R6

R5 O
R5=R6=R7=OH, R8=R2'=R4'=R6'=H
baicalein (17)
R5=R6=OH, R7=O-GlcUA, R8=R2'=R4'=R6'=H
baicalin (18)
R5=R7=OH, R8=OCH3, R6=R2'=R4'=R6'=H
wogonin (6)
R5=OH, R8=OCH3, R7=O-GlcUA, R6=R2'=R4''=R6'=H wogonoside (19)
R5=R7=OH, R6=OCH3, R8=R2'=R4'=R6'=H
oroxylin A (5)
R5=R2'=OH, R6=R7=R8=R6'=OCH3, R4'=H
skullcapflavone II (20)
R5=R7=R2'=R4'=OH, R8=R6'=OCH3, R6=H
ganhuangenin (21)
R5=R4'=OH, R7=OCH3, R6=R8=R2'=R6'=H,
genkwanin (22)
R3 '
R 2'
R'
4

HO

O
R'
R3 6

OH O
R3=R2'=R6'=OH, R3'=R4'=H
R3=R3'=R4'=OH, R2'=R6'=H
R3=O-rutinosyl, R3'=R4'=OH, R2'=R6'=H
R 3'
R2'
R4'
R7

viscidulin I (23)
quercetin (24)
rutin (25)

O
R'
R3 6

OH O
R3=R7=R2'=R6'=OH, R3'=R4'=H
R7=R4'=OH, R3=R2'=R3'=R6'=H
R7=R3'=OH, R4'=OCH3, R3=R2'=R6'=H
R7=O-rutinosyl, R3'=OH, R4'=OCH3, R3=R2'=R6'=H
HO

OH

O
O
daidzein (30)

O
OH
H3CO

OH

ganhuangemin (26)
naringenin (27)
hesperetin (28)
hesperidin (29)
OH
OH

2,6,2',4'-tetrahydroxy-6'-methoxychalcone (31)

Figure 2-16. Structures of compounds isolated from S. baicalensis
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2.4. Conclusion
Two types of secondary metabolites, i.e. flavonoids and diterpenoids have been reported
in many species of the genus Scutellaria, such as S. baicalensis, S. discolor, S. riuvlaris, S.
galericulata etc. However; this is the first report on the isolation of coumarins from the genus
Scutellaria. Similar prenylated dihyropyranocoumarins were reported from Chinese traditional
medicines (e.g. Angelica gigas and Peucedanum spp) with cytotoxicity (Ahn, et al., 1997),
neuroprotective (Kang et al., 2005, Lee J. et al., 2003) and protein kinase C (PKC) (Ahn, et al.,
1997) activating activities. All the compounds except wogonin and chrysin are reported for the
first time from S. lateriflora. The major flavonoids isolated from S. baicalensis as well as S.
lateriflora will be used as chemical markers for quality control analysis. Meanwhile, these pure
compounds will be tested on a panel of bioassays to provide scientific support for their
traditional uses as well as to find new applications.
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Chapter 3
Chemical Fingerprint Analysis of Scutellaria Species, Germander
and Dietary Supplements Claiming to Contain Skullcap Using HPLC-PDA

3.1 Introduction
Quality control when dealing with botanicals is much more difficult than for synthetic
drugs because of the high variability of chemical components involved. As botanical dietary
supplement (BDS), singular and in combinations, contain a myriad of mostly unique, or speciesspecific compounds in complex matrices, it is difficult to completely characterize all of these
compounds. It is also equally difficult to know precisely which one is responsible for the
therapeutic effects of an herbal medicine because these compounds often work synergistically.
In recent years, significant efforts have been made to devise methods for the quality control of
herbal materials as well as their products by utilizing quantitative methods and/or qualitative
fingerprinting technologies (Lin et al., 2001; Yang et al., 2005). Quantitative analysis methods
commonly used by the industry are analyzing the product for the presence of chemical markers
known to be present in the specific herbal as indicators or standards to assess quality of the
herbal medicine. Even though this has been an acceptable method for quality control, for herbal
complex systems, the presence of the chemical markers do not always guarantee an individual is
getting the actual herb stated by the product label, especially if the product has been spiked with
the chemical markers. So, the quantization method for the chemical markers can confirm the
compounds presence, but it may not confirm the presence of the plant material. Qualitative
analysis is typically used to demonstrate the general characteristics of herbal materials or their
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products. Many kinds of chemical fingerprint analysis methods, such as TLC, GC, HPLC-UV,
and HPLC-MS, are in rapidly developing that offer great potential for monitoring the quality of
herbal materials, particularly for identifying a particular herb and distinguishing it from closely
related species (Jiang, et al., 2005; Zschocke et al., 1998). By fingerprinting the entire pattern of
components present in one herb or its products, the complete information could be acquired. The
quality information acquired from fingerprinting profile makes the chemical composition in a
given herb visible and comparable in wholeness to determine not only the presence or absence of
desired markers or active constituents but the complete set of ratios of all detectable analytes.
Fingerprinting profile possesses two levels of significance: the „elementary‟ quality control and
„intensive‟ quality control.

The former („elementary‟ quality control) serves the routine

authentication and rapid overall quantifiable estimation of herbs and their products even if some
ingredients in the fingerprint are unknown yet (Xie et al., 2006). And the latter („intensive‟
quality control) means chromatographic fingerprint coupled with chemometrics to enhance the
high capability for processing the array of the parameters.

While the chromatographic

fingerprint can also serve as „quality data bank‟ in which the intact suit of ingredients has been
reserved for sustainable in-depth study. Fingerprinting has been introduced and accepted by the
WHO as a strategy for identification and quality evaluation of herbal medicinal products (WHO,
1991). Both the U.S. Food and Drug Administration (FDA) (FDA, 2004) and the European
Medicines Agency (EMEA, 2001) clearly state that the appropriate fingerprint chromatograms
should be used to assess the consistency of botanical products. In 2004, the State Food and Drug
Administration (SFDA) of China officially required all injections made from herbal medicine to
be standardized by chromatographic fingerprints (SFDA, 2004).
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Chromatographic techniques used for fingerprint analysis of herbal medicines include
TLC, GC, HPLC, and hyphenation procedures. Among them TLC is a convenient method for
determining the quality and possible adulteration of herbal products due to the advantages of its
simplicity, versatility, high velocity, specific sensitivity and simple sample preparation. Even
nowadays, TLC is still frequently used for the analysis of herbal medicines since various
pharmacopoeias such as American Herbal Pharmacopoeia (AHP) (Upton, Santa Cruz, US,
2002), Chinese drug monographs and analysis (Wagner, K¨otzting/Bayer, Wald, Germany,
1997), Pharmacopoeia of the People‟s Republic of China (Pharmacopoeia Commission, Beijing,
1997), etc. still use TLC to provide first characteristic fingerprints of many herbs. It is worth
noting that the technique of TLC is also being updated in progress and the different techniques
like rotation planar chromatography (RPC), overpressured-layer chromatography (OPLC), and
electroplanar chromatography (EPC) are reported (Nyiredy, 2003). Over the past decades, GC
has been a popular and useful analytical tool for the analysis of volatile compounds in herbal
medicines with the advantage of high sensitivity of detection for almost all the volatile chemical
compounds. Especially, with the use of hyphenated GC–MS instrument, reliable information on
the identity of the compounds is available as well. However, the most serious disadvantage of
GC is that it is not convenient for analysis of the samples containing polar and non-volatile
compounds.

For this, it is necessary to use tedious sample work-up which may include

derivatization. Therefore, liquid chromatography becomes another necessary tool to be applied
for the comprehensive analysis of the herbal medicines. HPLC is a versatile method for analysis
of almost all compounds in the herbal medicines when coupled with UV detector, ELSD, or
hyphenated techniques, such as HPLC–MS, HPLC-NMR. Some new techniques, including
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micellar electrokinetic capillary chromatography (MECC) (Albert et al., 1997), high-speed
counter-current chromatography (HSCCC), low-pressure size-exclusion chromatography (SEC)
(Pervin et al., 1995), reversed-phase ion-pairing HPLC (RP-IP-HPLC) (Karamanos et al., 1997;
Loganathan et al., 1990), and strong anion-exchange HPLC (SAX-HPLC) (Rice et al., 1989)
have been developed for good separation for some specific extracts of some herbal medicines.
In order to evaluate the similarity and difference between a number of chromatographic
fingerprints obtained from the same herbal medicine or from different species, several
chemometric approaches such as Hierachical Cluster Analysis, Principle Component Analysis,
Pattern Recognition and K-Nearest Neighbour Analysis were employed to deal with the
chromatographic fingerprint, and a great number of such papers have been published (Debeljak
et al., 2005; Gan et al., 2006; Gong et al., 2003, 2004, 2006; Li et al., 2004; Mok et al., 2006;
Nederkassel et al., 2006; Xu et al., 2006). It is worth noticing that the principle behind these
methods is statistical basis. Therefore, a reliable sample size is critical and should be calculated
properly before experiments to ensure the validity of the results.
3.2 Background and objectives
Flavonoids have been reported as characteristic components of Scutellaria genus. More
than 600 flavonoids have been reported from about 60 Scutellaria species, of which over 60 were
isolated from S. baicalensis (see section 1-2).

Previous studies for quality control of S.

baicalensis were focused on the qualitative and quantitative determination of a few major
flavonoids existed, including baicalein, baicalin, wogonin and wogonoside.

Different

chromatographic techniques, such as HPLC-UV (Katsura et al., 1982; Ma et al., 2003; Miyaichi
et al., 1986; Stojakowska et al., 1998; Takino et al., 1987; Tomimori et al., 1985; Zhang et al.,
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1998), HPLC–ESI tandem mass spectrometry (Guo et al., 2005; Zhang et al., 2007; Wu et al.,
2004a), CE (Myoung et al., 1999; Wang et al., 2005; Yu et al., 2007), MECC (Liu et al., 1994)
have been applied to evaluate the quality of raw material as well as the preparation claiming to
contain S. baicalensis.
To date, only a few papers have touched the field related to the assessment of the quality
of American skullcap and the discrimination between skullcap and its adulterant, germander.
Gafner et al. (Gafner et al., 2003) reported methods, including HPTLC, and digital
photomicroscopy to differentiate S. lateriflora and its potential adulterants T. canadense and T.
chamaedrys. In the HPTLC analysis, three flavonoids isolated from S. lateriflora, e.g. baicalein,
baicalin, and ikonnikoside, two phenylpropanoids from T. canadense, e.g. verbascoside and
teucrioside, were used as markers. Gao‟s group (Gao et al., 2008) developed a HPLC-UV
method to compare the flavonoid biomarker content (baicalein, baicalin, and wogonin) of eleven
commercial tinctures derived from S. lateriflora aerial parts (n=7) and S. baicalensis (n=4).
Results showed that the concentrations of these flavonoids varied widely. Makino (Makino et
al., 2008) analyzed the amounts of four flavonoids, including baicalein, baicalin, wogonin, and
wogon-7-O-glucuronide, in the roots, stems, and leaves of S. baicalensis and S. lateriflora, and
in the commercial products prepared from S. lateriflora. Experimental results indicated that
these flavonoids were detected in the roots of S. baicalensis, however, not in its aerial parts. The
contents of these flavonoids in the aerial parts of S. lateriflora were higher than that in the roots.
Recently, Zhang et al established an HPLC method to analyze twelve phenolic compounds,
including 10 flavonoids and two phenylethanoid glycosides, in commercial American skullcap
products from different sources (Zhang et al., 2009). The total analyzed ingredients varied
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widely for different samples and the relative proportions of ingredients in each sample were
significantly different. They suggested that the chemical variability of the commercial American
skullcap products might come from the plant raw materials that had variable chemical
compositions.

In another study, an HPLC-DAD/ESI-MS method was used to distinguish

between S. lateriflora and its adulterants using the phenylpropanoid verbascoside and teucrioside
as markers (Lin et al., 2009). Although the above mentioned methods had made progress, these
methods are limited in their ability to ensure identity of skullcap plant material being used in the
product.
Hence the main objective of our study was to develop a HPLC-PDA fingerprinting
method that can be applied to authenticate S. lateriflora, to distinguish it from its potential
adulterants, and to compare the chemical profiles of different species in this genus. In the
present study three classes of compounds, including eleven flavonoids isolated from Scutellaria
species, two phenylpropanoids verbascoside and teucrioside and one diterpene teucrin A isolated
from T. canadense, were used as markers to provide comprehensive analysis for the above
mentioned purposes.

Since the UV patterns are different and specific for each type of

compounds investigated, analysis of UV spectra of the known markers and relevant peaks in
samples will be quite valuable for identification of different species.
3.3. Experimental sections
3.3.1. Reagents and chemicals
All solvents, including acetonitrile, water and acetic acid, were of HPLC grade and
provided by Fisher Scientific (Fair Lawn, JN, USA) and Sigma (St. Louis, MO, USA),
respectively. The eleven standard flavonoids used in this study; namely baicalein (17), baicalin
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(18), oroxylin A (5), wogonin (6), chrysin (4), quercetin (24), rutin (25), daidzein (30),
naringenin (27), hesperetin (28), and hesperidin (29), were isolated from Scutellaria species by
authors (see Chapter 2 for details).

The phenylpropanoids, including verbascoside (I) and

teucrioside (II), one diterpene, teucrin A (III), were isolated at the National Center for Natural
Products Research (NCNPR). Their structures (see Figure 3-1) were elucidated based on the 1D
and 2D NMR spectra, HRMS data as well as comparison with reported data. The purity of these
standards was confirmed by chromatographic methods (TLC and HPLC).
3.3.2. Standard solutions
An individual stock solution of the standard compounds was prepared at a concentration
of1 mg/mL in methanol. 10 μL of each standard flavonoid solution was mixed and the mixture
was further diluted to a concentration of 50 μg/mL which was then used for HPLC analysis. 3
μL of each standard phenylpropanoid solution was mixed with 30 μL of teucrin A standard
solution to get the working solution for HPLC analysis. All these solutions were stored in
refrigerator.
3.3.3. Sample preparation
Ten species (total fourteen samples), including seven scutellaria related species and three
Teucrium species, were investigated in this study. The data associated with each species, such as
source and code number are listed in Table 3-1.
General extraction procedure - The dried powder of each plant material (about 1.000 g)
was extracted with 20 mL MeOH under ultrasonication for 30 min followed by centrifugation for
5 min at 1550 rpm. The supernatant was transferred to a 100 mL flask. The extraction was
repeated two more times and the respective supernatants were combined and evaporated to
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dryness. 2 mL of HPLC grade methanol were added to the dried extract and transferred to 5 mL
volumetric flask. The flask was rinsed with about 1.5 mL methanol twice and the final volume
was adjusted to 5 mL with methanol.
Prior to injection, this solution was mixed thoroughly and filtered through 0.45 μm
membrane. The first 0.5 mL was discarded and the remaining volume collected for HPLC
analysis. Each sample solution was injected in triplicate.
Three dietary supplements claiming to contain S. lateriflora were purchased through
commercial sources (see Table 3-2). The dosage form of these three samples is tincture. 2.0 mL
of sample solution was filtered through 0.45 μm membrane. The first 0.5 mL was discarded and
the remaining volume was collected then diluted to proper concentration for HPLC analysis.
3.3.4 Instrumentation and HPLC conditions
HPLC-PDA analysis was performed on a Waters 2695 Alliance Separations Module
(Waters, Milford, MA) connected with a Waters 2996 Photodiode Array Detector and separation
was investigated using two different HPLC columns, a Luna column RP-18 and a Gemini RP-18
column (250 x 4.6 mm i.d.; 5 µm particle size for each of column) from Phenomenex (Torrance,
CA, USA). The column was equipped with a 2 cm LC-18 guard column (Phenomenex Inc.).
The temperature of the column was maintained at 25 °C. The mobile phase consisted of
acetonitrile (A) and water (B), all containing 0.2% acetic acid, which were applied in the
following gradient: 0-5 min, 15%-20% A; 5-30 min, 20%-25% A; 30-60 min, 25%-55% A; 6065 min, 55% A; 65-70 min, 55%-100% A, then hold 5 min. Each run was followed by a 5
minutes washing procedure with 100% acetontrile. The flow rate was adjusted to 1 mL/min, and
the injection volume was 10 µL. Re-equilibration was done with 15% A for 12 min. Total run
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time was 75 min.
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Figure 3-1. Chemical structures of fourteen standard compounds used in this study
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Table 3-1. Species Analyzed in Present Study
species

code number

source

S. amoena

534:1/28/2003; SCAML

Da Li, Yun Nan, China

S. baicalensis

522:1/28/2003; SCABL (leaf)

S. baicalensis

503:1/27/2003; SCABL (root)

Nei Meng Gu, Wu Chuan Xian, China

S. barbata

533:1/28/2003; SCABL

Si Chuan, China

S. barbata

535:1/28/2005 SCABL

Shen Yang, China

S. integrifolia

SAR01204

unknown

S. lateriflora

#198 w/H-tet

unknown

S. lateriflora

1180:6/4/2004; SCLAL

Starwest Botanicals , Inc. USA

S. lateriflora

7828:11/11/2009; SCLAL

Bazaar of India

S. lateriflora

3257: 04/17/2007: SCLAL

FRONTIER NATURAL PRODUCTS
CO.OP (www.frontiercoop.com)

S. likiangensis

SCLIL

Yun Nan, China

S. rehderiana

524:1/28/2003; SCREL

Liao Ning, China

T. chamaedry

4849;11/16/2008; TECHL

Monsento

T. canadense

6544;06/03/2009; TECAL

Missouri Botanical Garden

2893;02/22/2008; TECAL

American Mercentile Corperation

8073;12/09/2009; TEFRL

Missouri Botanical Garden

T. fruticans

Table 3-2. Products Claiming to Contain S. lateriflora
product

code

dosage form

Scullcap

7825:11/11/2009; SCLAL tincture (59-65% alcohol by volume)

Scullcap

7827:11/11/2009; SCLAL

alcohol-free extract (1:1)

Scullcap

7828:11/11/2009; SCLAL

alcohol-free extract (1:1)

3.3.5. Method development
The qualified standards described in Chapter 2, and authenticated species S. lateriflora
(1180:6-4-2004; SCLAL) were used for analytical method development in this study.
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Initial fingerprinting method development began by extracting authenticated S. lateriflora
with methanol. The extract was then analyzed on two different HPLC columns, a Luna column
RP-18 and a Gemini RP-18 column, with a gradient solvent system (shown in Table 3-3). Three
UV wavelengths, including 250, 280 and 350 nm, were chosen for analysis. Regardless of the
gradient solvent system, a level baseline could be achieved only using a Luna column. Then, an
optimized mobile phase gradient for the Luna column was determined for the fingerprint
analysis. Initially, a mobile phase consisting of acetonitrile (A) and water (B), all containing
0.1% acetic acid, was used to investigate the separation of the extract of S. lateriflora. The
mobile phase was pumped at 1 mL/min under gradient manner (see Table 3-3). The HPLC
chromatogram of the plant extract is shown in Figure 3-2. In order to achieve good resolution
for a series of peaks to elute in less than 20 min in the HPLC chromatogram attempts were made
to modify gradient system (shown in Table 3-4) and the separation of the peaks in less than 20
min was achieved (shown in Figure 3-3). Subsequently, the continued method development
involved in applying further modified mobile phase (shown in Table 3-5) to get better separation
for the peaks occurring between 45-60 min. Even though separation was achieved under these
conditions, the peak shapes were not satisfactory due to peak tailing (see Figure 3-4). Therefore,
the concentration of acetic acid in binary mobile phase was adjusted from 0.1% to 0.2% and peak
shapes were optimized (shown in Figure 3-5). Once the fingerprint method had been developed
through the use of authenticated plant material, the mixture of standard solutions and other
species had to be tested to ensure its usefulness. All species of Scutellaria and Teucrium tested
are listed in the experimental section (Table 3-1). This method was applied successfully to the
mixture of eleven standard flavonoids (shown in Figure 3-6 and Table 3-7) and most of
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Scutellaria related samples investigated. Meanwhile, using this method good separation was
achieved for the mixture of three standards isolated from T. canadense (see Figure 3-7) and
Teucrium samples.

The proper sample concentration was obtained by testing a series of

concentrations for each sample.
The HPLC fingerprint method in the present study was validated by analysis of
chromatograms in the intra-and inter-day precision tests.

Five peaks were selected as

characteristic peaks in the chromatogram of the S. lateriflora (see Figure 3-8) as they had
relatively large peak areas and good resolution. Peak 4th was used as the reference peak. The
relative peak retention time (RPRT) and relative peak area (RPA) of each characteristic peak
related to the reference peak were calculated for expression of the HPLC fingerprint pattern. The
detection wavelength was 250 nm. Four individual samples of S. lateriflora on three consecutive
days under optimized HPLC conditions were analyzed.
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Table 3-3. HPLC Gradient Condition I for Fingerprint Analysis
flow (mL/min)

%ACN w/ 0.1% HOAc

%water w/ 0.1% HOAc

0.01

1.00

20.0

80.0

5.00

1.00

20.0

80.0

30.00

1.00

30.0

70.0

55.00

1.00

55.0

45.0

65.00

1.00

55.0

45.0

70.00

1.00

100.0

0.0

75.00

1.00

100.0

0.0

AU

time (min)

0.20

0.00
0.00

5.00

10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00
Minutes

Figure 3-2. HPLC chromatogram of S. lateriflora under the gradient elution system shown in
Table 3-3.
Table 3-4. HPLC Gradient Condition II for Fingerprint Analysis
time (min)

flow (mL/min)

%ACN w/ 0.1% HOAc

%water w/ 0.1% HOAc

0.01

1.00

15.0

85.0

5.00

1.00

20.0

80.0

30.00

1.00

25.0

75.0

55.00

1.00

50.0

50.0

65.00

1.00

55.0

45.0

70.00

1.00

100.0

0.0

75.00

1.00

100.0

0.0
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Figure 3-3. HPLC chromatogram of S. lateriflora under the gradient elution system shown in
Table 3-4.
Table 3-5. HPLC Gradient Condition III for Fingerprint Analysis
time (min) flow (mL/min)

%ACN w/ 0.1% HOAc

%water w/ 0.1% HOAc

0.01

1.00

15.0

85.0

5.00

1.00

20.0

80.0

30.00

1.00

25.0

75.0

60.00

1.00

55.0

45.0

65.00

1.00

55.0

45.0

70.00

1.00

100.0

0.0

75.00

1.00

100.0

0.0

AU

0.20
0.10
0.00
0.00 5.00 10.00 15.00 20.00 25.00 30.00 35.00 40.00 45.00 50.00 55.00 60.00 65.00 70.00 75.00
Minutes

Figure 3-4. HPLC chromatogram of S. lateriflora under the gradient elution system shown in
Table 3-5.
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Table 3-6. HPLC Gradient Condition IV for Fingerprint Analysis
flow (mL/min)

%ACN w/ 0.2% HOAc

%water w/ 0.2% HOAc

0.01

1.00

15.0

85.0

5.00

1.00

20.0

80.0

30.00

1.00

25.0

75.0

60.00

1.00

55.0

45.0

65.00

1.00

55.0

45.0

70.00

1.00

100.0

0.0

75.00

1.00

100.0

0.0

AU

ime (min)

0.20

0.00
0.00

10.00

20.00

30.00

40.00
Minutes

50.00

60.00

70.00

Figure 3-5. HPLC chromatogram of S. lateriflora under the gradient elution system shown in
Table 3-6.
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Figure 3-8. HPLC chromatographic fingerprinting profile of S. lateriflora (250 nm, for
precision study)
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Figure 3-6. HPLC chromatogram of a mixture of eleven standard flavonoids under optimized
gradient system.
Table 3-7. Retention Times and UV Absorptions of Standard flavonoids Obtained Under
Optimized HPLC Conditions
compound

retention time (min)

UV λmax (nm)

rutin (25)

11.06

254, 354

hesperidin (29)

18.15

283

baicalin (18)

26.80

214, 277, 316

daidzein (30)

30.78

247, 301 (sh)

quercetin (24)

37.44

209, 254, 372

naringenin (27)

43.97

216, 289

hesperitin (28)

45.95

286

baicalein (17)

47.09

216, 276, 322

wogonin (6)

55.74

218, 275

chrysin (4)

56.45

213, 267, 314

oroxylin A (5)

57.44

216, 271, 316
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Figure 3-7. HPLC chromatogram of a mixture of three standard compounds isolated from T.
candense under optimized gradient system.
3.4. Results and discussion
The optimized chromatographic conditions were obtained after evaluation of different
HPLC columns and running different mobile phases (described in experimental section). The
complex nature of the extract necessitated a relatively long analytical run to improve resolution.
Use of a PDA detector was extremely valuable for peak identification during the initial method
development. Multiple injections showed low standard error, indicating that the results were
highly reproducible. Precisions of RPRT and RPA of all characteristic peaks were within the
acceptable relative standard deviation (RSD) (n=4) 3.0%, indicating that the conditions used in
the qualitative chromatographic fingerprint analysis are satisfactory. The chemical fingerprint
method developed in this study was applied to verify S. lateriflora species present in ground
plant material and to distinguish between S. lateriflora and its potential adulterants, germander.
Also, it was applied to compare the chemical fingerprint profiles of different species in this
genus
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The comparison of the fingerprint profiles of S. lateriflora with its potential adulterants is
shown in Figure 3-9. Meanwhile, the mixture of three markers isolated from T. candense is
included. The comparison of the chromatograms of two sets of standard mixtures at 250, 280
and 350 nm (shown in Figure 3-6 and 3-7) found that selecting 250 nm as the detection
wavelength resulted in an acceptable response and enabled the detection of all 14 standards used
in this study. In Figure 3-9, the chromatogram of authenticated S. lateriflora species exhibits
very different fingerprint profile compared to that of Teucrium species. Since the UV spectra of
three standard markers isolated from T. canadense are different from that of flavonoids, the
combined analysis of the chromatograms and the UV spectra of a series of peaks occurring in
these two species allowed us to differentiate S. lateriflora from its potential adulterants
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Figure 3-9. Comparison of HPLC profiles of S. lateriflora with its potential adulterants
detected at wavelength 250 nm.
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Some species such as S. amoena, S. likiangensis, and S. rehderiana have been used as
substitutes as “Huang Qin” in China (Song et al., 1981). In the present study we found the
fingerprint profiles of these species are similar to that of S. baicalensis (shown in Figure 3-10)
which provided scientific support for this conventional use. As to the chromatograms of S.
lateriflora and S. baicalensis, their fingerprint profiles are not very similar. In addition, the
HPLC profile of S. barbata is different from that of S. baicalensis. In China, S. barbata named
“banzhilian” was used for different indication as S. baicalensis. From the chemical point of
view, the present results provide scientific evidence for their different uses.
Three samples of S. lateriflora obtained from different sources were investigated in this
study and Figure 3-11 details the fingerprint comparison of them with an authenticated sample.
The chromatogram of sample from India showed similar HPLC profile to that of authenticated
sample, but the fingerprints of the other two samples varied widely. Two samples of S. barabata
obtained from different sources were compared and the chromatograms of them are similar
(shown in Figure 3-12).

For the different parts of the plant investigated, for example, S.

baicalensis, the contents of flavonoids in the leaves were different from those in the root (see
Figure 3-13) which is consistent with the results reported ((Makino et al., 2008)). This method
was also applied to analyze three commercial products claiming to contain S. lateriflora and the
comparison of their HPLC profiles are shown in Figure 3-14. The results indicated that the
contents of flavonoids in the product of skullcap 7825 are similar to that of skullcap raw
materials, but different from the product of skullcap 7827 and 7828.
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Figure 3-10. Comparison of HPLC profiles of Scutellaria related species detected at
wavelength 280 nm.
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Figure 3-11. Comparison of HPLC profiles of S. lateriflora obtained from different sources
detected at wavelength 280 nm.
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Figure 3-12. Comparison of HPLC profiles of S. barabata from different sources detected
at wavelength 280 nm.
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Figure 3-13. Comparison of HPLC profiles of different part of S. baicalensis detected at
wavelength 280 nm.
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Figure 3-14. Comparison of HPLC profiles of commercial products claiming to contain S.
lateriflora detected at wavelength 280 nm.
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3.5. Conclusion
The HPLC-PDA fingerprinting analysis method described in this study is the first
detailed report of qualitative analytical method capable of using two sets of standards. The
mixture of eleven standard flavonoids allows not only analyzing the presence or absence of
desired markers in different Scutellaria species but also helping in comparison of the HPLC
profiles of all Scutellaria species. Meanwhile two sets of standards used in this study allow us to
differentiate S. lateriflora from its potential adulterants. The developed method in the present
study can be applied for the authenticity of S. lateriflora plant material and distinguishing it from
germander; also it will assist in the quality and safety assessment of commercial products
claiming to contain S. lateriflora.
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Chapter 4
Identification of Phenolic Compounds in Scutellaria lateriflora Using
High-Performance Liquid Chromatography-Electrospray Tandem Mass SpectrometryUltraviolet Photodiode Array

4.1. Introduction
The plant kingdom represents an extraordinary reservoir of novel molecules, of which
only a small percentage has received phytochemical investigation (Wolfender et al., 1996). It is
estimated that about 2% of all carbon photosynthesized by plants is converted into flavonoids or
closely related compounds (Markham, 1982). Flavonoids constitute a highly prominent class of
polyphenolic compounds and embrace a diversity of chemical structures. The structure of
flavonoids is composed of three rings with a basic C15 phenyl-benzopyrone skeleton (Figure 41). The substitution pattern of C ring, regarding the site of the B-ring as well as the keto,
hydroxyl, methoxyl, and glycosyl groups, defines the different flavonoid groups, including
flavones, flavonols, flavanones, flavanols, and isoflavones, etc. (Figure 4-2). In plant, flavonoids
are often present as O- or C-glycosides. The O-glycosides have sugar substituents bonded to a
hydroxyl group of the aglycone, whereas the C-glycosides have sugar substituents bonded to a
carbon of the flavonoid aglycone, generally at position 6-C and 8-C. The flavonoids act in plants
as antioxidants, antimicrobials, photoreceptors, visual attractors, and feeding repellants (Pietta,
2000). Many studies have suggested that flavonoids exhibit a broad array of pharmacological
activities, which include anti-inflammatory, antiallergic, antiviral, antioxidant, cancer preventive
activities and other benefits to human health which was summarized in chapter 1.
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Figure 4-1. Basic ring structure of flavonoids with labelling convention
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Figure 4-2. Basic structures of the major flavonoid classes
From the view point of phytochemical identification of flavonoids, difficulties mainly
arise because many of them are isomers, especially given that the biological activities of
flavonoids correlate with specific structural features.

Therefore, 2D NMR spectroscopy is

commonly used for the unambiguous assignment of the structures of flavonoids, even in the case
of simple known compounds, such as wogonin, oroxylin A, and gankwanin. The introduction of
LC-MS in the analysis of crude plant extract has represented an important step for the on-line
identification of unknown compounds or for dereplication of known constituents.
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Mass

spectrometer is a universal detector. It can achieve very high sensitivity and provide information
on the molecular weight as well as chemical structure (Wolfender et al., 1994).
To date, about seventeen flavonoids, including flavone, flavanone, and their glycosides,
five diterpenoids and three minor dihydropyranocoumarins, have been reported from the aerial
parts of American skullcap (Gafner et al., 2003; Li et al., 2009; Maurizio et al., 1998; Zhang et
al., 2009). The flavonoid components far outnumber the diterpenoids found in the aerial parts of
this plant. From the HPLC chromatogram of this plant (shown in chapter 3), it can be concluded
that some flavonoids have not been identified yet. Therefore, detailed identification of the
indigenous flavonoid components is necessary for better understanding of its traditional uses and
authentication of skullcap as well as its products.

Quantitative determination of its major

flavonoids has been reported recently (Gao et al., 2008; Lin et al., 2009). However, no efforts
have been attributed to develop LC-MS/MS methods for the identification of all the main
phenolic compounds.
For the purpose of phytochemical screening of flavonoids in S. lateriflora, a method of
analysis was developed based on liquid chromatography with photodiode array and tandem mass
spectrometric detection (LC-DAD/ESI-MSn) to identify the flavonoids of S. lateriflora.
In this study, thirteen flavonoids and one stilbene derivative were identified in S.
lateriflora, seven of which are described for the first time in S. lateriflora.
4.2. Experimental sections
4.2.1. Reagents and chemicals
All solvents, including acetonitrile, water and acetic acid, were of HPLC grade and
provided by Fisher Scientific (Fair Lawn, JN, USA) and Sigma (St. Louis, MO, USA),
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respectively.
Twelve standard flavonoids used in this study (shown in Figure 4-3), namely baicalein
(17), baicalin (18), chrysin (4), oroxylin A (5), wogonin (6), gankwanin (22), quercetin (24),
rutin (25), naringenin (27), hesperetin (28), hesperidin (29), and daidzein (30), were isolated
from Scutellaria species by authors (see Chapter 2 for details). Their structures were elucidated
based on the 1D and 2D NMR spectra, HRMS data as well as comparison with reported data.
The purity of these standards was confirmed by chromatographic methods (TLC and HPLC).
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Figure 4-3. Chemical structures of twelve standard flavonoids investigated

4.2.2. Standard solutions
Standard flavonoid solutions were prepared at a concentration of 1 mg/mL in methanol.
Working solutions were obtained by twenty folds dilutions of concentrations from 1mg/mL to 50
μg/mL. All these solutions were stored in refrigerator.
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4.2.3. Sample preparation
The aerial parts of S. lateriflora investigated were purchased from Starwest botanicals
(http://www.starwest-botanicals.com) and authenticated by Dr. Vaishali Joshi at the National
Center for Natural Products Research, University of Mississippi, where a voucher specimen
(voucher no. 2120) has been deposited.
The dried powder of the aerial parts (1.0520 g) of S. lateriflora was extracted with 20 mL
MeOH under ultrasonication for 30 min followed by centrifugation for 5 min at 1550 rpm. The
supernatant was transferred to 100 mL flask. This process was repeated twice and respective
supernatants were combined and evaporated to dryness. The residue was dissolved in 2 mL of
HPLC grade methanol and transferred to 5 mL volumetric flask. The flask was rinsed with about
1.5 mL methanol twice and the final volume was adjusted to 5 mL with methanol.
Prior to injection, this solution was mixed thoroughly and 2 mL of it was filtered through
0.45 μm membrane. The first 0.5 mL was discarded and the remaining volume was collected
into the HPLC sample vial for analysis.
4.2.4. LC/ESI-MSn conditions
Mass spectrometry experiment was performed on a LCQ ion trap instrument (Finnigan
MAT. Thermo Scientific, Waltham, MA, USA) with an electrospray source. Ultrahigh pure
helium (He) was used as the collision gas and high purity nitrogen (N2) as the nebulizing gas.
The operating parameters were optimized for baicalin in the negative ion mode . The optimized
MS conditions were as follows: electrospray voltage of the ion source at 3.5 kV with the shealth
gas at 45 arbitrary units (AU), capillary voltage at 28 V, auxiliary gas at 15 AU, capillary
temperature at 300 C, and tube lens offset voltage at -10 V. For full scan MS analysis, the
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spectra were recorded over the range of m/z 100–1000. A syringe pump was used for the direct
injection of pure standard dissolved in MeOH (about 50 μg /mL). Following each first-order MS
scan, the most intense ion (usually pseudomolecular ion during compound elution) was selected
and fragmented up to the MS4 stage by CID, each successive most-abundant fragment ion being
selected again as precursor ion for the next step. The collision energy for CID was between 3045%, and the isolation width of precursor ions was 1.0 U. The data were analyzed using the
XCalibur software.
The HPLC system employed in the LCQ ion trap instrument consists of a model TSP
P4000 quaternary pump coupled with a mode TSP AS3000 autosampler and a model TSP
UV6000 diode-array detector. The chromatographic analysis was conducted at ambient
temperature and the chromatographic separations were carried out on the same column using the
same elution program as developed in chapter 3.
4.3. Results and discussion
In the present study, we have examined the mass fragmentation behavior of twelve
standard flavonoids present in Scutellaria species in the negative ion mode and obtained
fragmentation patterns for each compounds. Thereafter we have characterized the phenolic
compounds from the methanol extract of S. lateriflora. For the identification of the different
compounds from the extract, sample was injected in full scan mode in order to choose the
compounds of interest. Then, the MS-MS scan mode was selected based on the predominant
ions obtained in the mass spectrum in full scan mode. The structure of each compound was
identified by the elucidation of its fragmentation pathway as well as by the comparison of its
fragmentation information to that of standard flavonoid obtained and reported data.
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For the convenience of discussion the CID-MS-MS spectra, the fragments recorded for
the two bonds cleavages of C ring have been annotated according to the nomenclature proposed
by Ma et al (Ma et al., 1997).

Scheme 4-1, adapted from Ma et al. shows the various

retrocyclization fragments observed in this study. The

i,j

A- and

i,j -

B represent product ions

containing intact A and B rings, the superscript i and j indicate the C-ring bonds that have been
broken.
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R3 '

R3 '
OH
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C 2

A
4
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Scheme 4-1. Nomenclature adopted for the different retrocyclization cleavage fragments of
deprotonated flavones, flavonols and flavanones observed in this study (adapted from Ma)
4.3.1 Fragmentation pathways of twelve standard flavonoids
In this study the ESI-MSn fragmentation behaviors as well as their corresponding UV
characteristics of twelve flavonoids (their structures shown in Figure. 4-3), including flavones
(baicalein, baicalin, chrysin, wogonin, oroxylin A, gankwanin), flavonols (quercetin and rutin),
flavanones (hesperetin, hesperidin and naringenin), and isoflavone (daidzein), have been
investigated in detail and summarized in Table 4-1. Some common features, for instance the
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losses of small neutral molecules and/or radicals from [M-H]- ions, such as CO (28 Da), CO2 (44
Da), H2O (18 Da), and/or .CH3 (15 Da), can be observed. It has been demonstrated that the
losses of CO and CO2 from the [M-H]- ion are due to the contraction of C ring (Fabre et al.,
2001) and other characteristic neutral losses are very useful for determination of the presence of
specific functional groups. Negative ion mode was chosen for ESI-MSn analysis in this study,
since background noise and interfering peaks derived from mobile phase were found to be much
less than in the positive mode.
Fragmentation pathways of hydroxylated flavones
The deprotonated molecular ion of baicalein with tri-hydroxyl groups on A ring, [M−H]−
at m/z 269, was obtained after full-scan ESI-MS. In the ESI-MS2 experiment, the product ion at
m/z 251 as base peak was observed, which is resulted from the loss of H2O from [M−H]− at m/z
269. Same product ion could not be observed for chrysin in this study as well as for luteolin
reported (Fabre et al., 2001), in which two hydroxy groups are located on C-5 and C-7 position,
respectively. Therefore, the ion involved in the loss of H2O can be observed only when the
flavone has vicinal hydroxy groups. The ion at m/z 241 is due to the loss of CO, and the m/z 223
ion is due to the successive loss of H2O and CO (see Scheme. 4-2). Baicalin is an O-glucuronide
of baicalein. Upon CID, the glycosidic bond was easily cleaved to generate an ion at m/z 269
attributed to the neutral loss of a glucuronic acid (∆m = 176 Da). In the MS3 experiment, ion at
m/z 269 produced the same fragments as baicalein described above.
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Table 4-1 LC-UV/MSn Characteristics of Twelve Standard Flavonoids
UV
λmax
(nm)
216,
274,
322
216,
275,
316
216,
274

[M-H]m/z

MSn ions m/z (relative abundance)

269

MS full scan: 269 (100);
MS2 [269]: 251 (100), 241 (30), 223 (32), 197 (20), 169 (7);
MS3 [251]: 223(100), 213 (7)
MS full scan: 891 (100), 445 (83),269 (62);
MS2 [445]: 269 (100), 175 (16)

oroxylin A
(5)

215,
271,
317

283

gankwanin
(22)

215,
266,
336
286

283

283

609

205,
255,
370

301

206,
255,
355
216,
287

609

212,
267,
311(sh)

253

compound

baicalein
(17)
baicalin
(18)
wogonin
(6)

hesperetin
(28)

hesperidin
(29)
quercetin
(24)

rutin (25)

narigenin
(27)

chrysin
(4)

445

283

301

271

MS full scan: 283 (100);
MS2 [283]: 268;
MS3 [268]: 240 (56), 239 (100), 224 (14), 223 (34), 212
(22), 211 (34), 163 (44);
MS4 [239]: 211 (100)
MS full scan: 283 (100);
MS2 [283]: 268;
MS3 [268]: 240 (36), 239 (100), 224 (12), 223 (20), 212
(38), 211 (25), 163 (7);
MS4 [239]: 211 (100)
MS full scan: 283 (100);
MS2 [283]: 268;
MS3 [268]: 240 (9), 239 (3)
MS full scan: 301 (100);
MS2 [301]: 286 (100), 283 (48), 257 (59), 242 (99), 233 (4),
215 (9), 199 (12), 125 (9);
MS3 [286]:258 (97), 242 (100), 201 (36), 174 (22), 164 (16)
MS full scan: 609 (100);
MS2 [609]: 301 (100)
MS full scan: 301 (31); 603 (100), 905 (31);
MS2 [301]: 273 (13), 257 (11), 193 (5), 179 (100), 151 (45);
MS3 [273]:245 (17), 229 (100), 163 (16);
MS3 [257]:239 (79), 229 (100), 211 (67);
MS3 [179]: 169 (30), 151 (100)
MS full scan: 609 (100); 1219 (69);
MS2 [609]: 301 (100), 300 (91), 271 (13);
MS3 [301]:273 (15), 271 (97), 257 (12), 255 (57), 179 (100)
MS full scan: 271 (100);
MS2 [271]: 177 (17), 151 (100);
MS3 [177]:133 (12), 109 (100);
MS3 [151]: 107 (100);
MS full scan: 253 (100);
MS2 [253]: 225 (2), 209 (20), 181 (2), 151 (4)
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daidzein
(30)

247,
302
(sh)

253

MS full scan: 253 (100); 507 (54);
MS2 [253]: 225 (16), 209 (7);

Fragmentation pathways of methoxylated flavone isomers
Wogonin (8-OCH3), oroxylin A (6-OCH3), and genkwanin (7-OCH3) are three
methoxylated flavone isomers with the same MW of 284. They exhibited a significant [M-HCH3]−• radical anion at m/z 268 as base peak and no other fragmentation was observed in their
MS2 spectra. The loss of a CH3 radical (15 Da) from the [M-H]− ion explained the presence of a
methoxy group. The MS3 product ion spectra of these three compounds, obtained under the
same conditions, are shown in Figure 4-4. In MS3 experiment of the [M-H-CH3]−• ion of
genkwanin, no any other fragmentation, except low signal intensity ions at m/z 240 (9, -CO) and
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239 (3, -COH•), were observed. This suggested that this radical anion is probably rearranged to a
stable 7-keto-diconjugated-3,4-enol derivative avoiding any further fragmentation for this 7methoxy-4′-hydroxyflavone aglycone (Fabre et al., 2001). But six ions were observed in MS3
spectra for both wogonin and oroxylin A. The product ion at m/z 240 was produced by the loss
of CO from 4-position, and ion at m/z 224 was produced by loss of CO2 from 1-O and 4-CO as
discussed in the literature (Fabre et al., 2001). The notable ions are those at m/z 239 and 223,
and the base peak at m/z 239. It was proposed that these ions are due to the respective losses of
COH• and CO2H• (Wu et al., 2004b) and is as shown in Scheme 4-3. The mechanism for the loss
of COH• may be loss from 4-CO and one hydrogen atom from the molecule, thus the molecule is
easy to form steady conjugated system. A similar fragmentation for the loss of CO2H• from the
loss of 1-O and 4-CO and one hydrogen atom has been observed. The ion at m/z 212 was
produced by the loss of two CO, the position is not known. Although the fragments of wogonin
were almost identical to those of oroxylin A in MS3 experiment, interesting differences between
these two isomers could be observed from MS3 spectra when we compared these two spectra
carefully (show in Table 4 -2). The relative abundance of ion 0,2A- at m/z 163 is higher than that
of the ion at m/z 212 for wogonin. On the contrary, the relative abundance of ion 0,2A- at m/z 163
is lower than that of the ion at m/z 212 for oroxylin A. This allowed us to distinguish these two
isomers. Based on the different fragmentation behaviors of their MS3 spectra these three isomers
can be differentiated.

(a)

(b)
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wogonin.268 #7 RT: 0.15 AV: 1 NL: 5.66E3
T: - c Full ms3 283.10@42.00 268.20@42.00 [ 100.00-400.00]
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Figure 4-4. ESI-MS3 spectra of three methoxylated flavone isomers: (a) wogonin; (b) oroxylin
A; (c) gankwanin
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Table 4-2. ESI-MSn Product Ions of Three Methoxylated flavonoids
scan mode
MS full scan
MS2 [283]

MS3 [268]

ion(s) produced
[M-H][M-H-CH3].[M-H-CH3-CO].[M-H-CH3-COH].[M-H-CH3-CO2].[M-H-CH3-CO2H].[M-H-CH3-2CO].0,2 A

wogonin
283
268
240 (56)
239 (100)
224 (14)
223 (34)
212 (22)
163 (44)

oroxylin A
283
268
240 (36)
239 (100)
224 (12)
223 (20)
212 (38)
163 (7)

gankwanin
283
268
240 (9)
239 (3)

Fragmentation pathways of flavanones
The fragmentation of three flavanones, narigenin, hespertin, and hesperidin, were
investigated.
The MS2 spectra of narigenin yielded the

1,3

A- ion at m/z 151 as the base peak. Also the

ion at m/z 177 with low relative intensity was observed, which was resulted from the loss of B
ring system. The ion at m/z 107 in the MS3 experiment was produced by the loss of CO2 from
the ion at m/z 151 (see Scheme 4-4).
The MS2 fragmentation pathway of hesperetin is much more complex than that of
narigenin (shown in Scheme 4-5). There are two main fragmentation pathways for hespertin.
The first pathway begins with the loss of CH3 from the anion [M-H]- to form the radical anion
[M-H-CH3]−•, followed by the losses of CO and CO2 in the MS3 experiment to form the ions at
m/z 258 and 242, respectively. The second main pathway related to almost all other fragmental
ion at m/z 257, 233, and 125, corresponding to the neutral loss of CO2, C3O2, and 1,4A- ion, from
the [M-H]- ion.
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Fragmentation pathways of flavonols
The fragments proposed for quercetin consecutive to CO and CO2 losses (b and d) are
similar to the corresponding luteolin fragments reported by Fabre (Fabre et al., 2001). Further
losses of CO2 and CO from b and d, respectively, give rise to the resonance-stabilized ion c (see
Scheme 4 -6). The most interesting fragment concerns the base peak at m/z 179. This

1,2

A-

diagnostic ion undergoes further loss of CO giving rise to a 1,2A- - CO ion at m/z 151. It is worth
mentioning that this specific pathway, involving the 1,2 bonds, observed in this study, was
consistent with the result observed for fisetin by other group (Fabre et al., 2001). In the MS2
experiment of rutin, the ion at m/z 301 as base peak was observed suggesting the loss of rutinose
residue.
Fragmentation pathways of isoflavonoidh
In this study the consecutive loss of CO from pseudomolecular ion of daidzein can be
observed in negative mode (see Scheme 4-7). Also it is worth noticing that the fragmentation
pathway of isoflavonoid daidzein is analogous to that of flavone chrysin in negative mode. But
the ratio of relative abundance of product ions at m/z 225 and 209 for these two types of
compounds with the hydroxy group at different ring is different (shown in table 4-3).

Table 4-3. Relative Intensity of Ions in ESI-MS/MS of Chrysin and Daidzein
compound

m/z=225 [M-H-CO] (%)

m/z=209 [M-H-CO2] (%)

chrysin

2

20

daidzein

16

7
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90

4.3.2 Characterization of phenolic compounds from S. lateriflora using HPLC-DAD/ESI-MSn
The LC-MS chromatogram (TIC) of the methanolic extract of skullcap in negative ion
mode is shown in Figure 4-5. The molecular mass of each component at its retention time (tR) in
full scan mode was recorded. Fourteen phenolic compounds were identified by the elucidation
of their fragmentation pathways and by comparison of their MS fragmentation patterns as well as
UV spectra (see Figure 4-6 and Table 4-4) with standard flavonoids or reported data.
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Figure 4-5. HPLC-ESI-MSn analysis of the extract of skullcap. (a)HPLC-UV chromatogram
monitored at 280 nm; (b) LC-negative ion ESI-MS total ion current (TIC) chromatogram.
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Table 4-4. LC-UV/MSn Identification of Phenolic Compounds in S. lateriflora
Peak
no.
32

tR
(min)
24.50

33

27.72

18

28.44

34

30.36

35

36.22

36

36.62

37

37.59

UV .λmax [M-H]ESI-MS (MSn) m/z
identification
(nm)
m/z
(relative abundance)
251, 301
417
ESI-MS: 417, 255;
5-(β-D-glucosyloxy)2
MS [417]: 255 (7), 237 3-hydroxy-trans(100), 211 (18)
stilbene-2-carboxylic
acidb
275, 350
445
ESI-MS: 445, 269;
norwogonin-7-O2
(sh)
MS [445]: 269 (100), 251 glucuronide b
(83), 241 (15), 223 (30), 197
(18), 171 (9), 151 (5), 137 (5)
268, 315
445
ESI-MS: 445, 269;
baicalin a
2
MS [445]: 269 (100), 251
(72), 241 (37), 223 (37), 197
(22), 171 (9), 145 (5)
242, 282,
447
ESI-MS: 447, 271;
5,6,7-trihydroxy
348 (sh)
MS2 [447]: 271 (100);
flavanone-7-O3
MS [271]: 253 (49), 243 glucuronide b
(100), 227 (24), 199 (13), 167 (dihydrobaicalin)
(8)
232, 282
445
ESI-MS: 445, 269;
galangin-7-O2
MS [445]: 269 (76), 241 glucuronide b
(65), 225 (100), 197 (45), 183
(7), 181 (9), 171 (8)
237, 282
461
ESI-MS: 461, 285;
dihydrooroxylin A-72
MS [461]: 285 (100), 270 O-glucuronide b
(22);
MS3 [285]: 270 (31), 269
(100), 243 (6), 166 (11)
268, 308
459
ESI-MS: 459, 283;
oroxylin
A-7-OMS2 [459]: 283 (100), 268 glucuronide b
(51), 175 (5), 113 (11)
MS3 [283]: 268 (100), 239 (8)
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Table 4-4. LC-UV/MSn Identification of Phenolic Compounds in S. lateriflora
(Cont.)
Peak
no.
19

38

39

17

6

5

4

a
b

tR
UV .λmax [M-H]ESI-MS (MSn) m/z
(min)
(nm)
m/z
(relative abundance)
39.67 236, 268
459
ESI-MS: 459, 283;
MS2 [459]: 283 (100), 268 (70),
175 (4);
MS3 [283]: 268 (100), 137 (4)
39.80 237, 280,
489
ESI-MS: 489, 313;
329
MS2 [489]: 313 (100), 298 (83),
283 (26);
MS3 [313]: 298 (100), 283 (3),
269 (5), 254 (5), 214 (3), 193
(3), 167 (3)
40.34 239, 291
461
ESI-MS: 461, 285;
MS2 [461]: 285 (100), 270 (32);
MS3 [285]: 270 (100), 243 (6),
223 (5), 166 (8)
47.50 270, 320
269
ESI-MS: 269, 251;
MS2 [269]: 251 (100), 241 (33),
223 (30), 197 (18), 169 (7)
56.22 280
283
ESI-MS: 283.18, 268.36;
MS2 [283]: 268 (100);
MS3 [268]: 240 (53), 239 (100),
224 (14), 223 (36), 212 (20), 211
(34), 163 (44)
58.06 272, 316
283
ESI-MS: 283.18, 268.36;
MS2 [283]: 268 (100);
MS3 [268]: 240 (32), 239 (100),
224 (14), 223 (20), 212 (39), 211
(27), 163 (8)
56.62 271,
253
ESI-MS: 253, 209;
320(sh)
MS2 [253]: 225 (4), 209 (26),
181 (2), 151 (6)

identification
wogonin-7-Oglucouronide b

5,7-dihydroxy-6,8dimethoxy flavone7-O-glucuronide b

dihydrowogonin-7O-glucuronide b
baicalein a
wogonin a

oroxylin A a

chrysin a

Identified by comparing the retention time, UV spectra and MSn data with standard flavonoids.
Identified by UV and MSn data in comparison with literature data.
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Compound 32 exhibited a UV spectrum with characteristic bands at 251 nm and 301 nm,
which are not consistent with the typical UV spectral pattern of flavonoids, suggesting a
nonflavonoid type of compounds. The characteristics of the UV spectrum of this compound are
identical with those of trans-stilbene (Beale et al., 1953; Suzuki et al., 1960). The ESI-MS in full
scan mode gave an ion [M-H]- at m/z 417 and an ion [M-H-164]- at m/z 255 produced by the loss
of a glucose residue. In the MS2 experiment, the ion at m/z 237 represented the base peak
resulted from the loss of H2O of [M-H-164]-, suggesting vicinal hydroxy groups or a hydroxy
and one free carboxylic group present in the molecule. The ion at m/z 211 was attributed to the
neutral loss of CO2, supporting the presence of carbony group. The proposed fragmentation
pathway of 32 was shown in scheme 4-8. Based on these results compound 32 was tentatively
identified as 5-(β-D-glucosyloxy)-3-hydroxy-trans-stilbene-2-carboxylic acid, which has been
isolated from Scutellaria scandens (Miyaichi et al., 1988a).

O
OH
COOH

C O

O
m/z=237

-H2O

O
OH
m/z=255

-CO2
O
m/z=211

Scheme 4-8. Proposed fragmentation pathways of compound 32 agylcone
Compound 33, 18 and 35 are isomers with the same ion [M-H]- at m/z 445 in full scan
mode. The product ion [M-H-176]- at m/z 269 was observed as base peak in MS2 experiment for
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these three isomers, indicating the neutral loss of a glucuronic acid reside from [M-H]- ion.
Since the glucoside bond of O-glucuronide was easily cleaved to generate its aglycone, this
neutral loss is very useful for the identification of O-glucuronides. In the MS2 experiment of
compound 33 and 18, ion at m/z 269 of both compounds produced the identically diagnostic
neutral losses of H2O (18 Da), CO (28 Da), and the losses of both H2O and CO (46 Da), resulting
in the ion at m/z 251, 241 and 223, respectively, whose fragmentation mechanism was consistent
with the standard baicalein. Since the tR value as well as the UV spectrum of compound 18 were
identical to those of authentic baicalin, it was identified as baicalin. Compound 33 exhibited the
same UV behavior as norwogonin 7-O-glucuronide (Oi et al., 1988), indicating 33 is
norwogonin-7-O-glucuronide. In the MS2 experiment of compound 35, no product ion attributed
to the neutral loss of H2O from its precursor ion at m/z 269, indicating absence of vicinal
hydroxy groups in A ring, whereas product ions at m/z 241 and 225, which resulted from the
neutral losses of CO and CO2 respectively, were predominant, suggesting 35 is galangin-7-Oglucuronide. The MS2 fragmentation behaviors as well as UV spectrum of this compound were
identical to those of reported data (Han et al., 2007).
The peak 34 showed [M-H]- ion at m/z 447 and aglycone [M-H-176]- signal at m/z 271 in
full scan mode, which are indicative of the presence of a glucuronic acid residue. Further MS2
spectra of m/z 271 yielded the ions at m/z 253, 243, 227, and 167. The ion at m/z 253 resulted
from the loss of H2O, revealing the presence of two OH groups in ortho position. The ions at
m/z 243 and 227 resulted from the neutral losses of CO and CO2 from the corresponding [M-H176]- ion. The ion at m/z 167 was attributed to the

1,3

A-, suggesting the occurrence of three OH

groups in A ring. The molecular mass of this compound was 2 Da greater than that of baicalin.
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Also band I, associated with the absorption ascribed to the B-ring cinnamoy system, was weak in
its UV spectrum, while band II, associated with absorption involving the A-ring benzoy system,
showed bathochromic shift with respect to the value of baicalin, indicating a flavanone-type
compound. Based on the evidence that all 7-O-glucuronides showed essentially identical UV
spectra with their corresponding aglycones (Liu et al., 2009), 7-OH glycosylation was proposed
for 34. On the basis of comparing the UV spectrum of 34 with reported data (Liu et al., 2009),
this compound was characterized as 5,6,7-trihydroxy-flavanone-7-O-glucuronide.
Peak 37 and 19 are isomers with the molecular weight of 460 Da. They showed the same
product ion [M-H-176]- at m/z 283, which indicated the loss of a glucuronic acid moiety as
discussed above. For the aglycone part of these two compounds a significant [M-H-CH3]−•
radical anion at m/z 268 presented as base and sole peak in their MS2 spectra, suggesting the
presence of a methoxy group for both compounds. To further investigate the structures of these
two isomers, tandem mass experiments were employed on the two [M-H-176-15]- ions at m/z
269. Although the products ions of m/z 269 for these two compounds were identical, the relative
intensities of ion at m/z 212 and m/z 163 were different. Comparison with the results obtained
for authentic wogonin and oroxylin A suggested that peak 37 and 19 are oroxylin A-7-Oglucuronide and wogonin-7-O-gluconide, respectively.
Compounds 36 and 39 both gave an [M-H]- ion at m/z 461 and their agylcone ion at m/z
285 (-176 Da), which suggested the presence of a glucuronic acid moiety. The UV spectra of
these two compounds only exhibited band II, indicating a flavanone skeleton. The MS2 spectra
of the ion at m/z 285 yielded an ion at m/z 270, which resulted from the loss of a CH3 radical (15
Da) from the ion [M-H-176]- at m/z 285. In addition, the ion
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1,3

A- at m/z 166, which are the

characteristic of flavanone, suggested that these two compounds are either dihydrowogonin or
dihydrooroxylin A. Compound 36 was identified as dihydrooroxylin A-7-O-glucopyranoside
since its UV spectrum was consist with the literature (Miyaichi et al., 1995) and 39 as
dihydrowogonin-7-O-glucopyranoside.
Compounds 38 exhibited an [M-H]- ion at m/z 489. CID of this compound produced ion
[M-H-176]- at m/z 313, which was resulted from the neutral loss of a glucuronic acid residue.
Fragments of m/z 298 and 283, due to the sequential losses of CH3 radicals, indicated the
presence of two methoxy groups. In the MS3 experiment of m/z 313, the product ion at m/z 298
was base peak. The product ion at m/z 269 was produced by the loss of COH•, and ion at m/z
254 was produced by loss of CO2 from m/z 298. The ion

0,2

A- at m/z 193 along with above

mentioned two ions at m/z 269 and 254 were indicative for the second methoxy group on A ring.
The UV spectrum of 38 was same as 5,7-dihydroxy-6,8-dimethoxy flavone-7-O-glucuronide
reported in the literature (Liu et al., 2009). Thus, compound 38 was identified as 5,7-dihydroxy6,8-dimethoxy flavone-7-O-glucuronide.
The peak at tR=12.9 min in TIC showed an [M-H]- ion at m/z 623 as well as product ion
[M-H-162]- at m/z 461 and [M-H-162-146]- at m/z 315 resulting from the sequential losses of
glucosyl (162 Da) and rhamnosyl (146 Da) residues, and revealing the presence of one glucose
and one rhamnose moieties. The molecular weight of the agylcone of this compound is 316.
This compound was tentatively characterizated as isorhamnetin-7-O-rhamnosylglucoside by Guo
et al (Han et al, 2007). The same compound was also observed by Yao‟s group (Liu et al., 2009)
from S. baicalensis, and they doubted the result from Guo et al since the UV spectrum for
isorhamnetin and its 7-O-glycosides reported were characterized by two bands at 253 and 370
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nm, which are quite different from that of the compound studied with absorptions at 290 and 330
nm. No conclusion was made based on the data obtained by Yao‟s group. In the present study
same UV spectral behavior and MS fragmentation patterns were also observed. We endeavored
to elucidate its structure based on the data obtained, but further MS/MS experiments are needed
to get sufficient information.
Compound 17, 6, 5, and 4 were positively characterized as baicalein, wogonin, oroxylin
A, and chrysin, respectively, by the comparison of their UV spectrum and MS n fragmentation
patterns with corresponding standards.
4.4. Conclusion
As has been demonstrated, the MS-MS spectra of the deprotonated molecules [M-H]- for
four types of flavonoids yielded different fragmentation profile. The diagnostic fragment ions
resulted from the cleavage of two bonds at positions 1/3, 0/2 and 0/4 of the C-ring are very
helpful for the structural determination of the A- and B-ring substitution patterns. Furthermore,
loss of internal sugar moiety linked to aglycone in the flavonoid glycoside together with those
fragment ions mentioned above are also useful for the determination of the properties of the
linkage between the sugar and aglycone (O- or C-glycosides), and the position of sugar
substitution in the aglycone. In addition, losses of H2O and .CH3, etc. are valuable in the
determination of the presence of some functional groups. Based on the differences in the relative
abundances of some specific ions isomeric methoxylated flavonoids can be discriminated. These
fragmentation patterns have been used as guidelines for the determination of the compounds in
crude plant extracts.
LC/ESI-MSn is a very promising complementary tool for the characterization of
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flavonoids. The LC/MS-MS method developed in the NCNPR was successfully employed to
separate and identify the major flavonoids from S. lateriflora, which provides knowledge of both
its chemical composition and its potential use as a source of natural antioxidants. In this study,
we have demonstrated how the combination of UV spectra and ESI-MSn spectra allows a fast
characterization of thirteen flavonoids and one stilbene derivative without time-consuming
isolation of compounds even if reference compounds are not available or on hand. It is worthy
noted that the choice of appropriate conditions for collision induced fragmentation is very
important to assure acquisition of enough fragmentation information for structural
characterization of these types of compounds. Also special care should be taken during the
interpretation of MS data since there are many isomers co-existed in the skullcap extract.
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Chapter 5
Evaluation of Bioactivities of Methanol Extracts of S. baicalensis L. and S. lateriflora
Georgi and Flavonoids Isolated from Them

5.1. Introduction
American skullcap has been reputed as a nerve tonic, sedative, and anticonvulsant among
Native Americans and Europeans (Millspaugh, 1974). It has been traditionally used to treat
epilepsy and other neurological disorders such as nervous tension states, hysteria, chorea,
anxiety, and insomnia.

Despite its extensive uses, there are limited data on its bioactive

constituents, the pharmacological properties and its safety issues. Results from in vivo animal
behavior trials suggested that the aqueous extract of plant material of American skullcap has
anxiolytic property, and that the flavonoids, and possibly the amino acids contents, may be
responsible for this activity (Awad et al., 2003). Two flavone-glycosides, scutellarein and
ikonnikoside I isolated from American skullcap, have been found to bind to one of the serotonin
receptors, the 5-HT7 receptor, in brain (Gafner et al., 2003). The 5-HT7 receptor is thought to
play a role in the pathogenesis of various ailments such as sleep disorders, depression, and
migraine (Gafner et al., 2003). Significant anxiolytic effects have been demonstrated in a double
blind, placebo-controlled study of healthy volunteers and results indicated that commercial
American skullcap products have clinical benefits as a relaxing nervine with no overt evidence of
toxicity or side effects (Wolfson et al, 2003).
Chinese skullcap has attracted attention since 1980‟s, and a number of studies related to
the evaluation of the bioactivities of aqueous extract of this species as well as its major
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flavonoids, including baicalein, baicalin, and wogonin, have been reported. The results showed
that both aqueous extract and the flavonoids isolated from it demonstrated diverse bioactivities,
as summarized in chapter 1.
The aim of the present study is to evaluate the bioactivities of crude extracts of the two
above mentioned skullcap species as well as thirteen individual flavonoids isolated from them to
provide scientific support for the traditional usages of these plants. In the present study, the
methanol extracts of S. baicalensis George (SBE), and S. lateriflora L (SLE) together with
thirteen flavonoids, including baicalein (17), baicalin (18), chrysin (4), oroxylin A (5), wogonin
(6), genkwanin (22), viscidulin I (23), quercetin (24), rutin (25), naringenin (27), hesperetin (28),
hesperidin (29) and daidzein (30), isolated from these two species, were tested in a panel of
bioassays to determine their anticancer, antioxidant, anti-inflammatory, estrogenic activity and
cytotoxic activities. In addition, their activities on peroxisome proliferator-activated receptoralpha and -gamma (PARP and PPARγ) were also evaluated.
5.2. Materials and methods
5.2.1. Materials
The aerial parts of S. lateriflora were purchased from Starwest botanicals
(http://www.starwest-botanicals.com) and authenticated by Dr. Vaishali Joshi at NCNPR,
University of Mississippi, where a voucher specimen (voucher no. 2120) has been deposited.
S. baicalensis ethanol extract was purchased from Chinese Herbs Direct and
authenticated by comparison of its TLC profiles with that of the authentic sample provided by
Dr. Vaishali Joshi.

A voucher specimen (Voucher No. 1181) has been deposited in the

repository of NCNPR.
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Both samples were extracted with MeOH and the MeOH extracts were dried in vacuo for
bioassay.
Thirteen standard flavonoids used in this study were isolated from S. baicalensis and S.
lateriflora. Their structures were elucidated based on the 1D and 2D NMR spectra, HRMS data
as well as comparison with reported data. The purity of these standards was confirmed by
chromatographic methods (TLC and HPLC).
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Figure 5-1. Structures of flavonoids tested
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5.2.2. Methods
5.2.2.1. Assays for in vitro cytotoxicity
The samples were tested for their in vitro cytotoxicity against a panel of normal cell lines
(Vero: monkey kidney fibroblasts and LLC-PK11: pig kidney epithelial cells) and solid tumor
cell lines (HepG2: human hepatocellular carcinoma, SK-MEL: human malignant melanoma, KB:
human epidermal carcinoma (oral), BT-549: human breast carcinoma, and SK-OV-3: human
ovary carcinoma) (Mustasa et al., 2004) All cell lines were obtained from American Type
Culture Collection (ATCC) and grown in RPM1-1640 medium supplemented with 10% bovine
calf serum (BCS) and amikacin (60 mg/L). HepG2 cells were grown in DMEM-F12 medium
supplemented with 10% fetal bovine serum (FBS). Cells (25,000 cells/well) were seeded in the
well of a 96-well plate and incubated for 24 h. Samples were added and followed by incubation
for 48 h. The number of viable cells was determined using the supravital dye Neutral Red.
Briefly, the cells were washed with saline and incubated for 3 h with a solution of neutral red.
The cells were washed again to remove extracellular dye. A solution of acidified ethanol was
added to liberate the incorporated dye from viable cells and the absorbance was read at 450nm.
5.2.2.2. Assay for antioxidant activity (inhibition of intracellular ROS generation)
Antioxidant activity was determined by the DCFH-DA method. Myelomonocytic HL-60
cells (1 × 106 cells/mL, ATCC) were suspended in RPMI-1640 medium (Roswell Park Memorial
Institute) supplemented with 10% FBS and antibiotics at 37 oC in 5% CO2: 95% air. The cell
suspension (125 µL) was added to a 96-well plate. After treatment with test compounds for 30
min, cells were stimulated with 100 ng/mL phorbol 12-myristate-13-acetate (PMA, Sigma) for
30 min. 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA, Molecular Probes, 5 µg/mL) was

105

added and cells were further incubated for 15 min.

Levels of DCF were measured on a

SpectrMax plate reader with excitation wavelength at 485 nm and emission at 530 nm.
Antioxidant activity of test samples is determined in terms of % decrease in DCF production
compared to the vehicle control. The cytotoxicity to HL-60 cells was also determined after
incubating the cells (2 x 104 cells/well in 225 µL) with test samples for 48 h by XTT {2,3-bis (2methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl]-2H-tetrazolium hydroxide} method
(Zhao et al, 2008). Briefly, 25 µL of XTT-PMS (phenazine methosulfate) solution (1 mg/mL
XTT solution supplemented by 25 µM of PMS) was added to each well. After incubating for 4 h
at 37oC, absorbance was measured on a plate reader (EL312e; Bio-Tek instruments, Winooski,
VT) at a dual wavelength of 450 - 630 nm.
5.2.2.3. Assay for anti-inflammatory activity (inhibition of NF-kB)
The SW1353 human chondrosarcoma cells were cultured in 1:1 mixture of dulbecco's
modified eagle medium/nutrient mixture F-12 (DMEM/F12) supplemented with 10% FBS, 100
U/mL penicillin G sodium, and 100 µg/mL streptomycin at 37 C in an atmosphere of 5% CO2
and 95% humidity. NF-kB luciferase plasmid construct was provided by Dr. David Pasco,
NCNPR, the University of Mississippi.
Cells (1.2 x 107) were washed once in an antibiotic and FBS-free DMEM/F12, and then
resuspended in 500 µL of antibiotic-free DMEM/F12 containing 2.5% FBS. NF-kB luciferase
plasmid construct was added to the cell suspension at a concentration of 50 μg/mL and incubated
for 5 min at room temperature. The cells were then electroporated at 160 V and one 70-ms pulse
using BTX disposable cuvettes model 640 (4-mm gap) in a BTX Electro Square Porator T 820
(BTX I, San Diego, CA). After electroporation, 1.25 x 105 cells per well were plated in 200 µL
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of DMEM/F12 containing 10% FBS and antibiotics. After 24 h, cells were treated with different
concentrations of test compounds for 30 min and then induced with PMA (70 ng/mL) for 8 h.
Cells were lyzed by adding 40 µL of a 1:1 mixture of lucLite reagent and PBS containing 1 mM
calcium and magnesium (Packard Instrument Company, Meriden, CT).

Light output was

detected on SpectraMax. Relative luciferase units (RLU) were 12-15 folds higher in PMA
induced cells versus uninduced controls (Ma, et al, 2007).
5.2.2.4. Assay for estrogenic activity
Yeast cells (Saccharomyces cerevisiae) expressing the human estrogen receptor alpha,
were cultured in 25 mL of growth medium for 24 h at 30 ˚C in a shaking incubator (Tabanca et
al., 2004). For the assay, seeded assay medium was prepared by adding 1.5 mL of this culture
and 250 L of chlorophenol red β-D-galactopyranoside (CPRG, 10 mg/mL) to 25 mL of fresh
growth medium (Routledge et al., 1996). Sample was dissolvd in DMSO (10 mM for pure
compounds and 10 mg/mL for extracts). Six serial dilutions were made on a 96-well plate and
10 L of diluted sample was transferred to the assay plate followed by addition of 190 L of
seeded assay medium to each well. Test concentrations ranged from 7.8 µg/mL to 250 µg/mL
for extract and 7.8

to 250

for pure compounds in duplicates. 17 β -Estradiol (E2) was used

as positive control and a dose-response curve with concentrations ranging from 3.1 nM to 100
nM was run in parallel to samples in every assay. The highest concentration of DMSO in the
vehile control was 0.25 %. The plates were shaken for 5 min and incubated for 72 h at 30 ºC. At
the end of incubation the plates were shaken, and the absorbance was measured at 540 nm.
Absorption at 630 nm was subtracted to correct for turbidity. % Maximal E2 response was
calculated as described earlier (Zhao et al, 2008).
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5.2.2.5. Assay for the activation of PPARα and PPARγ in CHO cells.
Chinese hamster ovary (CHO) cells were cultured in Ham‟s F12 medium containing 5%
newborn calf serum (NCS), 50 U/mL penicillin G and 50 µg/mL streptomycin sulfate at 37 oC in
an atmosphere of 90% humidity and 5% CO2.
The assay for activation of PPARα and PPARγ was performed as described earlier
(Jaradat et al., 2001) with some modifications.
The plasmids were kindly provided by Dr. Dennis Feller, Department of Pharmacology,
School of Pharmacy, the University of Mississippi. CHO cells were transfected for PPARα with
25 µg of PPARα plasmid and for PPARγ with 25 µg of PPRE-aP2-tk-luc reporter and 25 µg of
the expression construct pcMV-PPARγ. Electroporation was performed (Electro square porator
model T820) at 155 V for 70 msec and one pulse. Transfected cells were seeded into 96-well
tissue culture plate at a density of 5 x 104 cell/well and incubated for 24 h. Tested compounds at
different concentrations (0.1-30 µM) were added and after incubation with compounds for 24 h,
cells were lysed and the luciferase activity was determined by using luciferase assay system
(Promega). Plates were read on Spectra Max (Molecular Devices Corporation).
Fold induction in the activity of PPARα and PPARγ was calculated in comparison to the
vehicle control (0.3% DMSO) and presented as mean ± SME (n=3). Wy14643 and ciglitazone
were used as positive control for PPARα and PPARγ, respectively.
5.3. Results and discussion
5.3.1. In vitro cytotoxicity
The cytotoxicities of SBE and SLE together with thirteen flavonoids were evaluated
against a panel of normal cell lines and solid tumor cell lines. No cytotoxicity was observed for

108

most of the samples up to a highest concentration of 50 μM for purified compounds and 50
μg/mL for the extracts in any of the cell lines tested (data shown in Table 5-1). Based on these
results a conclusion might be made that the toxicity of American skullcap is very low and the
reports of hepatotoxic reactions of American skullcap is likely due to its adulterant germanders.
5.3.2. Antioxidant activity
Potent antioxidant activity was observed for the SEB and SLE with IC50 values of 2.5
μg/mL and 1.5 μg/mL, respectively. These results are consistent with published data (Cole et al.,
2008; Wojcikowshki et al., 2007).

Compounds 17, 18, 6, 24 ,25, and 29 showed strong

inhibition of ROS generation with IC50 values of 0.52, 0.32, 0.7, 0.7, 0.13, and 0.9 μM,
respectively (see Table 5-2) in comparison to the IC50 value of 0.01 μM for the positive control,
vitamin C. In order to determine the specificity of the antioxidant effect, their cytotoxicity to
HL-60 cells was also tested. The purpose of this experiment is to rule out the possibility that
antioxidant activity was not observed due to their toxicity. No cytotoxicity was observed for all
samples at the concentration of 12.5 μM or 62.5 μM (as indicated in Table 5-2).
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Table 5-1. Cytotoxicities (IC50) of Skullcap Extracts and Flavonoids Isolated from Them
sample
SBE
SLE
baicalein (17)

VERO
NA*
NA*
>50µM

PK-11
NA*
NA*
NA

HepG2
NA*
NA*
NA

SK-MEL
NA*
NA*
35 µM

KB
NA*
NA*
NA

BT-549 SK-OV-3
NA*
NA*
NA*
NA*
NA
NA

baicalin (18)
wogonin (6)
oroxylin A (5)
genkwanin (22)
chrysin (4)
viscidulin I (23)
quercetin (24)
rutin (25)
daidzein (30)
naringenin (27)
hesperetin (28)
hersperidin (29)
doxorubicin

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
>5

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
0.5

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
0.5

NA
NA
NA
NA
NA
NA
35 µM
NA
NA
NA
NA
NA
0.9

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
0.9

NA
NA
NA
NA
NA
NA
50 µM
NA
NA
NA
NA
NA
1

NA*: no cytotoxicity observed at 50µg/mL.
NA: no cytotoxicity observed at 50µM.
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NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
0.6

Table 5-2. Antioxidant Activities of Skullcap Extracts and Flavonoids Isolated from Them
sample

antioxidant activity IC50

cytotoxicity

(μM)

(HL-60 cells) (μM)

SBE

2.5#

NC#

SLE

1.5#

NC#

baicalein (17)

0.52

NC*

baicalin (18)

0.32

NC*

oroxylin A (5)

NA

NC

wogonin (6)

0.7

NC*

genkwanin (22)

NA

NC

chrysin (4)

NA

NC

viscidulin I (23)

NA

NC

quercetin (24)

0.7

NC*

rutin (25)

0.13

NC*

daidzein (30)

NA

NC

naringenin (27)

NA

>62.5

hesperetin (28)

2.3

NC

hesperidin (29)

0.9

NC*

vitamin C

0.01

NA: no activity up to 62.5 μM; NC: no cytotoxicity up to 62.5 μM; NC*: no cytotoxicity up to
12.5 μM.
#
: IC50 in μg/mL.
5.3.3. Anti-inflammatory activity
The anti-inflammatory activity was determined in terms of inhibition of NF-κB mediated
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transcription in SW1353 cells induced by PMA and the results were shown in Table 5-3. A
moderate activity was observed for compounds 6, 4, 24, and 25 with IC50 values of 39, 33, 40,
and 39 μM, respectively, in comparison with the positive control, parthenolide (IC50 of 4.1 μM).
In this experiment, a luciferase construct with binding sites for Sp-1 was used as a control
because this transcription factor is unresponsive to inflammatory mediators such as PMA.
Hence, the measurement of Sp-1-mediated luciferase expression is useful for detecting agents
that nonspecifically inhibit luciferase expression because of cytotoxicity, inhibition of luciferase
enzyme activity or light output (Ma et al., 2007). None of the samples inhibited Sp-1 dependent
luciferase expression, indicating that their effect on NF-κB was specific.
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Table 5-3. Anti-inflammatory Activity of Skullcap Extracts and Flavonoids Isolated from Them:
Effect on NF- κB Mediated Transcription

sample

IC50 (μM)
NF- κB

SP-1

SBE

NA#

NA

SLE

>50#

NA

baicalein (17)

NA

NA

baicalin (18)

NA

NA

oroxylin A (5)

>50

NA

wogonin (6)

39

NA

genkwanin (22)

NA

NA

chrysin (4)

33

NA

viscidulin I (23)

NA

NA

quercetin (24)

40

NA

rutin (25)

39

NA

daidzein (30)

NA

NA

naringenin (27)

NA

NA

hesperetin (28)

NA

NA

hesperidin (29)

NA

NA

parthenolide

4.1

6.2

NA: no activity up to 50 μM.
: IC50 in μg/mL.

#

5.3.4. Estrogenic activity
Phytoestrogens comprise a large group of plant-derived compounds, which include
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isoflavonoids, lignans, stilbenes and flavonoids. They have attracted scientific interest due to
their possible medical applications in the prevention of certain cancers and treatment of
osteoporosis and cardiovascular diseases (Munro et al., 2003; Ross et al., 2002; Stopper et al.,
2005). The estrogenic effects vary according to the phytoestrogenic substance studied, the
experimental system, and species. The mode of action of phytoestrogens seems to be complex,
and their efficacy and safety need to be evaluated individually (Fitzpatrick et al., 2003;
Moutsatsou et al., 2007; Ren et al., 2001; Sirtori et al., 2005).
In the present study, yeast estrogen screen (YES) assay was used to compare the
estrogenic activity of 17 β -Estradiol on estrogen receptor (ER)-α with two crude extracts SBE
and SLE and thirteen flavonoids isolated from SBE and SLE. Estrogenic response of E2 at 100
nM was defined as 100% and % maximal 17 β -Estradiol response of sample tested was
calculated at the highest effective dose in comparison to 100 nM 17 β -Estradiol. The extracts
SBE and SLE did not show any significant effect at the highest dose of 250 µg/mL. Out of the
tested compounds naringenin and daidzein showed strong estrogenic effects with 98% maximal
17 β -Estradiol response at 250 µM (naringenin) and 40% maximal 17 β -Estradiol response at
62.5 µM (daidzein) (Table 5-4). For most of the compounds highest effective dose was 250 µM
except for diadzein. The effect of daidzein was maximum at 125 and 62.5 µM. Toxic effect at
the highest dose of 250 µM could be responsible for a low estrogenic effect of daidzein at this
concentration. Previously, the estrogenic potency of naringenin was controversially discussed.
Strong estrogenic activity of naringenin was observed by Zand et al. (Rosenberg Zand et al.,
2000). Whereas, Ruh et al. reported that naringenin is a weak estrogen that also exhibits partial
antiestrogenic activity in the female rat uterus and MCF-7 human breast cancer cells (Rhu et al.,
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1995). Daidzein, which is one of the two major isoflavonic phytoestrogens in soy bean, has been
shown to have dual function, i. e. the estrogenic and anti-estrogenic properties in the presence of
high or low 17 β -Estradiol levels (Ni et al., 2010). Different results for the same compound
might be due to the differences in the test system used. The major conclusion that could be
drawn from the present study is that subtle changes in the structure of compounds, for instance
naringenin and hesperetin, can bring about a large change in their estrogenic activity.
Table 5-4. Estrogenic Response of Scutellaria Extracts and Flavonoids Isolated from Them

sample

% max E2 response

% max E2 response

% max E2 response

at 250 µM

at 125 µM

at 62.5 µM

#

SBE

NA

SLE

NA#

baicalein (17)

NA

baicalin (18)

NA

oroxylin A (6)

30%

18%

wogonin (5)

13%

10%

genkwanin (22)

16%

9%

chrysin (4)

9%

viscidulin I 23)

NA

quercetin (24)

11%

rutin (25)

NA

daidzein (30)

28%

39%

40%

naringenin (27)

98%

90%

66%

hesperetin (28)

10%

NA#: no activity up to 250 µg/mL. NA: no activity up to 250 µM. E2: 17β-estradiol.
% max E2 response: % maximal 17 β-estradiol response was calculated at the indicated doses in
comparison to 100 nM E2 as 100%.
5.3.5. Activation of PPARα and PPARγ in CHO cells
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PPARs are ligand-activated transcription factors that belong to the subfamily of nuclear
receptors (Schoonjans et al., 1997). They are pivotal regulators of body lipid homeostasis and
are proposed as possible therapeutic targets for metabolic disorders. They show broad, but
isoform-specific, tissue expression patterns. Currently, PPARs subfamily has been divided into
PPARα, PPARβ (also called PPARδ and NUC1) and PPARγ. Three PPAR isoforms differ in
their tissue distribution and ligand specificity (Forman et al., 1996). PPARα is predominantly
expressed in tissues exhibiting high catabolic rate of fatty acids (heart, liver, and kidney),
whereas PPARβ expression is ubiquitous, and its physiological role is unclear.

PPARγ is

expressed predominantly in adipose tissue, the adrenal gland, spleen, large colon and the immune
system (Chawla et al., 1994; Kliewer et al., 1994; Tontonoz et al., 1994). Therefore, PPARα is a
major regulator of fatty acid metabolism and catabolism within the body (Spiegelman, 1998).
PPARγ plays an important role in regulating adipocyte differentiation and glucose homeostasis
(Berger et al., 2005).

Agonists of PPARα and PPARγ have been developed as

antihyperlipidemic and antidiabetic agents.
In the present study two skullcap extracts (SBE and SLE) together with thirteen
flavonoids isolated from these extracts were first tested for their activation effects on PPARα and
PPARγ in CHO cells.

Induction of PPARs activity by each compound was tested at

concentrations ranging from 0.1 µM to 30 µM and fold induction was calculated against vehicle
control. Wy 14643 and ciglitazone were used as positive controls to evaluate the ability of tested
samples to activate PPARα and PPARγ, respectively. The results are summaried in Table 5-5
and shown in Figure 5-2 and 5-3. In this study a fold induction of 2 or more was considered as
significant induction in comparison to vehicle control.
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SLE significantly stimulated the PPARα activities in a dose-dependent manner. At the
dose of 10 µg/mL, the extract increased PPARα activity up to 2.6 folds over the vehicle control.
It is more potent than the activity of SBE, which showed 1.6 fold increase in activity over the
vehicle control (see figure 5-2). At the dose of 30 µg/mL, the fold of PPARα induction of SLE
is up to 4.9 compared to 2.4 of SBE. Of the tested flavonoids, compounds baicalein (17),
baicalin (18), wogonin (6), genkwanin (22), chrysin (4), quercetin (24), daidzein (30), naringenin
(27), and hesperetin (28) exhibited significant activation of PPARα at 10 µM (2.8, 2.4, 2.5, 2.0,
3.5, 2.1, 2.2, 2.2, and 2.9, respectively) (shown in Table 5-5). Most of them induced the PPARα
activity in a dose-dependent manner. The activity of these compounds was comparable to the
activity of the positive control Wy 14643 (1.8 fold) (Table 5-5 and Figure 5-2). However, there
was a cytotoxic effect in CHO cells with 30 µM of chrysin and hesperetin and a decrease in the
activation of PPARα was observed (Figure 5-2). Although another group (Fang et al., 2008)
reported that quercetin inhibited the activation of all three isoforms of PPARs (PPARγ IC50 =
56.3 μM; PPARα IC50 = 59.6 μM; PPARβ IC50 = 76.9 μM) in Cos-7 cells. Our studies showed
activiations at 10 μM. Oroxylin A (5), viscidulin I (23), rutin (25), and hesperidin (29), had no
effect on activation of PPARα, and the data are shown in Table 5-5.
Only baicalein (17), wogonin (6), and chrysin (4) showed significant induction of PPARγ
activity at a concentration of 10 µM (fold induction of 2.3, 2.0, and 3.4, respectively). However,
oroxylin A (5), quercetin (24), and daidzein (30) demonstrated an increase in the PPARγ activity
at a concentration of 30 µM (2.6, 6.9, and 2.7 folds, respectively), which were comparable to
positive control ciglitazone (3.0 fold induction).

Consistent with our results, chrysin was

previously reported to increase the PPARγ activity in a dose-dependent manner, with the EC50 of
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approximately 10 µM (Liang et al., 2001). It is worth noticing that compounds baicalein (17),
wogonin (6), and chrysin (4) demonstrated dual PPARα and PPARγ activity at the concentration
of 10 µM (see Figure 5-4), whereas quercetin (24) and daidzein (30) showed the same effects at
a concentration of 30 µM (Figure 5-5). To date, there is no report on the effects of skullcap
extracts on PPARs activation. The present study, for the first time, sheds some light on the fact
that the skullcap extracts have the potential to act as PPARα agonists. In our study, some of
flavonoids, including baicalein (17), baicalin (18), wogonin (6), chrysin (4), etc. were also found
to significantly induce PPARα activity. Hence it may be concluded that the induction for
PPARα activation produced by extracts may be due to the presence of these flavonoids, any of
these, or a combination of them having direct or indirect effects on PPARα. The mechanism of
action needs further detailed studies using individual compounds. Toxicity studies (data shown
before) have already proven that no toxicity was observed at a dose far above the dose used in
this investigation. Therefore, compounds, such as baicalein (17), baicalin (18), wogonin (6),
chrysin (4), quercetin (24), daidzein (30), etc. with significant PPARα activity might serve as
new leads with less adverse effects for treatment of PPARα-related diseases, such as obesity and
dyslipidemia. A growing body of evidence suggests that combined treatments with PPARα and
PPARγ agonists may potentially improve insulin resistance and alleviate atherogenic
dyslipidemia. A considerable amount of effort has thus been made in the development of dual
PPARα/γ agonists for the treatment of diabetes as well as the associated dyslipidemia.
Muraglitazar (Devasthale et al., 2005), tesaglitazar (McIntyre et al., 2003), KRP-297 (MK- 767)
(Calkin et al., 2003), and TAK-559 (Sakamoto, J. et al., 2004) are examples of late stage dual
PPARα/γ clinical candidates which have demonstrated efficacy in glucose normalization and
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correction of lipid abnormalities in diabetic patients. However, the development of all of these
advanced clinical candidates has been discontinued for multiple reasons, mainly due to
considerable side effects (Barlocco, 2005; Colca, A.C. 2007; Conlon, D. 2006; Najman, D.M.
2006; Nissen, S.E. 2006; Parra et al., 2006).

Our discovery of the compounds with dual

regulator function for PPARα/γ discovered in this study, such as baicalein (17), wogonin (6), and
chrysin (4) etc. might lead to PPAR agonists with improved risk-benefit profile for the treatment
of diabetic patients with the additional risk factor of dyslipidemia. Future studies will be carried
out to determine structure–activity relationships of potential PPARα and PPARγ agonists
screened in this study using molecular modeling.

The elucidation of structure–activity

relationships would help in identifying the key structural features of the ligand molecules for
activation of each subtype of the PPAR, which in turn, will assist us in design and discovery of
more safe and effective agonists.
5.4. Conclusion
In the present study the methanol extracts of American skullcap and Chinese skullcap
along with thirteen flavonoids isolated from them were evaluated their activities on a panel of
bioassays. Neither extracts of SBE and SLE nor pure compounds tested showed cytotoxicity
against a panel of mammalian normal and solid tumor cell lines at the high tested concentrations,
suggesting that American skullcap has very low toxicity and the previous reports of hepatotoxic
reactions of American skullcap might not be due to skullcap itself but could be due to its
adulterant germander. Significant antioxidant activity was observed for both skullcap extracts as
well as compounds, such as baicalein (17), baicalin (18), wogonin (6), quercetin (24), rutin (25),
and hesperidin (29). The antioxidant activity of American skullcap was firstly observed in the
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present study and was found to be stronger than Chinese skullcap. Naringenin (27) and daidzein
(30) showed marked estrogenic effects in the YES assay. Only a moderate anti-inflammatoy
activity was observed with wogonin (6) and chrysin (4) as indicated by the effect on NF-κB
mediated transcription. In this study, the most significant finding was the identification of
PPARs activation of skullcap extracts as well as their components, such as baicalein (17),
baicalin (18), wogonin (6), and chrysin (4), etc. Results of our study provide useful information
on possible new application of skullcap, especially American skullcap, for the treatment of
diabetic-related diseases. In addition, the activation of PPARs by pure flavonoids suggests their
potential to become leads as PPARα and PPARγ agonists.
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Table 5-5. Fold Induction of Tested Samples on PPARs at Different Concentrations
PPARα
30 µM

10 µM

30 µM

10 µM

1 µM

SBE*

2.4±0.9

1.2±0.15 1.3±0.55

1.9±0.30

1.7±0.45

1.2±0.25

SLE*

4.9±0.85 2.6±0.7

1.4±0.55

1.4±0.20

0.9±0.25

4.2±0.98 2.8±0.73 1.3±0.22 1.1±0.24 2.4±0.62

2.3±0.49

1.2±0.18

0.9±0.11

3.1±0.47 2.4±0.64 0.8±0.16 0.9±0.29 1.6±0.55

1.3±0.25

1.0±0.40

1.1±0.40

oroxylin A 1.3±0.30 1.2±0.10 1.2±0.60 0.9±0.20 2.6±0.05

1.3±0.05

1.1±0.25

1.0±0.25

4.1±0.76 2.5±0.47 1.4±0.36 1.1±0.29 2.9±0.70

2.0±0.40

1.4±0.33

1.2±0.16

genkwanin 2.6±0.62 2.0±0.82 2.1±0.87 1.2±0.44 1.7±0.15

1.8±0.20

1.2±0.15

1.0±0.15

chrysin (4) 3.1±0.05 3.5±0.00 1.9±0.10 1.4±0.20 2.0±0.05

3.4±0.05

1.4±0.50

1.1±0.15

viscidulin

1.1±0.10 0.8±0.10 0.8±0.00 1.1±0.05 1.1±0.05

1.2±0.00

1.1±0.05

0.9±0.20

2.8±0.45 2.1±0.45 1.0±0.15 1.1±0.20 6.7±0.15

1.2±0.60

1.0±0.55

0.9±0.10

rutin (25)

0.7±0.05 1.1±0.05 0.7±0.00 0.6±0.00 1.1±0.05

1.0±0.05

0.9±0.10

1.0±0.00

daidzein

5.3±0.65 2.2±0.40

1.4±0.55 2.7±0.10

1.8±0.25

1.8±0.55

1.0±0.10

4.9±1.70 2.2±0.55 1.2±0.15 1.2±0.70 1.5±0.40

1.3±0.33

1.0±0.18

0.9±0.20

2.1±0.20 2.9±0.55 1.8±0.95 1.2±0.25 1.7±0.29

1.1±0.24

0.9±0.13

0.7±0.13

1.0±0.10 0.9±0.20 0.7±0.10 0.7±0.00 1.1±0.30

1.3±0.10

1.0±0.40

0.9±0.15

3.1±0.25

1.6±0.20

1.6±0.05

baicalein

1 µM

PPARγ
0.1 µM

1.3±0.1

0.1 µM

(17)
baicalin
(18)

(5)
wogonin
(6)

(22)

I (23)
quercetin
(24)

1.2±0.4

(30)
naringenin
(27)
hesperetin
(28)
hesperidin
(29)
Wy 14643

1.9±0.05 1.8±0.05 1.2±0.00 0.9±0.10

ciglitazone

3.0±0.05

*The concentration unit of the extract is µg/mL.
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Figure 5-3. Effect of tested samples on PPARγ activation.
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Figure 5-5. Dual effect of tested samples on PPARs activation at 30 µM.
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Second Project

Phytochemical Investigation of Pfaffia paniculata (Martius) Kuntze
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Chapter 6
Introduction of Pfaffia paniculata (Martius) Kuntze

Around ninety species of Pfaffia (Amaranthaceae) are known in Central and South
American. In Brazil, twenty-seven species have been described to date, among which Pfaffia
paniculata (Martius) Kuntze, commonly nameed suma, is the most employed species in
commercial preparations in Brazil as “Brazilian ginseng” and has been commonly used for three
centuries for the same indications as American and Asian ginseng (Taniguchi et al., 1997;
Vasconcelos, 1982). It is a large, rambling, shrubby ground vine with an intricate, deep, and
extensive root system.

It is indigenous to the Amazon basin and other tropical parts of

(southern) Brazil, Ecuador, Panama, Paraguay, Peru, and Venezuela. Although harvested wild,
suma has been domesticated and farmed for quite some time. For instance, it has been cultured
successfully in Sichuan, Zejiang, and Guangxi province in China (Ling et al., 2006). Since its
first botanical recording in 1826, it has been referred to by several botanical names, including
Pfaffia paniculata, Hebanthe paniculata, Gomphrena paniculata, Gomphrena eriantha, Iresine
erianthos,

Iresine

paniculata,

Iresine

tenuis,

Pfaffia

eriantha,

Xeraea

paniculata

(http://www.rain-tree.com/plants.htm).
Traditionally suma has been used as a food that provided physical stamina and
endurance. The indigenous peoples of the Amazon region have used suma root for generations
for a wide variety of health purposes, including as a general tonic, as an energy rejuvenating, and
sexual tonic, and as a general cure-all for many types of illnesses, such as diabetes, ulcers, cancer
etc (De Oliveira, 1986; Taniguchi et al., 1997). The benefits of suma were such that the
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indigenous people of the jungle call it “para todo,” a Spanish word that means “for all things.”
In herbal medicine throughout the world today, suma is considered as a tonic and an adaptogen.
The herbal definition of an adaptogen is a plant that increases the body's resistance to adverse
influences by a wide range of physical, chemical, and biochemical factors and has a normalizing
or restorative effect on the body as a whole (Panossian et al., 1999). Therefore, suma was named
as Brazilian ginseng with many applications same as regular ginseng.
The root of this plant is such a rich source of β-ecdysterone that it is the subject of a
Japanese patent for the extraction methods employed to obtain it from suma root.
Approximately 2.5 g of β-ecdysterone can be extracted from 400 g of powdered suma root
(0.63%) (Wakunaga, 1984). Also it has very high saponin content (up to 11%) (De Oliveira et
al., 1980).

The specific saponins found in the roots of suma include a group of novel

nortriterpenoid saponins, named Pfaffic acid (hexacyclic nortriterpene) and their glycosides,
pfaffosides A-F. Besides these, a mixture of stigmasterol and sitosterol, their glycosides, and
allantoin have been reported (Nakai et al., 1984; Nishimoto et al., 1984; Takemoto et al., 1983).
Nutritionally, suma root contains 19 different amino acids, a large number of electrolytes, trace
minerals, iron, magnesium, zinc, vitamins A, B1, B2, E, K, and pantothenic acid. Its high
germanium content probably accounts for its properties as an oxygenator at the cellular level.
Besides, its high iron content may account for its traditional use for anemia (Zucchi et al., 2005).
Pharmacological studies showed that suma has anticancer, anti-inflammatory, and sexual
stimulatory activities.
Anti-inflammatory activity
The alcoholic extract of P. paniculata dried roots was studied for analgesic
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antiinflammatory activity in the rat paw oedema test, writhing test, hot plate test and increased
vascular permeability test. P. paniculata inhibited the carrageenin-induced rat paw oedema and
increased vascular permeability and showed analgesic activity on inflammatory pain but not on
noninflammatory pain. Moreover the extract was devoid of local irritant action (Mazzanti et al.,
1994).
Anticancer activity
The powdered root of P. paniculata orally administered to mice at a daily dose of 200
mg/Kg, for 10 days reduced the ascetic volume of Ehrlich tumor cells in mouse peritoneal cavity,
as well as the ascetic fluid volume. The result indicates that this effect is related to the antiinflammatory activity (Matsuzaki et al., 2003). Later, the same research group studied the
effects of the ethanolic extract, butanolic residue, and aqueous residue of ethanolic extract of P.
paniculata on animal survival and tumor growth in mice bearing Ehrlich tumor. The results
demonstrated antineoplastic effects on survival time of tumor bearing-mice following the
treatment with the butanolic residue of ethanolic extract of P. paniculata (Matsuzaki et al.,
2006). Also, a human breast tumor cell line, the MCF-7 Cells treated with butanolic extract
showed degeneration of cytoplasmic components and profound morphological and nuclear
alterations.

These results showed that this butanolic residue indeed contains cytotoxic

substances (Nagamine et al., 2009). The active components of this plant, at least in relation to
survival parameter, are likely to be present in the butanolic fraction. Since the main constituents
of butanolic residue obtained from the ethanolic extract are saponins, indicating that saponins
may be responsible for the antineoplastic effects. In fact, pfaffic acid and its glycosides termed
pfaffosides A-F, isolated from P. paniculata, have shown in vitro inhibitory effects on the
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growth of B-16 melanoma (Nakai et al., 1984) and the pfaffosides as well as pfaffic acid
derivatives in suma were patented as antitumor compounds in several Japanese patents in the
mid-1980s (Takemoto et al., 1984). These results support the hypothesis proposed above. In
another study, antiangiogenic activity was observed in the mouse cornea after the animal was
treated with 1000 mg/Kg of the methanol extract of P. paniculata. The anticancer activity
mediated by the P. paniculata may result from the intense stimulation of macrophages, natural
killer cells and cytotoxic T lymphocytes (Watanabe et al., 2000). Increased macrophage activity
was also observed by Pinello‟s group, suggesting that increased macrophage activity may be one
of the effects contributing to inhibition of the Ehrlich ascetic tumor growth in mice (Pinello et
al., 2006). On the other hand, chemopreventive effects of P. paniculata have been demonstrated
in vivo. Watanabe et al. reported an inhibition of enlargement of thymic lymphoma in mice
receiving 750 mg/Kg/week of a P. paniculata preparation for 24 week (Watanabe et al., 2000).
This is consistent with the study of Silva et al. that demonstrated chemopreventive effects using a
mouse hepatocarcinogensis model, when these animals received 2.0 % of the powdered roots of
this plant (v./v.) mixed in their chow (Silva et al., 2005).
Toxicity study was performed in which doses of 400 and 200 mg/Kg of powdered suma
root were administrated orally for 10 days to mice. The chosen doses are higher than that
recommended for humans, which varied from 100 to 300 mg per day. The evaluated parameters
were the body weight, the presence of serum Alanine transaminase (ALT) indicative of necrosis
in the liver, and the histopathological examination. None of these parameters showed alterations
in mice treated with P. paniculata (Matsuzaki et al., 2003). In addition, oral intake of powdered
P. paniculata root for 30 days induced no adverse reactions in mice, suggesting that P.
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panicualta can be consumed safely for long periods (Oshima et al., 2003). In another study, the
ethanolic extract of P. paniculata administrated by intraperitoneal injection (i.p.) to mice did not
produce behavioral effects up to 5 g/Kg in mice.

Sedation, motor incoordination, loss of

reflexes, hypothermia and mortality were observed only with the dose of 10.0 g/Kg (Mazzanti et
al., 1994).
Sexual stimulatory activities
P. paniculata extract, when administrated orally to male rats with the dose of 0.25, 0.5,
and 1.0 mL/Kg, improved the copulatory performance of sexually sluggish/impotent rats, but had
no effects on the copulatory behavior of sexually potent rats. The highest dose of 1.0 mL/Kg
increased the percentage of rats achieving ejaculation and significantly reduced mount,
intromission and ejaculation latencies, post-ejaculatory interval and intercopulatory interval
without affecting locomotor activity. The selective effect might act mainly by increasing central
noradrenergic and dopaminergic tone, and possibly oxytocinergic transmission (Arletti et al.,
1999; Oshima et al., 2003). These results provide experimental support to the folk reputation of
P. paniculata as sexual stimulant.
Gingseng is one of the most widely used herbal medicines in the world for its physical,
mental and sexual effects. It is one of the best-selling herbs in the Unite States (Yuan et al.,
2004). The general population might not be aware that different kinds of ginseng are prepared
from plants belonging to different species even different family, for example, Chinese or Korean
ginseng from Panax ginseng, American ginseng from Panax quinquefolium, Brazilian ginseng
from Pfaffia paniculata, and Siberian ginseng from Eleutherococcus senticosus, etc. (Janetzky et
al., 1997; Walker et al., 1994). More than fifty preparations, which were contained or produced
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from plant P. paniculata are available on USA market (Lafont et al., 2003), but no analytical
methods currently available to identify P. paniculata raw materials, and its products. Therefore,
the primary objective of this project was to investigate the chemical components which will be
used as marker compounds for the quality control of suma raw material as well as the products
claiming to contain this species.
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Chapter 7
Phytochemical investigation of Pfaffia paniculata (Martius) Kuntze

7.1 Introduction
As mentioned in Chapter 6, only very limited data associated with the chemical
constituents of P. paniculata were reported even though it has been widely used as “Brazilian
ginseng” for three centuries.

Previously, three types of secondary metabolites have been

reported from it, including phytosterols, pfaffic acid and their glycosides, named pfaffosides A-F
(saponins) and allantoin (Nakai et al., 1984; Nishimoto et al., 1984; Takemoto et al., 1983;
Wakunaga, 1984).
Herein, the detailed phytochemical investigation of P. paniculata was carried out. Two
new nortriterpenoids pfaffine A and B (40-41), one new compound pfaffine C (42a and b),
along with eleven known compounds were isolated from the roots of this plant (see Figure 7-1).
The structures of the new compounds were elucidated on the basis of extensive spectroscopic
(1D, 2D-NMR, HR-ESI-MS) and chemical degradation studies. Those known compounds were
identified as ecdysone (43) (Chan et al., 2005), 20-hydroxyecdysone (44) (Wang, T. et al., 2004),
pterosterone (45) (Coll et al., 1994), rapisterone (46) (Baltaev et al., 1987), pfaffic acid (47)
(Takemoto et al., 1983), pfameric acid (48) (Shiobara et al., 1993), mesembryanthemoidigenic
acid (49) (Ikuta et al., 1986), calenduloside E 6′-methyl ester (50) (Melek et al., 1996), oleanolic
acid 28-O-β-D-glucopyranoside (51) (Gupta et al., 2003), (+)-angelicoidenol-2-O-β-Dglucopyranoside (52) (Inoshiri et al.,1988), Vinillic acid (53) (Conrad et al., 2001), and
iresinoside A (54) (Shiobara et al., 1992) by comparison of spectroscopic data with those
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reported in the literature. All the fourteen compounds except ecdysone are reported for the first
time from this plant.
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Figure 7-1. Structures of compounds isolated from Pfaffia paniculata
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7.2 Experimental sections
7.2.1. General experimental procedures
Optical rotations were measured in MeOH using a Rudolph Research Auto Pol IV
polarmeter with a sodium lamp (589 nm) and a 0.5 dm microcell. High-resolution mass spectra
(HRESIMS) were performed on Bruker MicroTOF. NMR spectra were recorded in pyridine-d5
on either a Varian 600 or Brucker Avance 400 NMR spectrometers. All chemical shifts (δ) are
given in ppm with reference to solvent and coupling constant (Ј) is given in Hz. IR spectra were
obtained on a Perkin Elmer 100 FT-IR spectrometer. Column chromatography was carried out
on silica gel (40 µm for flash chromatography, J. T. Baker) and C18-reversed phase silica (230400 mesh, Sigma-Aldrich). The fractions were monitored by TLC on silica gel plates (0.25 mm,
Merck) as well as on RP-18 F254 plates (0.25 mm, Merck). Spots were visualized by heating at
105 °C for 1-2 min after spraying with anisaldehyde/H2SO4 reagent. HPLC was performed on
an octadecyl silane (ODS) column [Phenomenex prodigy 5μ ODS (3) 100A] and elutes were
monitored by a UV detector at 240 nm. L-cysteine methyl ester hydrochloride, dioxane, D- and
L-glucose were obtained

from Sigma-Aldrich (USA).

7.2.2. Plant material
The roots of Pfaffia paniculata Kuntze was purchased from American Mercantile
Corporation (american@americanmercantile.com) and authenticated by Dr. V. Joshi at the
National Center for Natural Products Research, University of Mississippi, where a voucher
specimen (No. 3096) has been deposited.
7.2.3. Extraction and isolation
The powder of the roots (2.4 Kg) of P. paniculata was extracted by stirring in MeOH (3 x
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2L) at room temperature three hrs each time and the MeOH extracts were combined. The MeOH
was evaporated under vacuum to get a brown viscous residue (437 g). The concentrate was
suspended in water and then partitioned with hexanes, chloroform and n-BuOH successively (see
Chart 7-1). The n-BuOH soluble fraction (72.1 g) was subjected to VLC on silica gel (600 g)
eluting with CHCl3 (2 L), CHCl3-MeOH-H2O [930:80:10 (1 L), 830:180:10 (1 L), 680:300:50
(2.5 L)] and MeOH (1.5 L) successively to give six fractions (A-F). Fraction B [CHCl3-MeOHH2O 830:180:10 (1 L), 2.5438 g] was subjected to reversed-phase C-18 flash chromatography
(100g, column: 4 x 15 cm) eluting with a gradient of MeOH-H2O (40:60 to 100:0 with elution
volume of 1603 mL at the flow rate of 4 mL/min, 18 mL for fraction size) to afford twelve
fractions. Subfraction 7 (between 780 to 950 mL, 0.2312 g) was separated by silica gel column
eluted with a gradient of CHCl3:EtOAc:MeOH or CHCl3:MeOH several times to get vinillic acid
(53, 10.2 mg). Subfraction 8-9 (between 958 to 1240 mL, 0.4154 g) was subjected to normalphase silica gel flash chromatography (Biotage Flash 12+M, 90g, column: 1.2 x 15 cm), eluted
with CHCl3-EtOAc-MeOH-H2O (15:8:4:1 with elution volume of 1000 mL at a flow rate of 5
mL/min and fraction volume of 18 mL for each) to afford pfameric acid (48, between 530 to 756
mL, 4.0 mg). Subfraction 10 (between 1242 to 1502 mL, 0.4268 g) was separated by silica gel
flash chromatography (Biotage Flash 40+M, 100g, column: 4 x 15 cm], 96 fractions were
collected through elution with a gradient of CHCl3-EtOAc-MeOH 1698 mL (1:1:2 to 1:1:8) at
the flow rate of 6 mL/min. Fractions 12-25 (between 72 to 150 mL, 287.2 mg) were subjected to
normal-phase followed by reversed-phase silica gel VLC several times to afford pfaffic acid (47,
6.3 mg) and emsembryanthemoidigenic acid (49, 9.3 mg). Fractions 26-33 (between 156 to 198
mL, 25.6 mg) were further purified by reversed-phase C-18 flash chromatography (Biotage Flash
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12+M, 9g, column: 1.2 x 15 cm) eluting with MeOH-H2O mixtures of increasing polarity (40:60
to 60:40 with elution volume of 2000 mL at a flow rate of 3 mL/min and fraction volume of 15
mL for each) afford pfaffine A (40, between 1638 to 1716 mL, 4.5 mg). Fraction C [CHCl3MeOH-H2O 680:300:50 (0.5 L), 0.4916 g] was subjected to silica gel VLC [500g, column: 4 x
15 cm) eluting with CHCl3-MeOH-H2O (7:2:1, 3 L with fraction volume of 15 mL for each) to
afford four subfractions.

Subfraction I (between 615 to 750 mL, 125.5 mg) was

chromatographied on RP-C18 VLC (10g, column: 3 x 13 cm) eluting with MeOH-H2O [(80:20
(200 mL), 84:16 (100 mL)] and MeOH (50mL)] to afford calenduloside E 6′-methyl ester (50,
between 235 to 250 mL, 2.1 mg). Subfraction II (between 915 to 1110 mL, 103.7 mg) was
subjected to RP-C18 VLC [10g, 3 x 13 cm] eluting with a gradient of MeOH-H2O [74:26 (200
mL), 75:25 (100 mL), 78:22 (200 mL), and MeOH (50 mL)], 86 fractions were collected.
Fractions 56-66 (between 285 to 355 mL, 13.7mg) were purified by preparative HPLC with a
gradient of MeOH-H2O as eluting solvent (60:40 to 90:10) at the flow rate of 2 min/mL to obtain
pfaffine B (41, 4.0mg). Fraction 81-86 (between 435 to 450 mL, 10.2 mg) was purified by
crystallization from MeOH to give oleanolic acid 28-O-β-D-glucopyranoside (51, 4.8 mg).
Subfraction III (between 1305 to 1525 mL, 99.2mg) was subjected to NP- as well as RP-C18
silica gel flash chromatography to give rapisterone (7, 2.0 mg). Subfraction IV (between 1635 to
1740 mL, 103.1 mg) afforded ptersterone (6, 13 mg) and (+)-angelicoidenol-2-O-β-Dglucopyranoside (52, 2.9 mg) after repeated NP- and RP-C18 flash chromatographies. Fraction
D [CHCl3-MeOH-H2O 680:300:50 (between 500 to 1000 mL), 0.7686 g] was chromatographied
on RP-C18 VLC (140g, column: 6 x 30 cm) eluting with a gradient of MeOH-H2O [5:95 (200
mL), 15:85 (200 mL), 20:80 (200 mL), 30:70 (mL), 40:60 (200 mL), 40:40 (200 mL), 20:80 (200
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mL), and MeOH (200 mL)] to afford ecdysone [43, MeOH-H2O 15:85 (200 mL), 100.3 mg] and
20-hydroxyecdysone [45, MeOH-H2O 30:70 (200 mL), 286.2 mg], respectively. Fraction F
[CHCl3-MeOH-H2O 680:300:50 (between 1000 to 2000 mL), 0.9636 g] was chromatographied
on RP-C18 VLC (140g, column: 6 x 30 cm) eluting with a gradient of MeOH-H2O [10:90 (200
mL), 20:80 (200 mL), 30:70 (mL), 40:60 (200 mL), 40:40 (200 mL), 20:80 (200 mL), and
MeOH (200 mL)]. Four fractions were obtained. Subfraction VI was applied to Sephadex LH20 eluting with MeOH to obtain two yellow pigments iresinoside A (54, 6.2 mg) and pfaffine C
(42, 5.4 mg).
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Pfaffia paniculata
2.4 Kg
MeOH, 8 L
residue

MeOH ext.
ANJ-35
437 g
solvent partition

hexane portion
ANJ-3-36-1
3.8186 g

n-butanol portion
ANJ-3-36-3
72.1 g

CHCl3 portion
ANJ-3-36-2
7.5411 g

silica gel VLC
CHCl3
CHCl3:MeOH:H2O
ANJ-3-39-1-6

ANJ-3-39-7-8
2.5432 g

ANJ-3-39-10

ANJ-3-39-9

RP 18-silica gel

ANJ-3-39-11-14

NP-VLC
CHCl3:MeOH:H2O

ANJ-3-46-7 ANJ-3-46-8 & 9
0.1233 g
0.4145 g

ANJ-3-39-15

RP-C18 VLC
MeOH:H2O

ANJ-3-46-10
ANJ-3-85-7 ANJ-3-85-1-4
0.4628 g
ANJ-4-13-3

sil-gel
sil-gel, CHCL3:MeOH
DCM"MeOH or RP-C18, MeOH:H2O
CHCl3:MeOH
sil-gel, CHCl3:MeOH
RP-C18, MeOH:H2O

sil-gel, CHCl3:MeOH
RP-C18 VLC RP-C18, MeOH:H2O
MeOH:H2O

compound 48
compound 41, 45, 46, 47, 50,51, 52
compound 40, 47, 49

silica gel repeatedly
CHCL3:EtOAC:MeOH or
CHCl3:MeOH

JL-6-95-1
JL-6-88-4
sephadex LH-20, MeOH
sil-gel, CHCL3:MeOH

compound 53
ANJ-3-67-1-3

ANJ-3-67-4

RP-C18 VLC
MeOH:H2O

JL-6-63-6

ANJ-4-13-4

ANJ-3-67-7-11

compound 42, 54
JL-6-77-3

sil-gel, CHCL3:MeOH sil-gel, CHCL3:MeOH
HPLC, MeOH:H2O

compound 43, 44

JL-6-93-1
JL-6-94-4

Chart 7-1. Scheme for isolation of chemical constituents from Pfaffia paniculata
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Pfaffine A (40): white powder; [α]25D + 11.3 (c 0.1, MeOH); IR νmax = 3357 (OH), 2937,
1650 (C=O), 1443, 1031 cm-1; 1H- (600 Hz) and 13C- NMR (150 Hz) data, see Table 7-1; HRESI-MS: m/z = 455.31863 [M-H]- (calcd. for 455.31614).
Pfaffine B (41): white powder; [α]25D + 8.7 (c 0.46, MeOH); IR νmax = 3356 (OH), 2928,
1731 cm-1 (C=O), 1380, 1027; 1H- (600 Hz) and

13

C- NMR (150 Hz) data, see Table 7-2; HR-

ESI-MS: m/z =625.37055 [M + Na]+ (calcd. for 625.37109).
Pfaffine C (42): yellow powder; [α]25D - 67.3 (c 0.1, MeOH); UV (MeOH) λmax (log ε)
275 (0.72), 380 (1.21) nm; IR νmax = 3284 (OH), 2923, 1672 (C=O), 1602 (aromatic –C=C–);
1531, 1514, 1259, 1163, 1060, 1019, 831 cm-1; 1H- (600 Hz) and 13C- NMR (150 Hz) data, see
Table 7-3 and 7-4, respectively; HR-ESI-MS: m/z = 469.3183 [M-H]- (calcd. for 469.3151).
A solution (3.0 mg) of compound 41 in 1N HCl (1.5 mL) was stirred at 80 C for 4 h.
After cooling, the solution was neutralized with NH4OH and partitioned between EtOAc (2 mL)
and H2O (2 mL). The aqueous layer after drying was dissolved in pyridine (0.3 mL) and 0.1 M
L-cysteine methyl ester hydrochloride in pyridine (1.0 mL) was added. The mixture was heated
at 60 C for 1h and an equal volume of Ac2O was added and heated one more hour. The
acetylated thiazolidine derivatives were analyzed by GC using a capillary column DB-5 ms (30
m x 0.25 mm x 0.25 µm). Temperatures of injector and detector were 250 C for both. A
temperature gradient system was used starting at 100 C for 1 min and increasing to 250 C at a
rate of 10 C/min. D-glucose was identified by comparison of its retention time (tR 22.21 min)
with that of authentic sample after being treated in the same manner.
7.3. Results and discussion
Structural elucidation of compounds
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Compound 40 was obtained as a white powder, [α]D +11.3 (c 0.1, MeOH). Its molecular
formula C29H44O4 was deduced from the negative-ion high-resolution electrospray ionization
mass spectrum (HR-ESI-TOF-MS), showing a pseudomolecular ion [M-H]- at m/z 455.3186
(calcd. for 455.3161), together with
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C NMR spectrum (29 carbon signals). Its IR spectrum

exhibited absorption bands due to free hydroxy (3357 cm-1), carbonyl groups (1650 cm-1). The
1

H NMR spectrum of 40 displayed five singlet resonances for tertiary methyl groups at δH 1.36,

1.27, 1.06, 1.06, and 0.92, two singlets at δH 4.81 and 4.77 assigned to an exomethylene group,
two oxymethine protons at δH 3.48 and 4.66, and an olefinic proton at δH 5.52 (brd) (shown in
Table 7-1 and Figure 7-3). The
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C NMR spectrum showed 29 carbon signals including five

methyls, ten methylenes, six (two of which are oxygenated) methines, and eight quaternary
carbons (shown in Figure 7-4 and 7-5). The two signals at δ 122.3 and 144.4 ascribable to C-12
and C-13 suggested a ∆12 oleanene skeleton (Mahato et al., 1994). On the basis of the 1H-1H
COSY (shown in Figure 7-6), HMQC (shown in Figure 7-7), DEPT ( shown in Figure 7-5)
spectra, and molecular formula C29H44O4, compound 40 was suggested to be noroleanic acid type
triterpene. The 20(29)-exomethylene group was ascertained by long-range correlations between
H-19α, β (δH = 2.75, 2.29) /C-20 (δC = 150.1), H-19α, β /C-29 (δC = 106.6), H-21α (δH = 2.60) /C20,29, H-29a, b (δH = 4.81, 4.77)/C-19 (δC = 42.3), H-29a, b /C-21 in the HMBC spectrum of 40
(Figure 7-8). The positions of the two hydroxy groups were established on the basis of the
HMBC and nuclear overhauser effect spectroscopy (NOESY) experiments.

The HMBC

spectrum of 40 (shown in Figure 7-8) showed correlations between the oxymethine proton at δH
= 3.48 and the carbons C-4 (δC = 39.5), C-23 (δC = 28.9), and C-24 (δC = 16.7), conforming the
location of one hydroxy group at C-3. The 3β-OH equatorial orientation was established using
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H-3 α coupling constant (Jtrans = 10.8 Hz) and the correlation observed in the NOESY spectrum
(shown in Figure 7-9), between the two axial protons H-3α (δH = 3.48) and H-5 (δH = 0.89).
Furthermore, the HMBC spectrum exhibited correlations between the second oxymethine proton
at δH = 4.66 and the carbons C-17 (δC = 50.8), C-22 (δC = 33.9), and C-28 (δC = 183.0). These
data suggested the second hydroxy group to be located at C-16. The NOESY spectrum displayed
important correlations between the proton H-16 (δH = 4.66) and the methyl protons CH3-27 (δH =
1.36), H-19 α (δH = 2.75), and H-21 α (δH = 2.60), suggesting α-axial orientation of the proton H16. Therefore, the structure of compound 40 was established as 3β, 16β-dihydroxy-30-norolean12, 20(29)-dien-28-oic acid, for which the name pfaffine A was adopted.
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Table 7-1. NMR Data of Compound 40 in Pyridine-d5
No.
1α
1β
2
3
4
5
6α
6β
7α
7β
8
9
10
11
12
13
14
15α
15β
16
17
18
19α
19β
20
21α
21β
22α
22β
23
24
25
26
27
28
29a
29b

1

H [δ (ppm), mult.,
J (Hz)]
1.02 (1H, m)
1.57 (1H, m)
1.82 (2H, m)
3.48 (1H, dd, 10.8, 3.6)
0.89 (1H, brd, 10.8)
1.60 (1H, m)
1.39 (1H, m)
1.57 (1H)
1.40 (1H)
1.65 (1H, dd, 10.2, 7.2)
1.90 (1H, m)
5.52 (1H, brd)

1.81 (1H, m)
2.44 (1H, t, 12.0)
4.66 (1H, dd, 11.4, 4.2)
3.53 (1H, dd,13.8, 4.8)
2.75 (1H, t, 13.8)
2.29 (1H, dd 13.8, 4.8)
2.60 (1H, brt, 13.8)
2.28 (1H, brd, 16.2)
3.08 (1H, d 12.0)
1.81 (1H, m)
1.27 (3H, s)
1.06 (3H, s)
0.92 (3H, s)
1.06 (3H, s)
1.36 (3H, s)
4.81 (1H, s)
4.77 (1H, s)

13

C
[δ (ppm)]
39.0
28.2
78.1
39.5
55.9
18.9

COSY

HMBC

H-2
H-2
H-1α, β, 3
H-2

C-4, 23, 24

H-6α, 6β
H-5, 6β
H-5, 6α

C-3, 4, 6, 7, 9, 10, 23, 24, 25

H-11

C-5, 8, 10, 11, 14, 25, 26

H-9, 12
H-11

C-9
C-9, 11, 14, 18

H-16, 15β
H-16, 15α
15α, β

C-14, 16, 17, 27
C-14, 16, 17, 27
C-17, 22, 28

H-19α, β
H-18, 19β
H-18, 19α

C-12, 13, 14, 16, 17, 19, 28
C-17, 20, 29
C-17, 20, 21, 29

H-21β, 22α, β
H-21α, 22α, β
H-21α, β, 22β
H-21α, β, 22α

C-20, 22, 29

33.5
39.8
47.4
37.4
23.9
122.3
144.4
44.6
38.9
65.5
50.8
50.3
42.3
150.1
30.7
33.9
28.9
16.7
15.7
17.8
27.0
183.0
106.6

C-5
C-5, 8
C-5

C-17, 20, 21
C-17, 20
C-3, 4, 5
C-3, 4, 5
C-1, 5, 9, 10
C-7, 9, 14
C-8, 14, 15
C-19, 20, 21
C-19, 20, 21

143

H 29 H
H

H
20
H

18

12

25

28
COOH

16

3

HO
H

OH

9

1

H

H

5
H

Figure 7-2. Key HMBC and NOE correlations for compound 40.
Green line indicates HMBC and red line shows NOE correlations

Figure 7-3. 1H-NMR spectrum of compound 40 in pyridine-d5
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Figure 7-4. 13C-NMR spectrum of compound 40 in pyridine-d5

Figure 7-5. DEPT spectrum of compound 40 in pyridine-d5
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Figure 7-6. 1H-1H COSY spectrum of compound 40 in pyridine-d5

Figure 7-7. HSQC spectrum of compound 40 in pyridine-d5
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Figure 7-8. HMBC spectrum of compound 40 in pyridine-d5

Figure 7-9. ROESY spectrum of compound 40 in pyridine-d5
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Compound 41 was obtained as a white powder, [α]D + 8.7 (c 0.46, MeOH). The positive
HR-ESI-MS of compound 41 gave an [M + Na]+ ion at m/z 625.37055 consistent with the
pseudomolecular formula C35H54O8Na (calcd. for [M+Na]+ 625.37109).
displayed 35 carbon resonances in its
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Compound 41

C NMR spectrum (see Figure 7-11), of which 29 were

assigned to a noroleanic acid type triterpene moiety and 6 to a monosaccharide portion. For the
aglycon portion, along with five methyl resonances (δC = 28.9, 26.1, 17.6, 16.6, 15.7), four sp2hybridized carbon signals (δC = 123.4, 143.5, 107.4, 148.6), and one signal for hydroxymethine
group (δC = 78.7) could be observed (shown in Figure 7-12). These data, when correlated with
data from 1H NMR spectrum (shown in Figure 7-10) [five methyl singlets at δH = 1.26, 1.24,
1.13, 1.05, 0.93, one olefinic proton at δH = 5.48, and one oxymethine at δH = 3.46], confirmed
that the aglycon of 41 possessed a noroleanic acid type triterpene skeleton. A detailed analysis
of the NMR spectroscopic data (1H, 13C, HSQC, and H-H COSY) of the aglycon moiety of 41 in
comparison with those of 40 showed that the difference of 41 from 40 is only for the absence of
the secondary alcoholic function at C-16. The 1H NMR spectrum for the sugar portion of
compound 41 showed one anomeric proton signal at δH = 6.31 ( 1H, d, J=8.4 Hz). The chemical
shifts of all the individual protons and carbons of the sugar unit were assigned on the basis of
COSY (see Figure 7-13) and HSQC (see Figure 7-14) spectral analysis.

The sugar unit,

identified as β-glucopyranosyl which was deduced from its 3JH-1,H-2 coupling constant of 8.4
(Woldemichael et al., 2001), was placed at C-28 of the aglycon on the basis of the HMBC
correlation (shown in Figure 7-15) between the anomeric proton at δH = 6.31 and the C-28
carbon resonance at δC = 175.8. The configuration of the glucose unit was established as D after
acid hydrolysis of 41 followed by derivatization and GC analysis (Hara et al., 1987) (see
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Experimental section). Thus the structure of compound 41 was deduced as 3β-hydroxy-30norolean-12,20(29)-dien-28-oic acid-28-O-β-D-glucoside based on the above evidence and was
given the trivial name pfaffine B.

Table 7-2. NMR Data of Compound 41 in Pridine-d5
1

No.

H [δ (ppm),
mult., J (Hz)]

1α
1β
2α
2β
3

1.00 (1H, dt)
1.56 (1H, m)
1.84 (1H, m)
1.84 (1H, m)
3.46 (1H, brd,
7.2)

4
5
6α
6β
7α
7β
8
9
10
11
12
13
14
15α
15β
16α
16β
17
18
19α
19β
20

0.87 (1H, d,
11.4)
1.55(1H, m)
1.37 (1H, m)
1.50 (1H, brd
14.4)
1.37 (1H, m)

13

C
[δ
(ppm)]
39.1
28.3

1.92 (2H, m)
5.48 (1H, brd)

1.22 (1H)
2.38 (1H, dt)
2.20 (1H, dt)
2.09 (1H, m)
3.16 (1H, dd,
13.8, 4.8)
2.63 (1H, t,
13.8)
2.23 (1H, m)

COSY

NOSEY

H-1β, 2
H-1α
H-1, 3

H-3
H-3

78.2

H-23, 24

H-2

H-1α, 2α, 5, 23

39.5
55.9

H-23, 24
H-23, 24, 25

H-6β

H-1α, 3, 23, 9, 6α, 7α

18.9

H-5

33.2

H-26

H-6β
H-5, 6α
H-7β

H-5, 23
H-26, 24, 25
H-5, 27, 9

H-7α

47.8
37.4
23.9
123.4
143.5
42.2
28.2

H-6α, 7β, 9, 26,
27
H-25, 26
H-5, 9, 25
H-9
H-11, 18
H-11, 18, 27
H-15β, 26, 27
H-27

23.7

H-18, 22β

47.4
48.2

H-18, 22β, 19β

41.8

H-18, 29α, β

40.0
1.66 (1H, t, 8.7)

HMBC

148.6

H-19α, 19β, 21β
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H-11

H-1α, 5, 7α, 11, 27

H-9, 12
H-11

H-11, 18, 19β

H-15β
H-15α, 16α
H-15β, 16α
H-16α

H-26, 16β
H-27
H-15β

H-19α, β

H-19β, 22β

H-18, 19β

H-27

H-18, 19α

H-12, 29α

21α

2.23 (1H, m)

21β
22α
22β
23
24
25
26
27
28
29a
29b
1′

2.07 (1H, m)
2.03 (1H, m)
1.71 (1H, dt)
1.26 (3H, s)
1.05 (3H, s)
0.93 (3H, s)
1.13 (3H, s)
1.24 (3H, s)

2′
3′
4′
5′
6′α
6′β
3-OH

4.78 (1H, s)
4.71 (1H, s)
6.31 (1H, d,
8.4)
4.21 (1H, t, 8.4)
4.29 (1H, t, 9.0)
4.35 (1H, t, 9.0)
4.03 (1H, brd,
9.0)
4.40 (1H, dd,
11.4, 3.6)
4.47 (1H, brd,
10.2)
5.75

30.2

37.7

H-19β, 22β, 29α,
β
H-21α, 16β

28.9
16.6
15.7
17.6
26.1
175.8
107.4

H-3, 5, 24
H-3, 5, 23,
H-5, 9
H-9
H-15β
H-18, 22β, 1′
H-19α, 21α

95.9

H-2′

74.2
78.9
71.2
79.4

H-2′

62.4

C-2, 3, 4
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H-21β, 22β
H-21α
H-22β
H-21α, 22α

H-2′

H-18
H-5, 24, 6α
H-25, 23
H-24, 26
H-24, 6β, 15β
H-9, 7α, 16α, 19α
H-19β
H-21β, α
H-5′, 3′

H-1′, 3′
H-2′, 4′
H-3′, 5′
H-4′, 6′ α,
β
H-5′, 6′ β

H-4′
H-1′, 5′
H-2′
H-1′, 3′, 6′ α, β

H-5′, 6′ β

H-5′

H-5′

Figure 7-10. 1H-NMR spectrum of compound 41 in pyridine-d5

Figure 7-11. 13C-NMR spectrum of compound 41 in pyridine-d5
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Figure 7-12. DEPT spectrum of compound 41 in pyridine-d5

Figure 7-13. 1H-1H COSY spectrum of compound 41 in pyridine-d5
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Figure 7-14. HSQC spectrum of compound 41 in pyridine-d5

Figure 7-15. HMBC spectrum of compound 41 in pyridine-d5
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Figure 7-16. ROESY spectrum of compound 41 in pyridine-d5
Compound 42 was obtained as a yellow powder. Its molecular formula was determined
to be C29H30O12 by the negative-ion HRMS, showing a pseudomolecular ion [M-H]- at m/z
469.3183 (calcd. for 469.3151).

The IR spectrum exhibited absorption bands due to free

hydroxy (3284 cm-1), carbonyl groups (1672 cm-1), and aromatic ring system (1602 cm-1). The
characteristic UV absorption at λ 275 and 380 nm suggested the existence of a α，β-unsaturated
α-pyrone ring (Scott, 1964). The 1H and 13C NMR spectra (see Figure 7-18 and 7-19) exhibited
two sets of signals in a ratio of ca 3:2, indicating that compound 42 is a mixture of two
components.

Further purification using preparative RP-HPLC resulted in obtaining two

compounds. On the re-examination of each elute after removal of the solvent, two peaks were
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again detected. These results suggested that compound 42 is consisted of two interchangeable
isomers (shown in Figure 7-17). Two sets of AB olefinic signals at 6.58 (1H, d, J=16.2 Hz)/7.29
(1H, d, J=16.2 Hz) (major) and 5.92 (1H, d, J=12.3 Hz)/6.68 (1H, d, J=12.3 Hz) (minor) were
assigned to trans and cis double bonds, indicating that compound 42 was a mixture of trans and
cis isomers. Two p-substituted phenyl groups were suggested for each component by four sets of
A2B2 quartets in 1H NMR spectrum, e.g. 7.34 (1H, d, J=9.0 Hz)/6.64 (1H, d, J=9.0 Hz) and 7.25
(1H, d, J=9.0 Hz)/6.64 (1H, d, J=9.0 Hz) for the major component, and 7.25 (1H, d, J=8.4
Hz)/6.68 (1H, d, J=8.4 Hz) and 7.22 (1H, d, J=8.4 Hz)/6.63 (1H, d, J=8.4 Hz) for the minor one.
A CH3OOCCH2CH- unit for each component was deduced from the correlation of H-9 at δH =
4.80/4.77 ppm (major/minor) and H2-10 at δH = 3.25/3.20 ppm (major/minor) in COSY spectrum
(see Figure 7-20), and the HMBC (see Figure 7-22) correlations of C-11 at δC = 175.14/175.05
ppm (major/minor) with H-10 and methyl protons at δH = 3.60/3.59 ppm (major/minor). A
glucose moiety was readily identified by the 1H and 13C NMR data listed in Table 7-3 and 7-4.
The β-configuration of this glucose was determined by the large coupling constant (J=7.8 Hz) of
the anomeric proton and the chemical shift of the anomeric carbon at δC = 100.98/101.26 ppm
(major/minor). There are five pairs of carbon at δC = 165.83/165.72 (C-2), 109.85/110.83 (C-3),
166.92/166.25 (C-4), 98.82/100.12 (C-5), 160.97/160.44 (C-6) ppm (major/minor) and one pair
of proton at δH = 6.47/6.58 (H-5) (major/minor) remained in the carbon and proton NMR
respectively. These signals and the HMBC correlations between H-5 and C-3,4,6 suggested a
tri-substituted pyran-2-one unit. The HMBC correlations (shown in Figure 7-23) of H-9/C-2,3,5
and H-7/C-5,6 confirmed the pyran-2-one ring and established the connections of C-9 to C-3 and
C-7 to C-6. The HMBC correlations of H-9/C-1′′,2′′,6′′ and H-2′′,6′′/C-9 indicated C-1′′ of one
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of the phenyls connected to C-9. The connection of another phenyl group to C-8 was established
by the HMBC correlations of H-8/C1′,2′,6′ and H-2′,6′/C-8. The glucose moiety was determined
to connect to C-5 by the HMBC correlation of the anomeric proton and C-5. The 1H and

13

C

NMR data of compound 42a are similar to those of compound 54 which was firstly reported
from P. iresinoides (Shiobara et al, 1992), except that of the carboxylic group in 54 was
esterified by a methyl group in 42a (see Table 7-3 and 7-4). Thus, the structure of compound 42
was determined as depicted. The absolute configuration of C-9 needs to be determined.

OH

OH
HO
HO

E

OH
O

HO
O
H

O
O

HO

Z-E isomerization
OH

aqueous MeOH

HO

Z

O
H

O
O

COOCH3
OH

Figure 7-17. Z-E isomerization of compound 42 in aqueous MeOH
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OH
O
OH

COOCH3

Figure 7-18. 1H-NMR spectrum of compound 42 in MeOH-d4

Figure 7-19. 13C-NMR spectrum of compound 42 in MeOH-d4
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Figure 7-20. 1H-1H COSY spectrum of compound 42 in MeOH-d4

Figure 7-21. HSQC spectrum of compound 42 in MeOH-d4
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Figure 7-22. HMBC spectrum of compound 42 in MeOH-d4
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Figure 7-23. Key HMBC correlations of compound 42a
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Table 7-3. 1H-NMR Data of Compound 42a and 42b [δ (ppm), mult., J (Hz)]
No.

compound 42a

compound 42b

compound 54

4

6.47 (1H, s)

6.58 (1H, s)

6.51 (1H, s)

7

6.59 (1H, d, 16.2)

5.93 (1H, d, 12.3)

6.66 (1H, d, 16.2)

8

7.31 (1H, d, 16.2)

6.76 (1H, d, 12.3)

7.29 (1H, d, 16.2)

9

4.80 (1H, m)

4.77 (1H, m)

4.84 (1H, m)

10

3.25 (2H, m)

3.20 (2H, m)

3.00 (2H, brd, 7.8)

11-Me

3.60 (3H, s)

3.59 (1H, s)

2′, 6′

7.34 (1H, d, 9.0 for each)

7.25 (1H, d, 8.4 for each)

7.41 (1H, d, 9.0 for each)

3′, 5′

6.69 (1H, d, 9.0 for each)

6.68 (1H, d, 8.4 for each)

6.78 (1H, d, 9.0 for each)

2′′, 6′′

7.25 (1H, d, 9.0 for each)

7.22 (1H, d, 8.4 for each)

7.28 (1H, d, 9.0 for each)

3′′, 5′′

6.64 (1H, d, 9.0 for each)

6.63 (1H, d, 8.4 for each)

6.64 (1H, d, 9.0 for each)

Glc-1

5.11 (1H, d, 7.8)

4.80 (1H, d, 7.8)

5.01 (1H, d, 7.8)

Glc-2

3.54 (1H, m)

3.48 (1H, m)

3.63 (1H, t, 8.4)

Glc-3

3.45 (1H, m)

3.45 (1H, m)

3.51 (1H, t, 9.0)

Glc-4

3.35 (1H, m)

3.35 (1H, m)

3.40 (1H, t, 9.0)

Glc-5

3.51 (1H, m)

3.51 (1H, m)

3.54 (1H, m)

Glc-6

3.69 (1H, dd, 12.0, 6.3)

3.69 (1H, dd, 12.0, 6.3)

3.69 (1H, dd, 12.3, 6.3)

3.92 (1H, dd, 12.0, 2.1)

3.92 (1H, dd, 12.0, 2.1)

3.93 (1H, dd, 12.3, 2.1)
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Table 7-4. 13C-NMR Data of Compound 42a and 42b [δ (ppm)]
No.

compound 42a

compound 42b

compound 54

2

165.83

165.72

166.6

3

109.85

110.83

110.6

4

98.28

100.12

99.4

5

166.92

166.25

166.6

6

160.97

160.44

159.9

7

115.46

118.36

117.5

8

137.3

139.6

138.1

9

37.04

37.01

39.0

10

37.28

37.14

41.9

11

175.14

175.05

181.1

11-Me

52.15

52.13

1′

126.1*

126.2*

128.6

2′, 6′

130.48

132.10

130.4

3′, 5′

118.18

117.66

116.9

4′

164.4*

162.8*

160.4

1′′

133.91

133.68

135.7

2′′, 6′′

129.97

130.00

130.3

3′′, 5′′

115.84

115.85

115.8

4′′

157.05

157.10

156.6

Glc-1

100.98

101.26

101.6

2

74.71

74.64

74.8

3

78.20

78.22

78.2

4

71.22

70.69

71.4

5

78.62

78.30

78.7

6

62.48

61.87

62.7

*: Signals exchangeable
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The behavior of compound 42 on HPLC can be explained by a trans-cis isomerization to
afford a equilibrium of mixture in aqueous MeOH, by which a similar reaction was reported to
occur for yangonin , that is, 6-(p-methoxystyryl)-4-methoxy-2-pyrone (Smith et al, 1984). In the
present study, compound 54 was purified as a single E-isomer using preparative normal-phase
TLC and organic solvents.

Since compound 42 and several related compounds were not

resolved on normal-phase TLC, the fraction containing compound 42 and others was then
subjected to HPLC separation using a Phenomenex prodigy 5μ ODS column and gradient elution
of methanol-water. The peak at tR=7.2 min was collected and when examined by HPLC this
peak gave two peaks. Attempts to obtain the individual compounds were unsuccessful because
each compound apparently re-equilibrated to give the mixture after separation was carried out
again.

In order to confirm the proposed isomerization behavior of compound 42 NMR

techniques were applied. Compound 54 was prepared in MeOH-d4 for NMR analysis. After one
day standing in daylight the compound was stable and the NMR spectrum kept the same (shown
in Figure 7-24). When one drop of deuterium oxide was added into the solution, two sets of
signals were detected after 20 min.

The signals at δH = 6.76 and 5.93 ppm (J=12.3)

corresponding to a cis-double bond became more and more intense with the time increased.
After 20 hrs two sets of signals were at the ratio of ca. 1:1. Therefore, it can be concluded that
trans-cis isomerization occurred in aqueous solution but in organic solvents such as chloroform
and methanol virtually no change occurred.
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MeOH, 1d

MeOH+D2O, 20min

MeOH+D2O, 2h

MeOH+D2O, 20h

Figure 7-24. Z-E isomerization test of compound 54 in aqueous MeOH
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7.4. Conclusion
In the present study, four types of compounds, including seven triterpenoids, four
steroids, one monoterpenoid, two pigments and vanillic acid, have been isolated from the roots
of P. paniculata. The compounds reported herein will be served as markers for quantification of
raw material as well as preparations claiming to contain P. paniculata. Also, efforts have been
made to investigate the isomerization of pigments.
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Chapter 8
Concluding Remarks
American skullcap has been used more than three decades for its reputed tonic,
tranquilizing, and antispasmodic remedies. Currently it is one of the most popular botanicals
with many products on the USA market. The hepatotoxic reactions have been reported after
skullcap-containing preparations were ingested. Meanwhile, it was reported to be adulterated
with germander, e.g. Teucrium chamaedry, and T. canadense, which is a group of plants with
hepatotoxicity. Due to the lack of stringent regulations from FDA there is a paucity of scientific
evidence to evaluate the safety, quality, and efficacy of these products. Therefore, safety,
efficacy, and quality control of the products claiming to contain this species are of major
concern. Among them control quality of skullcap products presents a formidable analytical
challenge in view of lack of information about the authenticity of raw materials, complexity of
the constituents in the plant materials, and unavailability of qualified reference standards. In this
dissertation, investigation of the chemical constituents, development of analytical method for
quality control, and evaluation of biological activities of the raw materials as well as the
compounds isolated from it have been carried out.
8.1. Contributions of this dissertation
Chromatographic separation of the MeOH extract of the aerial parts of American skullcap
resulted in the isolation of sixteen compounds, including three minor coumarins of which two are
new compounds, six flavonoids, four triterpenes, two steroids, and one fatty acid. The structures
of all the compounds were elucidated via spectroscopic (NMR, UV, and FT-IR) and
spectrometric (HRESI-MS) methods. The absolute configuration of two new coumarins was
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determined by comparison of the experimental and theoretical calculated CD spectra. As a part
of our efforts in phytochemical study HPLC-DAD/ESI-MSn method has been developed to
characterize thirteen flavonoids and one stilbene derivative without time-consuming isolation of
compounds. The ESI-MSn fragmentation pathways of four types of flavonoid standards have
been examined and analyzed. These fragmentation patterns provide very useful guides for the
characterization of different types of flavonoids. Based on the results we obtained it can be
concluded that flavonoids are the major constituents in the American skullcap, some of which
are also reported from other species in this genus, such as S. baicalensis. In order to compare
and obtain more marker compounds, the chemical components of S. baicalensis, which is the
most often used herb medicine in this genus, were also studied and seventeen flavonoids have
been isolated.
Using eleven major flavonoids isolated from S. baicalensis as well as S. lateriflora as
chemical markers a simple HPLC-PDA fingerprinting method has been established. In present
study, two phenylpropanoids, verbascoside and teucrioside, and one diterpene, teucrin A isolated
from T. canadense were also used as markers to provide comparative analysis. The results
indicated that this method can be applied to authenticate S. lateriflora, to distinguish it from its
potential adulterants, to compare the chemical profiles of different species in this genus, and to
assess the quality of the products claiming to contain S. lateriflora. Since the UV patterns are
different and specific for each type of compounds investigated, analysis of UV spectra of the
known markers and relevant peaks in samples is quite valuable for the identification of each
peak.
Another major contribution of this dissertation is to put the two skullcap extracts and
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thirteen flavonoids isolated from them into one study to evaluate their bioactivities on a panel of
bioassay. Neither extracts of SBE and SLE nor pure compounds tested showed cytotoxicity
against a panel of mammalian normal and solid tumor cell lines at the highest test concentrations,
suggesting that the reports of hepatotoxic reactions on American skullcap might not due to
skullcap itself but its adulterant germander. Significant antioxidant activity was observed for
both skullcap extracts as well as their components, such as baicalein, baicalin, wogonin,
quercetin, rutin, and hesperidin.

The antioxidant activity of American skullcap was first

observed in present study and it is stronger than Chinese skullcap. Naringenin and daidzein
showed strong estrogenic effects in the YES assay. Moderate anti-inflammatoy activity was
observed with wogonin and chrysin on NF-κB mediated transcription test. The most significant
finding was the identification of PPARs activation of skullcap extracts as well as their
characteristic components, including baicalein, baicalin, wogonin, and chrysin, etc. Results of
our study provide useful information on possible new application of skullcap, especially
American skullcap, for the treatment of diabetic-related diseases. In addition, the capability of
pure flavonoids on PPARs suggests their potential to become leads of PPARα and PPARγ
agonists.
Pfaffia paniculata is another species studied in this dissertation. It is the most employed
species in commercial preparations in Brazil as “Brazilian ginseng” and has been commonly
used for three centuries as the same indications as American and Asian ginseng. However, all
these so-called ginsengs belong to different species even different family. More than fifty
preparations which contain or are produced from P. paniculata are available on USA market, but
no analytical method existed to identify P. paniculata raw materials, and its products. As a final
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remark we investigated the chemical components of P. paniculata and obtained four types of
compounds, including seven triterpenoids, four steroids, one monoterpenoid, two yellow
compounds and vanillic acid, among which two triterpenoids pfaffine A and B, and one yellow
compound pfaffine C are new. All fourteen compounds except ecdysone are reported for the
first time from this plant.

The compounds reported herein will be served as markers for

quantification of raw material as well as preparations claiming to contain P. paniculata. From
the NMR-based stability study of pigment iresinoside A, it can be concluded that trans-cis
isomerization of this type of compound occurred in aqueous solution but in organic solvents such
as chloroform and methanol virtually no change occurred.
8.2. Future work
The characteristic components isolated from both of skullcap species, including baicalein,
baicalin, wogonin, and chrysin, etc. showed significant PPARs activation effect. The mechanism
of action will be studied using isolated individual compounds. Meanwhile, structure–activity
relationships of potential PPARα and PPARγ agonists screened in this study will be carried out
using molecular modeling. The evaluation of structure–activity relationships would help in
identifying the key structural features of the ligand molecules for activation of each subtype of
the PPAR, which in turn, will assist us in design and discovery of more safe and effective
agonists.
NMR-based metabolomics analysis has been applied to a wide array of fields, such as on
the identification of disease biomarkers and investigation of microbial fermentation processes
and biotransformations, etc. Studying plant metabolomics is particularly challenging due to the
occurrence of substantially more and complex compounds compared with animals and
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microorganisms and still in its infancy.

Some pioneer applications to plant metabolomics

analysis have been presented recently, mostly concentrating on the impact of environmental
factors on plants.

We will try to use NMR-based metabolomics analysis to differentiate

American skullcap from its potential adulterant and to assess the quality of its products. This
method may complement the HPLC-PDA fingerprint method discussed in this dissertation from
different points of view.
In order to evaluate and control the quality of the products produced from P. paniculata
quantitative analysis method will be set up. Primary analysis result indicated that the content of
ecdysones in P. paniculata is overwhelming. HPLC-PDA or HPLC-MS method will be applied
to quantitatively analyze ecdysones using ecdysone and 20-hydroxyecdysone obtained in this
dissertation as markers.
8.3. Related publications
The publications listed below are direct consequence of the evolution of this dissertation during
my Ph. D. program.
[1] Li, J.; Wang, Y.H.; Smillie, T.; Khan, I.A. Identification of Phenolic Compounds in
Scutellaria lateriflora Using High-Performance Liquid Chromatography-Electrospray Tandem
Mass Spectrometry-Ultraviolet Photodiode Array. in preparation
[2] Li, J.; Wang, Y.H.; Khan, I.A. Chemical Fingerprint Analysis of Scutellaria Species,
Germander and Dietary Supplements Claiming to Contain Skullcap Using HPLC-PDA. in
preparation.
[3] Li, J.; Jadhav, A.N.; Khan, I.A. Triterpenoids from Brazilian Ginseng, Pfaffia paniculata.
Planta Medica 2010, 76, 635-639.
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professors in several projects, as a PI, one of my projects entitled “Chemical and Biological
Studies on the Protein Kinase C Inhibitor from Spatholubus suberctus” was granted by National
Scientific Foundation of China (NSF). In 1998 I was promoted to vice chairman of Department
of Biochemistry. The experience of being vice chairman enhanced my ability of management
and organization of research work.
In 1999 I was employed as an imported drug reviewer by the Center for Drug Evaluation,
State Drug Administration (SFDA in China) and promoted to a leader of imported drug team and
vice director of the department of imported drug later. My job was to review CMC parts
(chemistry, manufacturing and quality control) of imported drug applications. During the four
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